{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Pymaceuticals Inc.\n",
    "---\n",
    "\n",
    "### Analysis\n",
    "\n",
    "- Add your analysis here.\n",
    " "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "0        k403     Ramicane  Male          21          16          0   \n",
      "1        k403     Ramicane  Male          21          16          5   \n",
      "2        k403     Ramicane  Male          21          16         10   \n",
      "3        k403     Ramicane  Male          21          16         15   \n",
      "4        k403     Ramicane  Male          21          16         20   \n",
      "...       ...          ...   ...         ...         ...        ...   \n",
      "1888     z969     Naftisol  Male           9          30         25   \n",
      "1889     z969     Naftisol  Male           9          30         30   \n",
      "1890     z969     Naftisol  Male           9          30         35   \n",
      "1891     z969     Naftisol  Male           9          30         40   \n",
      "1892     z969     Naftisol  Male           9          30         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "0              45.000000                 0  \n",
      "1              38.825898                 0  \n",
      "2              35.014271                 1  \n",
      "3              34.223992                 1  \n",
      "4              32.997729                 1  \n",
      "...                  ...               ...  \n",
      "1888           63.145652                 2  \n",
      "1889           65.841013                 3  \n",
      "1890           69.176246                 4  \n",
      "1891           70.314904                 4  \n",
      "1892           73.867845                 4  \n",
      "\n",
      "[1893 rows x 8 columns]\n"
     ]
    }
   ],
   "source": [
    "# Dependencies and Setup\n",
    "import matplotlib.pyplot as plt\n",
    "import pandas as pd\n",
    "import scipy.stats as st\n",
    "\n",
    "# Study data files\n",
    "\n",
    "mouse_data = pd.read_csv(\"data/Mouse_metadata.csv\")\n",
    "study_results = pd.read_csv(\"data/Study_results.csv\")\n",
    "\n",
    "# Merge the datasets into one dataframe based on a common column (in this case, \"Mouse ID\")\n",
    "combined_data = pd.merge(mouse_data, study_results, on=\"Mouse ID\")\n",
    "\n",
    "# Read the mouse data and the study results\n",
    "mouse_metadata = pd.read_csv(mouse_metadata_path)\n",
    "study_results = pd.read_csv(study_results_path)\n",
    "\n",
    "# Display the data table for preview\n",
    "print(combined_data)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of mice: 249\n"
     ]
    }
   ],
   "source": [
    "# Find the number of unique mice\n",
    "num_mice = combined_data[\"Mouse ID\"].nunique()\n",
    "\n",
    "# Print the number of mice\n",
    "print(\"Number of mice:\", num_mice)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Duplicate Mouse IDs: ['g989']\n"
     ]
    }
   ],
   "source": [
    "# Our data should be uniquely identified by Mouse ID and Timepoint\n",
    "# Get the duplicate mice by ID number that shows up for Mouse ID and Timepoint. \n",
    "\n",
    "# Identify duplicate mice by Mouse ID and Timepoint\n",
    "duplicate_mice = combined_data[combined_data.duplicated(subset=[\"Mouse ID\", \"Timepoint\"], keep=False)]\n",
    "\n",
    "# Get the unique Mouse IDs of duplicate rows\n",
    "duplicate_mice_ids = duplicate_mice[\"Mouse ID\"].unique()\n",
    "\n",
    "# Print the Mouse IDs of duplicate rows\n",
    "print(\"Duplicate Mouse IDs:\", duplicate_mice_ids)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Mouse ID</th>\n",
       "      <th>Timepoint</th>\n",
       "      <th>Tumor Volume (mm3)</th>\n",
       "      <th>Metastatic Sites</th>\n",
       "      <th>Drug Regimen</th>\n",
       "      <th>Sex</th>\n",
       "      <th>Age_months</th>\n",
       "      <th>Weight (g)</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>107</th>\n",
       "      <td>g989</td>\n",
       "      <td>0</td>\n",
       "      <td>45.000000</td>\n",
       "      <td>0</td>\n",
       "      <td>Propriva</td>\n",
       "      <td>Female</td>\n",
       "      <td>21</td>\n",
       "      <td>26</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>137</th>\n",
       "      <td>g989</td>\n",
       "      <td>0</td>\n",
       "      <td>45.000000</td>\n",
       "      <td>0</td>\n",
       "      <td>Propriva</td>\n",
       "      <td>Female</td>\n",
       "      <td>21</td>\n",
       "      <td>26</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>329</th>\n",
       "      <td>g989</td>\n",
       "      <td>5</td>\n",
       "      <td>48.786801</td>\n",
       "      <td>0</td>\n",
       "      <td>Propriva</td>\n",
       "      <td>Female</td>\n",
       "      <td>21</td>\n",
       "      <td>26</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>360</th>\n",
       "      <td>g989</td>\n",
       "      <td>5</td>\n",
       "      <td>47.570392</td>\n",
       "      <td>0</td>\n",
       "      <td>Propriva</td>\n",
       "      <td>Female</td>\n",
       "      <td>21</td>\n",
       "      <td>26</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>620</th>\n",
       "      <td>g989</td>\n",
       "      <td>10</td>\n",
       "      <td>51.745156</td>\n",
       "      <td>0</td>\n",
       "      <td>Propriva</td>\n",
       "      <td>Female</td>\n",
       "      <td>21</td>\n",
       "      <td>26</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>681</th>\n",
       "      <td>g989</td>\n",
       "      <td>10</td>\n",
       "      <td>49.880528</td>\n",
       "      <td>0</td>\n",
       "      <td>Propriva</td>\n",
       "      <td>Female</td>\n",
       "      <td>21</td>\n",
       "      <td>26</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>815</th>\n",
       "      <td>g989</td>\n",
       "      <td>15</td>\n",
       "      <td>51.325852</td>\n",
       "      <td>1</td>\n",
       "      <td>Propriva</td>\n",
       "      <td>Female</td>\n",
       "      <td>21</td>\n",
       "      <td>26</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>869</th>\n",
       "      <td>g989</td>\n",
       "      <td>15</td>\n",
       "      <td>53.442020</td>\n",
       "      <td>0</td>\n",
       "      <td>Propriva</td>\n",
       "      <td>Female</td>\n",
       "      <td>21</td>\n",
       "      <td>26</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>950</th>\n",
       "      <td>g989</td>\n",
       "      <td>20</td>\n",
       "      <td>55.326122</td>\n",
       "      <td>1</td>\n",
       "      <td>Propriva</td>\n",
       "      <td>Female</td>\n",
       "      <td>21</td>\n",
       "      <td>26</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1111</th>\n",
       "      <td>g989</td>\n",
       "      <td>20</td>\n",
       "      <td>54.657650</td>\n",
       "      <td>1</td>\n",
       "      <td>Propriva</td>\n",
       "      <td>Female</td>\n",
       "      <td>21</td>\n",
       "      <td>26</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1195</th>\n",
       "      <td>g989</td>\n",
       "      <td>25</td>\n",
       "      <td>56.045564</td>\n",
       "      <td>1</td>\n",
       "      <td>Propriva</td>\n",
       "      <td>Female</td>\n",
       "      <td>21</td>\n",
       "      <td>26</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1380</th>\n",
       "      <td>g989</td>\n",
       "      <td>30</td>\n",
       "      <td>59.082294</td>\n",
       "      <td>1</td>\n",
       "      <td>Propriva</td>\n",
       "      <td>Female</td>\n",
       "      <td>21</td>\n",
       "      <td>26</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1592</th>\n",
       "      <td>g989</td>\n",
       "      <td>35</td>\n",
       "      <td>62.570880</td>\n",
       "      <td>2</td>\n",
       "      <td>Propriva</td>\n",
       "      <td>Female</td>\n",
       "      <td>21</td>\n",
       "      <td>26</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     Mouse ID  Timepoint  Tumor Volume (mm3)  Metastatic Sites Drug Regimen  \\\n",
       "107      g989          0           45.000000                 0     Propriva   \n",
       "137      g989          0           45.000000                 0     Propriva   \n",
       "329      g989          5           48.786801                 0     Propriva   \n",
       "360      g989          5           47.570392                 0     Propriva   \n",
       "620      g989         10           51.745156                 0     Propriva   \n",
       "681      g989         10           49.880528                 0     Propriva   \n",
       "815      g989         15           51.325852                 1     Propriva   \n",
       "869      g989         15           53.442020                 0     Propriva   \n",
       "950      g989         20           55.326122                 1     Propriva   \n",
       "1111     g989         20           54.657650                 1     Propriva   \n",
       "1195     g989         25           56.045564                 1     Propriva   \n",
       "1380     g989         30           59.082294                 1     Propriva   \n",
       "1592     g989         35           62.570880                 2     Propriva   \n",
       "\n",
       "         Sex  Age_months  Weight (g)  \n",
       "107   Female          21          26  \n",
       "137   Female          21          26  \n",
       "329   Female          21          26  \n",
       "360   Female          21          26  \n",
       "620   Female          21          26  \n",
       "681   Female          21          26  \n",
       "815   Female          21          26  \n",
       "869   Female          21          26  \n",
       "950   Female          21          26  \n",
       "1111  Female          21          26  \n",
       "1195  Female          21          26  \n",
       "1380  Female          21          26  \n",
       "1592  Female          21          26  "
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Optional: Get all the data for the duplicate mouse ID. \n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Create a clean DataFrame by dropping the duplicate mouse by its ID.\n",
    "# Filter out rows with Mouse ID 'g989'\n",
    "cleaned_data = combined_data[combined_data['Mouse ID'] != 'g989']\n",
    "\n",
    "# Drop duplicates based on Mouse ID and Timepoint\n",
    "cleaned_data = cleaned_data.drop_duplicates(subset=['Mouse ID', 'Timepoint'], keep='first')\n",
    "\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Original DataFrame:\n",
      "  Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "0     k403     Ramicane  Male          21          16          0   \n",
      "1     k403     Ramicane  Male          21          16          5   \n",
      "2     k403     Ramicane  Male          21          16         10   \n",
      "3     k403     Ramicane  Male          21          16         15   \n",
      "4     k403     Ramicane  Male          21          16         20   \n",
      "\n",
      "   Tumor Volume (mm3)  Metastatic Sites  \n",
      "0           45.000000                 0  \n",
      "1           38.825898                 0  \n",
      "2           35.014271                 1  \n",
      "3           34.223992                 1  \n",
      "4           32.997729                 1  \n",
      "\n",
      "Cleaned DataFrame:\n",
      "  Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "0     k403     Ramicane  Male          21          16          0   \n",
      "1     k403     Ramicane  Male          21          16          5   \n",
      "2     k403     Ramicane  Male          21          16         10   \n",
      "3     k403     Ramicane  Male          21          16         15   \n",
      "4     k403     Ramicane  Male          21          16         20   \n",
      "\n",
      "   Tumor Volume (mm3)  Metastatic Sites  \n",
      "0           45.000000                 0  \n",
      "1           38.825898                 0  \n",
      "2           35.014271                 1  \n",
      "3           34.223992                 1  \n",
      "4           32.997729                 1  \n"
     ]
    }
   ],
   "source": [
    "# First, let's display the original DataFrame\n",
    "print(\"Original DataFrame:\")\n",
    "print(combined_data.head()) \n",
    "\n",
    "# Next, display the cleaned DataFrame\n",
    "print(\"\\nCleaned DataFrame:\")\n",
    "print(cleaned_data.head()) \n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of mice in the clean DataFrame: 248\n"
     ]
    }
   ],
   "source": [
    "# Checking the number of mice in the clean DataFrame.\n",
    "num_mice_cleaned = cleaned_data['Mouse ID'].nunique()\n",
    "print(\"Number of mice in the clean DataFrame:\", num_mice_cleaned)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Duplicate mouse IDs in the original DataFrame: ['k403' 's185' 'x401' 'm601' 'g791' 's508' 'f966' 'm546' 'z578' 'j913'\n",
      " 'u364' 'n364' 'y793' 'r554' 'm957' 'c758' 't565' 'a644' 'i177' 'j989'\n",
      " 'i738' 'a520' 'w914' 'r811' 'g288' 'i334' 'q610' 'd251' 'l897' 'c458'\n",
      " 'b742' 'b128' 'j246' 'a411' 'j119' 'w150' 'v923' 'g316' 's710' 'l509'\n",
      " 'r944' 'e662' 'u196' 'q597' 'a444' 'i557' 'r921' 'w678' 'y449' 'a203'\n",
      " 'a251' 'a262' 'a275' 'a366' 'a401' 'a457' 'a492' 'a577' 'a685' 'a699'\n",
      " 'a788' 'a818' 'a897' 'a963' 'b313' 'b487' 'b559' 'b759' 'b879' 'c139'\n",
      " 'c264' 'c282' 'c302' 'c326' 'c402' 'c559' 'c580' 'c757' 'c766' 'c819'\n",
      " 'c832' 'c895' 'c927' 'd164' 'd474' 'e213' 'e227' 'e291' 'e476' 'e584'\n",
      " 'f129' 'f234' 'f278' 'f345' 'f394' 'f436' 'f545' 'f993' 'g107' 'g296'\n",
      " 'g497' 'g558' 'g570' 'g867' 'g989' 'h246' 'h333' 'h531' 'i386' 'i477'\n",
      " 'i635' 'i669' 'i901' 'j235' 'j296' 'j365' 'j755' 'j984' 'k210' 'k382'\n",
      " 'k483' 'k510' 'k603' 'k754' 'k804' 'k862' 'k894' 'l215' 'l264' 'l471'\n",
      " 'l490' 'l558' 'l661' 'l700' 'l725' 'l733' 'm133' 'm269' 'm331' 'm550'\n",
      " 'm650' 'm756' 'n304' 'n630' 'n671' 'n678' 'n763' 'n923' 'n967' 'o287'\n",
      " 'o302' 'o331' 'o523' 'o562' 'o725' 'o795' 'o809' 'o813' 'o926' 'o973'\n",
      " 'p136' 'p189' 'p310' 'p387' 'p438' 'p981' 'q119' 'q132' 'q483' 'q511'\n",
      " 'q582' 'q633' 'q787' 'r107' 'r157' 'r604' 'r701' 'r850' 's121' 's141'\n",
      " 's152' 's166' 's187' 's337' 's565' 's619' 't198' 't451' 't718' 't724'\n",
      " 't994' 'u149' 'u327' 'u946' 'v289' 'v295' 'v339' 'v409' 'v603' 'v719'\n",
      " 'v764' 'v766' 'v835' 'v989' 'v991' 'w140' 'w151' 'w167' 'w193' 'w350'\n",
      " 'w422' 'w540' 'w575' 'w584' 'w697' 'w746' 'x111' 'x209' 'x264' 'x402'\n",
      " 'x581' 'x613' 'x773' 'x822' 'x930' 'y163' 'y260' 'y478' 'y601' 'y769'\n",
      " 'y865' 'z234' 'z314' 'z435' 'z581' 'z795' 'z969']\n"
     ]
    }
   ],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "908     g989     Propriva  Female          21          26          0   \n",
      "910     g989     Propriva  Female          21          26          5   \n",
      "912     g989     Propriva  Female          21          26         10   \n",
      "914     g989     Propriva  Female          21          26         15   \n",
      "916     g989     Propriva  Female          21          26         20   \n",
      "918     g989     Propriva  Female          21          26         25   \n",
      "919     g989     Propriva  Female          21          26         30   \n",
      "920     g989     Propriva  Female          21          26         35   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "908           45.000000                 0  \n",
      "910           48.786801                 0  \n",
      "912           51.745156                 0  \n",
      "914           51.325852                 1  \n",
      "916           55.326122                 1  \n",
      "918           56.045564                 1  \n",
      "919           59.082294                 1  \n",
      "920           62.570880                 2  \n"
     ]
    }
   ],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Mouse IDs with duplicate entries: ['k403' 's185' 'x401' 'm601' 'g791' 's508' 'f966' 'm546' 'z578' 'j913'\n",
      " 'u364' 'n364' 'y793' 'r554' 'm957' 'c758' 't565' 'a644' 'i177' 'j989'\n",
      " 'i738' 'a520' 'w914' 'r811' 'g288' 'i334' 'q610' 'd251' 'l897' 'c458'\n",
      " 'b742' 'b128' 'j246' 'a411' 'j119' 'w150' 'v923' 'g316' 's710' 'l509'\n",
      " 'r944' 'e662' 'u196' 'q597' 'a444' 'i557' 'r921' 'w678' 'y449' 'a203'\n",
      " 'a251' 'a262' 'a275' 'a366' 'a401' 'a457' 'a492' 'a577' 'a685' 'a699'\n",
      " 'a788' 'a818' 'a897' 'a963' 'b313' 'b487' 'b559' 'b759' 'b879' 'c139'\n",
      " 'c264' 'c282' 'c302' 'c326' 'c402' 'c559' 'c580' 'c757' 'c766' 'c819'\n",
      " 'c832' 'c895' 'c927' 'd164' 'd474' 'e213' 'e227' 'e291' 'e476' 'e584'\n",
      " 'f129' 'f234' 'f278' 'f345' 'f394' 'f436' 'f545' 'f993' 'g107' 'g296'\n",
      " 'g497' 'g558' 'g570' 'g867' 'g989' 'h246' 'h333' 'h531' 'i386' 'i477'\n",
      " 'i635' 'i669' 'i901' 'j235' 'j296' 'j365' 'j755' 'j984' 'k210' 'k382'\n",
      " 'k483' 'k510' 'k603' 'k754' 'k804' 'k862' 'k894' 'l215' 'l264' 'l471'\n",
      " 'l490' 'l558' 'l661' 'l700' 'l725' 'l733' 'm133' 'm269' 'm331' 'm550'\n",
      " 'm650' 'm756' 'n304' 'n630' 'n671' 'n678' 'n763' 'n923' 'n967' 'o287'\n",
      " 'o302' 'o331' 'o523' 'o562' 'o725' 'o795' 'o809' 'o813' 'o926' 'o973'\n",
      " 'p136' 'p189' 'p310' 'p387' 'p438' 'p981' 'q119' 'q132' 'q483' 'q511'\n",
      " 'q582' 'q633' 'q787' 'r107' 'r157' 'r604' 'r701' 'r850' 's121' 's141'\n",
      " 's152' 's166' 's187' 's337' 's565' 's619' 't198' 't451' 't718' 't724'\n",
      " 't994' 'u149' 'u327' 'u946' 'v289' 'v295' 'v339' 'v409' 'v603' 'v719'\n",
      " 'v764' 'v766' 'v835' 'v989' 'v991' 'w140' 'w151' 'w167' 'w193' 'w350'\n",
      " 'w422' 'w540' 'w575' 'w584' 'w697' 'w746' 'x111' 'x209' 'x264' 'x402'\n",
      " 'x581' 'x613' 'x773' 'x822' 'x930' 'y163' 'y260' 'y478' 'y601' 'y769'\n",
      " 'y865' 'z234' 'z314' 'z435' 'z581' 'z795' 'z969']\n",
      "Entries for Mouse ID: k403\n",
      "  Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "0     k403     Ramicane  Male          21          16          0   \n",
      "1     k403     Ramicane  Male          21          16          5   \n",
      "2     k403     Ramicane  Male          21          16         10   \n",
      "3     k403     Ramicane  Male          21          16         15   \n",
      "4     k403     Ramicane  Male          21          16         20   \n",
      "5     k403     Ramicane  Male          21          16         25   \n",
      "6     k403     Ramicane  Male          21          16         30   \n",
      "7     k403     Ramicane  Male          21          16         35   \n",
      "8     k403     Ramicane  Male          21          16         40   \n",
      "9     k403     Ramicane  Male          21          16         45   \n",
      "\n",
      "   Tumor Volume (mm3)  Metastatic Sites  \n",
      "0           45.000000                 0  \n",
      "1           38.825898                 0  \n",
      "2           35.014271                 1  \n",
      "3           34.223992                 1  \n",
      "4           32.997729                 1  \n",
      "5           33.464577                 1  \n",
      "6           31.099498                 1  \n",
      "7           26.546993                 1  \n",
      "8           24.365505                 1  \n",
      "9           22.050126                 1  \n",
      "Entries for Mouse ID: s185\n",
      "   Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "10     s185    Capomulin  Female           3          17          0   \n",
      "11     s185    Capomulin  Female           3          17          5   \n",
      "12     s185    Capomulin  Female           3          17         10   \n",
      "13     s185    Capomulin  Female           3          17         15   \n",
      "14     s185    Capomulin  Female           3          17         20   \n",
      "15     s185    Capomulin  Female           3          17         25   \n",
      "16     s185    Capomulin  Female           3          17         30   \n",
      "17     s185    Capomulin  Female           3          17         35   \n",
      "18     s185    Capomulin  Female           3          17         40   \n",
      "19     s185    Capomulin  Female           3          17         45   \n",
      "\n",
      "    Tumor Volume (mm3)  Metastatic Sites  \n",
      "10           45.000000                 0  \n",
      "11           43.878496                 0  \n",
      "12           37.614948                 0  \n",
      "13           38.177232                 0  \n",
      "14           36.866876                 0  \n",
      "15           33.949940                 0  \n",
      "16           32.959671                 1  \n",
      "17           28.328531                 1  \n",
      "18           25.472143                 1  \n",
      "19           23.343598                 1  \n",
      "Entries for Mouse ID: x401\n",
      "   Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "20     x401    Capomulin  Female          16          15          0   \n",
      "21     x401    Capomulin  Female          16          15          5   \n",
      "22     x401    Capomulin  Female          16          15         10   \n",
      "23     x401    Capomulin  Female          16          15         15   \n",
      "24     x401    Capomulin  Female          16          15         20   \n",
      "25     x401    Capomulin  Female          16          15         25   \n",
      "26     x401    Capomulin  Female          16          15         30   \n",
      "27     x401    Capomulin  Female          16          15         35   \n",
      "28     x401    Capomulin  Female          16          15         40   \n",
      "29     x401    Capomulin  Female          16          15         45   \n",
      "\n",
      "    Tumor Volume (mm3)  Metastatic Sites  \n",
      "20           45.000000                 0  \n",
      "21           45.473753                 0  \n",
      "22           39.113891                 0  \n",
      "23           39.776250                 0  \n",
      "24           36.065835                 0  \n",
      "25           36.617120                 0  \n",
      "26           32.915292                 0  \n",
      "27           30.206825                 0  \n",
      "28           28.167397                 0  \n",
      "29           28.484033                 0  \n",
      "Entries for Mouse ID: m601\n",
      "   Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "30     m601    Capomulin  Male          22          17          0   \n",
      "31     m601    Capomulin  Male          22          17          5   \n",
      "32     m601    Capomulin  Male          22          17         10   \n",
      "33     m601    Capomulin  Male          22          17         15   \n",
      "34     m601    Capomulin  Male          22          17         20   \n",
      "35     m601    Capomulin  Male          22          17         25   \n",
      "36     m601    Capomulin  Male          22          17         30   \n",
      "37     m601    Capomulin  Male          22          17         35   \n",
      "38     m601    Capomulin  Male          22          17         40   \n",
      "39     m601    Capomulin  Male          22          17         45   \n",
      "\n",
      "    Tumor Volume (mm3)  Metastatic Sites  \n",
      "30           45.000000                 0  \n",
      "31           41.408591                 1  \n",
      "32           36.825367                 1  \n",
      "33           35.464612                 1  \n",
      "34           34.255732                 1  \n",
      "35           33.118756                 1  \n",
      "36           31.758275                 1  \n",
      "37           30.834357                 1  \n",
      "38           31.378045                 1  \n",
      "39           28.430964                 1  \n",
      "Entries for Mouse ID: g791\n",
      "   Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "40     g791     Ramicane  Male          11          16          0   \n",
      "41     g791     Ramicane  Male          11          16          5   \n",
      "42     g791     Ramicane  Male          11          16         10   \n",
      "43     g791     Ramicane  Male          11          16         15   \n",
      "44     g791     Ramicane  Male          11          16         20   \n",
      "45     g791     Ramicane  Male          11          16         25   \n",
      "46     g791     Ramicane  Male          11          16         30   \n",
      "47     g791     Ramicane  Male          11          16         35   \n",
      "48     g791     Ramicane  Male          11          16         40   \n",
      "49     g791     Ramicane  Male          11          16         45   \n",
      "\n",
      "    Tumor Volume (mm3)  Metastatic Sites  \n",
      "40           45.000000                 0  \n",
      "41           45.851531                 0  \n",
      "42           40.170558                 0  \n",
      "43           40.678129                 0  \n",
      "44           41.211897                 0  \n",
      "45           35.569399                 1  \n",
      "46           34.952583                 1  \n",
      "47           30.960392                 1  \n",
      "48           31.369406                 1  \n",
      "49           29.128472                 1  \n",
      "Entries for Mouse ID: s508\n",
      "   Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "50     s508     Ramicane  Male           1          17          0   \n",
      "51     s508     Ramicane  Male           1          17          5   \n",
      "52     s508     Ramicane  Male           1          17         10   \n",
      "53     s508     Ramicane  Male           1          17         15   \n",
      "54     s508     Ramicane  Male           1          17         20   \n",
      "55     s508     Ramicane  Male           1          17         25   \n",
      "56     s508     Ramicane  Male           1          17         30   \n",
      "57     s508     Ramicane  Male           1          17         35   \n",
      "58     s508     Ramicane  Male           1          17         40   \n",
      "59     s508     Ramicane  Male           1          17         45   \n",
      "\n",
      "    Tumor Volume (mm3)  Metastatic Sites  \n",
      "50           45.000000                 0  \n",
      "51           38.711872                 0  \n",
      "52           34.850998                 0  \n",
      "53           35.276906                 0  \n",
      "54           35.928651                 0  \n",
      "55           36.338569                 0  \n",
      "56           35.474022                 0  \n",
      "57           35.846141                 0  \n",
      "58           32.798171                 0  \n",
      "59           30.276232                 0  \n",
      "Entries for Mouse ID: f966\n",
      "   Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "60     f966    Capomulin  Male          16          17          0   \n",
      "61     f966    Capomulin  Male          16          17          5   \n",
      "62     f966    Capomulin  Male          16          17         10   \n",
      "63     f966    Capomulin  Male          16          17         15   \n",
      "64     f966    Capomulin  Male          16          17         20   \n",
      "\n",
      "    Tumor Volume (mm3)  Metastatic Sites  \n",
      "60           45.000000                 0  \n",
      "61           38.796474                 0  \n",
      "62           35.624403                 0  \n",
      "63           32.623003                 0  \n",
      "64           30.485985                 0  \n",
      "Entries for Mouse ID: m546\n",
      "   Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "65     m546     Ramicane  Male          18          16          0   \n",
      "66     m546     Ramicane  Male          18          16          5   \n",
      "67     m546     Ramicane  Male          18          16         10   \n",
      "68     m546     Ramicane  Male          18          16         15   \n",
      "69     m546     Ramicane  Male          18          16         20   \n",
      "70     m546     Ramicane  Male          18          16         25   \n",
      "71     m546     Ramicane  Male          18          16         30   \n",
      "72     m546     Ramicane  Male          18          16         35   \n",
      "73     m546     Ramicane  Male          18          16         40   \n",
      "74     m546     Ramicane  Male          18          16         45   \n",
      "\n",
      "    Tumor Volume (mm3)  Metastatic Sites  \n",
      "65           45.000000                 0  \n",
      "66           42.998876                 0  \n",
      "67           43.748224                 0  \n",
      "68           39.897435                 0  \n",
      "69           36.712295                 0  \n",
      "70           37.444445                 0  \n",
      "71           37.969934                 0  \n",
      "72           38.627536                 1  \n",
      "73           35.114575                 1  \n",
      "74           30.564625                 1  \n",
      "Entries for Mouse ID: z578\n",
      "   Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "75     z578     Ramicane  Male          11          16          0   \n",
      "76     z578     Ramicane  Male          11          16          5   \n",
      "77     z578     Ramicane  Male          11          16         10   \n",
      "78     z578     Ramicane  Male          11          16         15   \n",
      "79     z578     Ramicane  Male          11          16         20   \n",
      "80     z578     Ramicane  Male          11          16         25   \n",
      "81     z578     Ramicane  Male          11          16         30   \n",
      "82     z578     Ramicane  Male          11          16         35   \n",
      "83     z578     Ramicane  Male          11          16         40   \n",
      "84     z578     Ramicane  Male          11          16         45   \n",
      "\n",
      "    Tumor Volume (mm3)  Metastatic Sites  \n",
      "75           45.000000                 0  \n",
      "76           42.188787                 0  \n",
      "77           42.952118                 0  \n",
      "78           38.688516                 0  \n",
      "79           36.890016                 0  \n",
      "80           37.414114                 0  \n",
      "81           37.815935                 0  \n",
      "82           38.504824                 0  \n",
      "83           34.022093                 0  \n",
      "84           30.638696                 0  \n",
      "Entries for Mouse ID: j913\n",
      "   Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "85     j913     Ramicane  Female           4          17          0   \n",
      "86     j913     Ramicane  Female           4          17          5   \n",
      "87     j913     Ramicane  Female           4          17         10   \n",
      "88     j913     Ramicane  Female           4          17         15   \n",
      "89     j913     Ramicane  Female           4          17         20   \n",
      "90     j913     Ramicane  Female           4          17         25   \n",
      "91     j913     Ramicane  Female           4          17         30   \n",
      "92     j913     Ramicane  Female           4          17         35   \n",
      "93     j913     Ramicane  Female           4          17         40   \n",
      "94     j913     Ramicane  Female           4          17         45   \n",
      "\n",
      "    Tumor Volume (mm3)  Metastatic Sites  \n",
      "85           45.000000                 0  \n",
      "86           44.014900                 0  \n",
      "87           44.497162                 0  \n",
      "88           45.252534                 0  \n",
      "89           42.168341                 0  \n",
      "90           37.860669                 0  \n",
      "91           34.757240                 0  \n",
      "92           35.170148                 0  \n",
      "93           31.001861                 1  \n",
      "94           31.560470                 1  \n",
      "Entries for Mouse ID: u364\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "95      u364    Capomulin  Male          18          17          0   \n",
      "96      u364    Capomulin  Male          18          17          5   \n",
      "97      u364    Capomulin  Male          18          17         10   \n",
      "98      u364    Capomulin  Male          18          17         15   \n",
      "99      u364    Capomulin  Male          18          17         20   \n",
      "100     u364    Capomulin  Male          18          17         25   \n",
      "101     u364    Capomulin  Male          18          17         30   \n",
      "102     u364    Capomulin  Male          18          17         35   \n",
      "103     u364    Capomulin  Male          18          17         40   \n",
      "104     u364    Capomulin  Male          18          17         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "95            45.000000                 0  \n",
      "96            45.760886                 1  \n",
      "97            46.568417                 2  \n",
      "98            47.212200                 2  \n",
      "99            40.343948                 2  \n",
      "100           35.503616                 2  \n",
      "101           35.978334                 2  \n",
      "102           35.459490                 2  \n",
      "103           36.024138                 2  \n",
      "104           31.023923                 3  \n",
      "Entries for Mouse ID: n364\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "105     n364     Ramicane  Male           4          17          0   \n",
      "106     n364     Ramicane  Male           4          17          5   \n",
      "107     n364     Ramicane  Male           4          17         10   \n",
      "108     n364     Ramicane  Male           4          17         15   \n",
      "109     n364     Ramicane  Male           4          17         20   \n",
      "110     n364     Ramicane  Male           4          17         25   \n",
      "111     n364     Ramicane  Male           4          17         30   \n",
      "112     n364     Ramicane  Male           4          17         35   \n",
      "113     n364     Ramicane  Male           4          17         40   \n",
      "114     n364     Ramicane  Male           4          17         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "105           45.000000                 0  \n",
      "106           45.521875                 0  \n",
      "107           40.375138                 0  \n",
      "108           36.940274                 0  \n",
      "109           37.478868                 0  \n",
      "110           33.205008                 0  \n",
      "111           33.817758                 0  \n",
      "112           34.487522                 1  \n",
      "113           34.954733                 1  \n",
      "114           31.095335                 1  \n",
      "Entries for Mouse ID: y793\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "115     y793    Capomulin  Male          17          17          0   \n",
      "116     y793    Capomulin  Male          17          17          5   \n",
      "117     y793    Capomulin  Male          17          17         10   \n",
      "118     y793    Capomulin  Male          17          17         15   \n",
      "119     y793    Capomulin  Male          17          17         20   \n",
      "120     y793    Capomulin  Male          17          17         25   \n",
      "121     y793    Capomulin  Male          17          17         30   \n",
      "122     y793    Capomulin  Male          17          17         35   \n",
      "123     y793    Capomulin  Male          17          17         40   \n",
      "124     y793    Capomulin  Male          17          17         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "115           45.000000                 0  \n",
      "116           41.019913                 0  \n",
      "117           41.630010                 1  \n",
      "118           42.283665                 1  \n",
      "119           40.716428                 2  \n",
      "120           38.992734                 2  \n",
      "121           35.726023                 2  \n",
      "122           36.327870                 2  \n",
      "123           31.475411                 2  \n",
      "124           31.896238                 2  \n",
      "Entries for Mouse ID: r554\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "125     r554    Capomulin  Female           8          17          0   \n",
      "126     r554    Capomulin  Female           8          17          5   \n",
      "127     r554    Capomulin  Female           8          17         10   \n",
      "128     r554    Capomulin  Female           8          17         15   \n",
      "129     r554    Capomulin  Female           8          17         20   \n",
      "130     r554    Capomulin  Female           8          17         25   \n",
      "131     r554    Capomulin  Female           8          17         30   \n",
      "132     r554    Capomulin  Female           8          17         35   \n",
      "133     r554    Capomulin  Female           8          17         40   \n",
      "134     r554    Capomulin  Female           8          17         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "125           45.000000                 0  \n",
      "126           45.781746                 1  \n",
      "127           39.005494                 2  \n",
      "128           35.463758                 2  \n",
      "129           36.015589                 2  \n",
      "130           33.893345                 3  \n",
      "131           32.680655                 3  \n",
      "132           33.069337                 3  \n",
      "133           31.804841                 3  \n",
      "134           32.377357                 3  \n",
      "Entries for Mouse ID: m957\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "135     m957    Capomulin  Female           3          19          0   \n",
      "136     m957    Capomulin  Female           3          19          5   \n",
      "137     m957    Capomulin  Female           3          19         10   \n",
      "138     m957    Capomulin  Female           3          19         15   \n",
      "139     m957    Capomulin  Female           3          19         20   \n",
      "140     m957    Capomulin  Female           3          19         25   \n",
      "141     m957    Capomulin  Female           3          19         30   \n",
      "142     m957    Capomulin  Female           3          19         35   \n",
      "143     m957    Capomulin  Female           3          19         40   \n",
      "144     m957    Capomulin  Female           3          19         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "135           45.000000                 0  \n",
      "136           45.622381                 1  \n",
      "137           46.414518                 1  \n",
      "138           39.804453                 1  \n",
      "139           38.909349                 1  \n",
      "140           37.695432                 1  \n",
      "141           38.212479                 1  \n",
      "142           32.562839                 1  \n",
      "143           32.947615                 1  \n",
      "144           33.329098                 1  \n",
      "Entries for Mouse ID: c758\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "145     c758     Ramicane  Male           9          17          0   \n",
      "146     c758     Ramicane  Male           9          17          5   \n",
      "147     c758     Ramicane  Male           9          17         10   \n",
      "148     c758     Ramicane  Male           9          17         15   \n",
      "149     c758     Ramicane  Male           9          17         20   \n",
      "150     c758     Ramicane  Male           9          17         25   \n",
      "151     c758     Ramicane  Male           9          17         30   \n",
      "152     c758     Ramicane  Male           9          17         35   \n",
      "153     c758     Ramicane  Male           9          17         40   \n",
      "154     c758     Ramicane  Male           9          17         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "145           45.000000                 0  \n",
      "146           45.578678                 0  \n",
      "147           46.287992                 0  \n",
      "148           46.940945                 1  \n",
      "149           43.126311                 1  \n",
      "150           43.602267                 1  \n",
      "151           44.118270                 1  \n",
      "152           37.802385                 1  \n",
      "153           32.833189                 1  \n",
      "154           33.397653                 1  \n",
      "Entries for Mouse ID: t565\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "155     t565    Capomulin  Female          20          17          0   \n",
      "156     t565    Capomulin  Female          20          17          5   \n",
      "157     t565    Capomulin  Female          20          17         10   \n",
      "158     t565    Capomulin  Female          20          17         15   \n",
      "159     t565    Capomulin  Female          20          17         20   \n",
      "160     t565    Capomulin  Female          20          17         25   \n",
      "161     t565    Capomulin  Female          20          17         30   \n",
      "162     t565    Capomulin  Female          20          17         35   \n",
      "163     t565    Capomulin  Female          20          17         40   \n",
      "164     t565    Capomulin  Female          20          17         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "155           45.000000                 0  \n",
      "156           45.895647                 0  \n",
      "157           46.749006                 0  \n",
      "158           44.440949                 0  \n",
      "159           39.070214                 0  \n",
      "160           37.342210                 0  \n",
      "161           32.868916                 0  \n",
      "162           33.515671                 0  \n",
      "163           33.949341                 0  \n",
      "164           34.455298                 0  \n",
      "Entries for Mouse ID: a644\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "165     a644     Ramicane  Female           7          17          0   \n",
      "166     a644     Ramicane  Female           7          17          5   \n",
      "167     a644     Ramicane  Female           7          17         10   \n",
      "168     a644     Ramicane  Female           7          17         15   \n",
      "169     a644     Ramicane  Female           7          17         20   \n",
      "170     a644     Ramicane  Female           7          17         25   \n",
      "171     a644     Ramicane  Female           7          17         30   \n",
      "172     a644     Ramicane  Female           7          17         35   \n",
      "173     a644     Ramicane  Female           7          17         40   \n",
      "174     a644     Ramicane  Female           7          17         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "165           45.000000                 0  \n",
      "166           45.550158                 0  \n",
      "167           46.380713                 0  \n",
      "168           46.910892                 0  \n",
      "169           45.865065                 0  \n",
      "170           41.481224                 0  \n",
      "171           37.211121                 0  \n",
      "172           35.128631                 0  \n",
      "173           35.779451                 0  \n",
      "174           32.978522                 1  \n",
      "Entries for Mouse ID: i177\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "175     i177     Ramicane  Male          10          18          0   \n",
      "176     i177     Ramicane  Male          10          18          5   \n",
      "177     i177     Ramicane  Male          10          18         10   \n",
      "178     i177     Ramicane  Male          10          18         15   \n",
      "179     i177     Ramicane  Male          10          18         20   \n",
      "180     i177     Ramicane  Male          10          18         25   \n",
      "181     i177     Ramicane  Male          10          18         30   \n",
      "182     i177     Ramicane  Male          10          18         35   \n",
      "183     i177     Ramicane  Male          10          18         40   \n",
      "184     i177     Ramicane  Male          10          18         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "175           45.000000                 0  \n",
      "176           44.065398                 0  \n",
      "177           41.020929                 0  \n",
      "178           40.330935                 0  \n",
      "179           35.345361                 0  \n",
      "180           34.082180                 1  \n",
      "181           34.711473                 1  \n",
      "182           35.152166                 1  \n",
      "183           35.557933                 2  \n",
      "184           33.562402                 3  \n",
      "Entries for Mouse ID: j989\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "185     j989     Ramicane  Male           8          19          0   \n",
      "186     j989     Ramicane  Male           8          19          5   \n",
      "187     j989     Ramicane  Male           8          19         10   \n",
      "188     j989     Ramicane  Male           8          19         15   \n",
      "189     j989     Ramicane  Male           8          19         20   \n",
      "190     j989     Ramicane  Male           8          19         25   \n",
      "191     j989     Ramicane  Male           8          19         30   \n",
      "192     j989     Ramicane  Male           8          19         35   \n",
      "193     j989     Ramicane  Male           8          19         40   \n",
      "194     j989     Ramicane  Male           8          19         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "185           45.000000                 0  \n",
      "186           45.620718                 1  \n",
      "187           46.343832                 1  \n",
      "188           41.128354                 1  \n",
      "189           41.635344                 1  \n",
      "190           39.934112                 1  \n",
      "191           34.671781                 1  \n",
      "192           35.115590                 1  \n",
      "193           35.501190                 1  \n",
      "194           36.134852                 1  \n",
      "Entries for Mouse ID: i738\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "195     i738    Capomulin  Female          23          20          0   \n",
      "196     i738    Capomulin  Female          23          20          5   \n",
      "197     i738    Capomulin  Female          23          20         10   \n",
      "198     i738    Capomulin  Female          23          20         15   \n",
      "199     i738    Capomulin  Female          23          20         20   \n",
      "200     i738    Capomulin  Female          23          20         25   \n",
      "201     i738    Capomulin  Female          23          20         30   \n",
      "202     i738    Capomulin  Female          23          20         35   \n",
      "203     i738    Capomulin  Female          23          20         40   \n",
      "204     i738    Capomulin  Female          23          20         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "195           45.000000                 0  \n",
      "196           45.595685                 0  \n",
      "197           43.421014                 0  \n",
      "198           37.978778                 0  \n",
      "199           38.531136                 0  \n",
      "200           34.973438                 0  \n",
      "201           35.578780                 1  \n",
      "202           36.175953                 1  \n",
      "203           36.843898                 2  \n",
      "204           37.311846                 2  \n",
      "Entries for Mouse ID: a520\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "205     a520     Ramicane  Male          13          21          0   \n",
      "206     a520     Ramicane  Male          13          21          5   \n",
      "207     a520     Ramicane  Male          13          21         10   \n",
      "208     a520     Ramicane  Male          13          21         15   \n",
      "209     a520     Ramicane  Male          13          21         20   \n",
      "210     a520     Ramicane  Male          13          21         25   \n",
      "211     a520     Ramicane  Male          13          21         30   \n",
      "212     a520     Ramicane  Male          13          21         35   \n",
      "213     a520     Ramicane  Male          13          21         40   \n",
      "214     a520     Ramicane  Male          13          21         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "205           45.000000                 0  \n",
      "206           38.723707                 0  \n",
      "207           36.429388                 0  \n",
      "208           35.590254                 0  \n",
      "209           35.947745                 0  \n",
      "210           36.558581                 1  \n",
      "211           36.947710                 1  \n",
      "212           37.624710                 1  \n",
      "213           38.259725                 1  \n",
      "214           38.810366                 1  \n",
      "Entries for Mouse ID: w914\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "215     w914    Capomulin  Male          24          21          0   \n",
      "216     w914    Capomulin  Male          24          21          5   \n",
      "217     w914    Capomulin  Male          24          21         10   \n",
      "218     w914    Capomulin  Male          24          21         15   \n",
      "219     w914    Capomulin  Male          24          21         20   \n",
      "220     w914    Capomulin  Male          24          21         25   \n",
      "221     w914    Capomulin  Male          24          21         30   \n",
      "222     w914    Capomulin  Male          24          21         35   \n",
      "223     w914    Capomulin  Male          24          21         40   \n",
      "224     w914    Capomulin  Male          24          21         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "215           45.000000                 0  \n",
      "216           45.893720                 0  \n",
      "217           43.231963                 0  \n",
      "218           43.688449                 0  \n",
      "219           41.108092                 0  \n",
      "220           40.291917                 0  \n",
      "221           40.993110                 0  \n",
      "222           41.664916                 1  \n",
      "223           35.611309                 2  \n",
      "224           36.041047                 2  \n",
      "Entries for Mouse ID: r811\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "225     r811     Ramicane  Male           9          19          0   \n",
      "226     r811     Ramicane  Male           9          19          5   \n",
      "227     r811     Ramicane  Male           9          19         10   \n",
      "228     r811     Ramicane  Male           9          19         15   \n",
      "229     r811     Ramicane  Male           9          19         20   \n",
      "230     r811     Ramicane  Male           9          19         25   \n",
      "231     r811     Ramicane  Male           9          19         30   \n",
      "232     r811     Ramicane  Male           9          19         35   \n",
      "233     r811     Ramicane  Male           9          19         40   \n",
      "234     r811     Ramicane  Male           9          19         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "225           45.000000                 0  \n",
      "226           45.625802                 0  \n",
      "227           39.453903                 0  \n",
      "228           40.022292                 0  \n",
      "229           40.772803                 0  \n",
      "230           37.614011                 0  \n",
      "231           38.242066                 0  \n",
      "232           36.003020                 1  \n",
      "233           36.520033                 1  \n",
      "234           37.225650                 1  \n",
      "Entries for Mouse ID: g288\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "235     g288    Capomulin  Male           3          19          0   \n",
      "236     g288    Capomulin  Male           3          19          5   \n",
      "237     g288    Capomulin  Male           3          19         10   \n",
      "238     g288    Capomulin  Male           3          19         15   \n",
      "239     g288    Capomulin  Male           3          19         20   \n",
      "240     g288    Capomulin  Male           3          19         25   \n",
      "241     g288    Capomulin  Male           3          19         30   \n",
      "242     g288    Capomulin  Male           3          19         35   \n",
      "243     g288    Capomulin  Male           3          19         40   \n",
      "244     g288    Capomulin  Male           3          19         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "235           45.000000                 0  \n",
      "236           45.839400                 0  \n",
      "237           46.304003                 1  \n",
      "238           42.172301                 1  \n",
      "239           42.957120                 1  \n",
      "240           42.368692                 1  \n",
      "241           42.874461                 1  \n",
      "242           38.954115                 1  \n",
      "243           36.356851                 1  \n",
      "244           37.074024                 1  \n",
      "Entries for Mouse ID: i334\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "245     i334     Ramicane  Female           8          20          0   \n",
      "246     i334     Ramicane  Female           8          20          5   \n",
      "247     i334     Ramicane  Female           8          20         10   \n",
      "248     i334     Ramicane  Female           8          20         15   \n",
      "249     i334     Ramicane  Female           8          20         20   \n",
      "250     i334     Ramicane  Female           8          20         25   \n",
      "251     i334     Ramicane  Female           8          20         30   \n",
      "252     i334     Ramicane  Female           8          20         35   \n",
      "253     i334     Ramicane  Female           8          20         40   \n",
      "254     i334     Ramicane  Female           8          20         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "245           45.000000                 0  \n",
      "246           41.020518                 0  \n",
      "247           41.631247                 0  \n",
      "248           39.158001                 0  \n",
      "249           39.687832                 0  \n",
      "250           38.248817                 1  \n",
      "251           39.005554                 1  \n",
      "252           39.769552                 2  \n",
      "253           40.442370                 2  \n",
      "254           36.374510                 2  \n",
      "Entries for Mouse ID: q610\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "255     q610     Ramicane  Female          18          21          0   \n",
      "256     q610     Ramicane  Female          18          21          5   \n",
      "257     q610     Ramicane  Female          18          21         10   \n",
      "258     q610     Ramicane  Female          18          21         15   \n",
      "259     q610     Ramicane  Female          18          21         20   \n",
      "260     q610     Ramicane  Female          18          21         25   \n",
      "261     q610     Ramicane  Female          18          21         30   \n",
      "262     q610     Ramicane  Female          18          21         35   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "255           45.000000                 0  \n",
      "256           45.629494                 0  \n",
      "257           44.991485                 0  \n",
      "258           45.889028                 0  \n",
      "259           46.585433                 0  \n",
      "260           40.146450                 0  \n",
      "261           40.668343                 1  \n",
      "262           36.561652                 2  \n",
      "Entries for Mouse ID: d251\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "263     d251     Ramicane  Female           8          19          0   \n",
      "264     d251     Ramicane  Female           8          19          5   \n",
      "265     d251     Ramicane  Female           8          19         10   \n",
      "266     d251     Ramicane  Female           8          19         15   \n",
      "267     d251     Ramicane  Female           8          19         20   \n",
      "268     d251     Ramicane  Female           8          19         25   \n",
      "269     d251     Ramicane  Female           8          19         30   \n",
      "270     d251     Ramicane  Female           8          19         35   \n",
      "271     d251     Ramicane  Female           8          19         40   \n",
      "272     d251     Ramicane  Female           8          19         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "263           45.000000                 0  \n",
      "264           41.746355                 1  \n",
      "265           42.432258                 1  \n",
      "266           39.472787                 1  \n",
      "267           37.652091                 1  \n",
      "268           38.097513                 1  \n",
      "269           38.718256                 2  \n",
      "270           37.708529                 2  \n",
      "271           38.265404                 2  \n",
      "272           37.311236                 2  \n",
      "Entries for Mouse ID: l897\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "273     l897    Capomulin  Male          17          19          0   \n",
      "274     l897    Capomulin  Male          17          19          5   \n",
      "275     l897    Capomulin  Male          17          19         10   \n",
      "276     l897    Capomulin  Male          17          19         15   \n",
      "277     l897    Capomulin  Male          17          19         20   \n",
      "278     l897    Capomulin  Male          17          19         25   \n",
      "279     l897    Capomulin  Male          17          19         30   \n",
      "280     l897    Capomulin  Male          17          19         35   \n",
      "281     l897    Capomulin  Male          17          19         40   \n",
      "282     l897    Capomulin  Male          17          19         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "273           45.000000                 0  \n",
      "274           45.462243                 0  \n",
      "275           46.154737                 0  \n",
      "276           44.061521                 0  \n",
      "277           44.813093                 0  \n",
      "278           45.354679                 0  \n",
      "279           39.352792                 1  \n",
      "280           37.682767                 1  \n",
      "281           38.343902                 1  \n",
      "282           38.846876                 1  \n",
      "Entries for Mouse ID: c458\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "283     c458     Ramicane  Female          23          20          0   \n",
      "284     c458     Ramicane  Female          23          20          5   \n",
      "285     c458     Ramicane  Female          23          20         10   \n",
      "286     c458     Ramicane  Female          23          20         15   \n",
      "287     c458     Ramicane  Female          23          20         20   \n",
      "288     c458     Ramicane  Female          23          20         25   \n",
      "289     c458     Ramicane  Female          23          20         30   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "283           45.000000                 0  \n",
      "284           45.722279                 0  \n",
      "285           44.454378                 1  \n",
      "286           45.107423                 2  \n",
      "287           39.505135                 2  \n",
      "288           37.753150                 2  \n",
      "289           38.342008                 2  \n",
      "Entries for Mouse ID: b742\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "290     b742    Capomulin  Male           7          21          0   \n",
      "291     b742    Capomulin  Male           7          21          5   \n",
      "292     b742    Capomulin  Male           7          21         10   \n",
      "293     b742    Capomulin  Male           7          21         15   \n",
      "294     b742    Capomulin  Male           7          21         20   \n",
      "295     b742    Capomulin  Male           7          21         25   \n",
      "296     b742    Capomulin  Male           7          21         30   \n",
      "297     b742    Capomulin  Male           7          21         35   \n",
      "298     b742    Capomulin  Male           7          21         40   \n",
      "299     b742    Capomulin  Male           7          21         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "290           45.000000                 0  \n",
      "291           41.534097                 0  \n",
      "292           41.999228                 0  \n",
      "293           39.524843                 0  \n",
      "294           37.950355                 0  \n",
      "295           38.617684                 0  \n",
      "296           39.167949                 0  \n",
      "297           39.847576                 0  \n",
      "298           38.255627                 0  \n",
      "299           38.939633                 0  \n",
      "Entries for Mouse ID: b128\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "300     b128    Capomulin  Female           9          22          0   \n",
      "301     b128    Capomulin  Female           9          22          5   \n",
      "302     b128    Capomulin  Female           9          22         10   \n",
      "303     b128    Capomulin  Female           9          22         15   \n",
      "304     b128    Capomulin  Female           9          22         20   \n",
      "305     b128    Capomulin  Female           9          22         25   \n",
      "306     b128    Capomulin  Female           9          22         30   \n",
      "307     b128    Capomulin  Female           9          22         35   \n",
      "308     b128    Capomulin  Female           9          22         40   \n",
      "309     b128    Capomulin  Female           9          22         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "300           45.000000                 0  \n",
      "301           45.651331                 0  \n",
      "302           43.270852                 0  \n",
      "303           43.784893                 0  \n",
      "304           42.731552                 0  \n",
      "305           43.262145                 1  \n",
      "306           40.605335                 1  \n",
      "307           37.967644                 1  \n",
      "308           38.379726                 2  \n",
      "309           38.982878                 2  \n",
      "Entries for Mouse ID: j246\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "310     j246    Capomulin  Female          21          21          0   \n",
      "311     j246    Capomulin  Female          21          21          5   \n",
      "312     j246    Capomulin  Female          21          21         10   \n",
      "313     j246    Capomulin  Female          21          21         15   \n",
      "314     j246    Capomulin  Female          21          21         20   \n",
      "315     j246    Capomulin  Female          21          21         25   \n",
      "316     j246    Capomulin  Female          21          21         30   \n",
      "317     j246    Capomulin  Female          21          21         35   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "310           45.000000                 0  \n",
      "311           45.641438                 0  \n",
      "312           46.408361                 0  \n",
      "313           43.312654                 0  \n",
      "314           44.020370                 0  \n",
      "315           44.555226                 0  \n",
      "316           38.044082                 1  \n",
      "317           38.753265                 1  \n",
      "Entries for Mouse ID: a411\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "318     a411     Ramicane  Male           3          22          0   \n",
      "319     a411     Ramicane  Male           3          22          5   \n",
      "320     a411     Ramicane  Male           3          22         10   \n",
      "321     a411     Ramicane  Male           3          22         15   \n",
      "322     a411     Ramicane  Male           3          22         20   \n",
      "323     a411     Ramicane  Male           3          22         25   \n",
      "324     a411     Ramicane  Male           3          22         30   \n",
      "325     a411     Ramicane  Male           3          22         35   \n",
      "326     a411     Ramicane  Male           3          22         40   \n",
      "327     a411     Ramicane  Male           3          22         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "318           45.000000                 0  \n",
      "319           45.466677                 0  \n",
      "320           40.759788                 1  \n",
      "321           41.484169                 1  \n",
      "322           38.087373                 1  \n",
      "323           38.701438                 1  \n",
      "324           39.130737                 1  \n",
      "325           39.717236                 1  \n",
      "326           40.258818                 1  \n",
      "327           38.407618                 1  \n",
      "Entries for Mouse ID: j119\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "328     j119    Capomulin  Female           7          23          0   \n",
      "329     j119    Capomulin  Female           7          23          5   \n",
      "330     j119    Capomulin  Female           7          23         10   \n",
      "331     j119    Capomulin  Female           7          23         15   \n",
      "332     j119    Capomulin  Female           7          23         20   \n",
      "333     j119    Capomulin  Female           7          23         25   \n",
      "334     j119    Capomulin  Female           7          23         30   \n",
      "335     j119    Capomulin  Female           7          23         35   \n",
      "336     j119    Capomulin  Female           7          23         40   \n",
      "337     j119    Capomulin  Female           7          23         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "328           45.000000                 0  \n",
      "329           45.838998                 0  \n",
      "330           46.425366                 0  \n",
      "331           47.322984                 0  \n",
      "332           48.158209                 1  \n",
      "333           42.417166                 1  \n",
      "334           43.013681                 1  \n",
      "335           43.765705                 1  \n",
      "336           44.585090                 1  \n",
      "337           38.125164                 1  \n",
      "Entries for Mouse ID: w150\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "338     w150    Capomulin  Male          23          23          0   \n",
      "339     w150    Capomulin  Male          23          23          5   \n",
      "340     w150    Capomulin  Male          23          23         10   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "338           45.000000                 0  \n",
      "339           39.202129                 0  \n",
      "340           39.952347                 0  \n",
      "Entries for Mouse ID: v923\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "341     v923    Capomulin  Female          19          21          0   \n",
      "342     v923    Capomulin  Female          19          21          5   \n",
      "343     v923    Capomulin  Female          19          21         10   \n",
      "344     v923    Capomulin  Female          19          21         15   \n",
      "345     v923    Capomulin  Female          19          21         20   \n",
      "346     v923    Capomulin  Female          19          21         25   \n",
      "347     v923    Capomulin  Female          19          21         30   \n",
      "348     v923    Capomulin  Female          19          21         35   \n",
      "349     v923    Capomulin  Female          19          21         40   \n",
      "350     v923    Capomulin  Female          19          21         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "341           45.000000                 0  \n",
      "342           45.704434                 0  \n",
      "343           39.848223                 0  \n",
      "344           40.457989                 0  \n",
      "345           39.648296                 0  \n",
      "346           40.156413                 1  \n",
      "347           40.752216                 2  \n",
      "348           41.439242                 2  \n",
      "349           42.151015                 2  \n",
      "350           40.658124                 2  \n",
      "Entries for Mouse ID: g316\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "351     g316    Capomulin  Female          22          22          0   \n",
      "352     g316    Capomulin  Female          22          22          5   \n",
      "353     g316    Capomulin  Female          22          22         10   \n",
      "354     g316    Capomulin  Female          22          22         15   \n",
      "355     g316    Capomulin  Female          22          22         20   \n",
      "356     g316    Capomulin  Female          22          22         25   \n",
      "357     g316    Capomulin  Female          22          22         30   \n",
      "358     g316    Capomulin  Female          22          22         35   \n",
      "359     g316    Capomulin  Female          22          22         40   \n",
      "360     g316    Capomulin  Female          22          22         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "351           45.000000                 0  \n",
      "352           44.022752                 0  \n",
      "353           44.502042                 0  \n",
      "354           45.216743                 0  \n",
      "355           45.933322                 1  \n",
      "356           46.809225                 1  \n",
      "357           44.221480                 2  \n",
      "358           44.702833                 2  \n",
      "359           45.565821                 2  \n",
      "360           40.159220                 2  \n",
      "Entries for Mouse ID: s710\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "361     s710    Capomulin  Female           1          23          0   \n",
      "362     s710    Capomulin  Female           1          23          5   \n",
      "363     s710    Capomulin  Female           1          23         10   \n",
      "364     s710    Capomulin  Female           1          23         15   \n",
      "365     s710    Capomulin  Female           1          23         20   \n",
      "366     s710    Capomulin  Female           1          23         25   \n",
      "367     s710    Capomulin  Female           1          23         30   \n",
      "368     s710    Capomulin  Female           1          23         35   \n",
      "369     s710    Capomulin  Female           1          23         40   \n",
      "370     s710    Capomulin  Female           1          23         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "361           45.000000                 0  \n",
      "362           43.180977                 0  \n",
      "363           43.688026                 0  \n",
      "364           41.845235                 0  \n",
      "365           42.629963                 1  \n",
      "366           43.060409                 1  \n",
      "367           43.571703                 1  \n",
      "368           44.160519                 1  \n",
      "369           40.171920                 1  \n",
      "370           40.728578                 1  \n",
      "Entries for Mouse ID: l509\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "371     l509    Capomulin  Male          17          21          0   \n",
      "372     l509    Capomulin  Male          17          21          5   \n",
      "373     l509    Capomulin  Male          17          21         10   \n",
      "374     l509    Capomulin  Male          17          21         15   \n",
      "375     l509    Capomulin  Male          17          21         20   \n",
      "376     l509    Capomulin  Male          17          21         25   \n",
      "377     l509    Capomulin  Male          17          21         30   \n",
      "378     l509    Capomulin  Male          17          21         35   \n",
      "379     l509    Capomulin  Male          17          21         40   \n",
      "380     l509    Capomulin  Male          17          21         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "371           45.000000                 0  \n",
      "372           45.851193                 0  \n",
      "373           46.759074                 0  \n",
      "374           47.488599                 1  \n",
      "375           48.070452                 2  \n",
      "376           44.006257                 2  \n",
      "377           44.708055                 2  \n",
      "378           40.207288                 2  \n",
      "379           40.770813                 2  \n",
      "380           41.483008                 3  \n",
      "Entries for Mouse ID: r944\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "381     r944    Capomulin  Male          12          25          0   \n",
      "382     r944    Capomulin  Male          12          25          5   \n",
      "383     r944    Capomulin  Male          12          25         10   \n",
      "384     r944    Capomulin  Male          12          25         15   \n",
      "385     r944    Capomulin  Male          12          25         20   \n",
      "386     r944    Capomulin  Male          12          25         25   \n",
      "387     r944    Capomulin  Male          12          25         30   \n",
      "388     r944    Capomulin  Male          12          25         35   \n",
      "389     r944    Capomulin  Male          12          25         40   \n",
      "390     r944    Capomulin  Male          12          25         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "381           45.000000                 0  \n",
      "382           45.737145                 0  \n",
      "383           46.544292                 0  \n",
      "384           47.373423                 0  \n",
      "385           43.225671                 1  \n",
      "386           41.086991                 1  \n",
      "387           41.680791                 1  \n",
      "388           40.401765                 2  \n",
      "389           41.042045                 2  \n",
      "390           41.581521                 2  \n",
      "Entries for Mouse ID: e662\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "391     e662     Ramicane  Male           8          24          0   \n",
      "392     e662     Ramicane  Male           8          24          5   \n",
      "393     e662     Ramicane  Male           8          24         10   \n",
      "394     e662     Ramicane  Male           8          24         15   \n",
      "395     e662     Ramicane  Male           8          24         20   \n",
      "396     e662     Ramicane  Male           8          24         25   \n",
      "397     e662     Ramicane  Male           8          24         30   \n",
      "398     e662     Ramicane  Male           8          24         35   \n",
      "399     e662     Ramicane  Male           8          24         40   \n",
      "400     e662     Ramicane  Male           8          24         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "391           45.000000                 0  \n",
      "392           45.816283                 0  \n",
      "393           46.409084                 0  \n",
      "394           43.553773                 0  \n",
      "395           44.001296                 0  \n",
      "396           44.664594                 1  \n",
      "397           45.350232                 1  \n",
      "398           43.220276                 1  \n",
      "399           44.006724                 2  \n",
      "400           40.659006                 2  \n",
      "Entries for Mouse ID: u196\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "401     u196     Ramicane  Male          18          25          0   \n",
      "402     u196     Ramicane  Male          18          25          5   \n",
      "403     u196     Ramicane  Male          18          25         10   \n",
      "404     u196     Ramicane  Male          18          25         15   \n",
      "405     u196     Ramicane  Male          18          25         20   \n",
      "406     u196     Ramicane  Male          18          25         25   \n",
      "407     u196     Ramicane  Male          18          25         30   \n",
      "408     u196     Ramicane  Male          18          25         35   \n",
      "409     u196     Ramicane  Male          18          25         40   \n",
      "410     u196     Ramicane  Male          18          25         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "401           45.000000                 0  \n",
      "402           45.557464                 1  \n",
      "403           46.422943                 1  \n",
      "404           47.227171                 1  \n",
      "405           46.105363                 1  \n",
      "406           46.705325                 1  \n",
      "407           47.622816                 2  \n",
      "408           47.001465                 2  \n",
      "409           43.453687                 2  \n",
      "410           40.667713                 3  \n",
      "Entries for Mouse ID: q597\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "411     q597     Ramicane  Male          20          25          0   \n",
      "412     q597     Ramicane  Male          20          25          5   \n",
      "413     q597     Ramicane  Male          20          25         10   \n",
      "414     q597     Ramicane  Male          20          25         15   \n",
      "415     q597     Ramicane  Male          20          25         20   \n",
      "416     q597     Ramicane  Male          20          25         25   \n",
      "417     q597     Ramicane  Male          20          25         30   \n",
      "418     q597     Ramicane  Male          20          25         35   \n",
      "419     q597     Ramicane  Male          20          25         40   \n",
      "420     q597     Ramicane  Male          20          25         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "411           45.000000                 0  \n",
      "412           45.766111                 0  \n",
      "413           42.537986                 0  \n",
      "414           41.395660                 0  \n",
      "415           41.925587                 0  \n",
      "416           42.575707                 1  \n",
      "417           43.339161                 1  \n",
      "418           43.807201                 1  \n",
      "419           44.471821                 2  \n",
      "420           45.220869                 2  \n",
      "Entries for Mouse ID: a444\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "421     a444     Ramicane  Female          10          25          0   \n",
      "422     a444     Ramicane  Female          10          25          5   \n",
      "423     a444     Ramicane  Female          10          25         10   \n",
      "424     a444     Ramicane  Female          10          25         15   \n",
      "425     a444     Ramicane  Female          10          25         20   \n",
      "426     a444     Ramicane  Female          10          25         25   \n",
      "427     a444     Ramicane  Female          10          25         30   \n",
      "428     a444     Ramicane  Female          10          25         35   \n",
      "429     a444     Ramicane  Female          10          25         40   \n",
      "430     a444     Ramicane  Female          10          25         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "421           45.000000                 0  \n",
      "422           44.005975                 0  \n",
      "423           44.512560                 0  \n",
      "424           43.001280                 0  \n",
      "425           41.714619                 0  \n",
      "426           42.291394                 0  \n",
      "427           42.786278                 0  \n",
      "428           41.735951                 0  \n",
      "429           42.504926                 0  \n",
      "430           43.047543                 0  \n",
      "Entries for Mouse ID: i557\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "431     i557    Capomulin  Female           1          24          0   \n",
      "432     i557    Capomulin  Female           1          24          5   \n",
      "433     i557    Capomulin  Female           1          24         10   \n",
      "434     i557    Capomulin  Female           1          24         15   \n",
      "435     i557    Capomulin  Female           1          24         20   \n",
      "436     i557    Capomulin  Female           1          24         25   \n",
      "437     i557    Capomulin  Female           1          24         30   \n",
      "438     i557    Capomulin  Female           1          24         35   \n",
      "439     i557    Capomulin  Female           1          24         40   \n",
      "440     i557    Capomulin  Female           1          24         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "431           45.000000                 0  \n",
      "432           42.261665                 0  \n",
      "433           42.992077                 0  \n",
      "434           43.529876                 0  \n",
      "435           43.967895                 0  \n",
      "436           44.596219                 0  \n",
      "437           45.261384                 0  \n",
      "438           45.941949                 0  \n",
      "439           46.821070                 1  \n",
      "440           47.685963                 1  \n",
      "Entries for Mouse ID: r921\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "441     r921     Ramicane  Female           5          25          0   \n",
      "442     r921     Ramicane  Female           5          25          5   \n",
      "443     r921     Ramicane  Female           5          25         10   \n",
      "444     r921     Ramicane  Female           5          25         15   \n",
      "445     r921     Ramicane  Female           5          25         20   \n",
      "446     r921     Ramicane  Female           5          25         25   \n",
      "447     r921     Ramicane  Female           5          25         30   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "441           45.000000                 0  \n",
      "442           45.568211                 0  \n",
      "443           42.711927                 0  \n",
      "444           43.527261                 0  \n",
      "445           44.136316                 0  \n",
      "446           42.655341                 1  \n",
      "447           43.419381                 1  \n",
      "Entries for Mouse ID: w678\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "448     w678     Ramicane  Female           5          24          0   \n",
      "449     w678     Ramicane  Female           5          24          5   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "448           45.000000                 0  \n",
      "449           43.166373                 0  \n",
      "Entries for Mouse ID: y449\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "450     y449     Ramicane  Male          19          24          0   \n",
      "451     y449     Ramicane  Male          19          24          5   \n",
      "452     y449     Ramicane  Male          19          24         10   \n",
      "453     y449     Ramicane  Male          19          24         15   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "450           45.000000                 0  \n",
      "451           45.877545                 0  \n",
      "452           46.378092                 0  \n",
      "453           44.183451                 0  \n",
      "Entries for Mouse ID: a203\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "454     a203    Infubinol  Female          20          23          0   \n",
      "455     a203    Infubinol  Female          20          23          5   \n",
      "456     a203    Infubinol  Female          20          23         10   \n",
      "457     a203    Infubinol  Female          20          23         15   \n",
      "458     a203    Infubinol  Female          20          23         20   \n",
      "459     a203    Infubinol  Female          20          23         25   \n",
      "460     a203    Infubinol  Female          20          23         30   \n",
      "461     a203    Infubinol  Female          20          23         35   \n",
      "462     a203    Infubinol  Female          20          23         40   \n",
      "463     a203    Infubinol  Female          20          23         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "454           45.000000                 0  \n",
      "455           48.508468                 0  \n",
      "456           51.852437                 1  \n",
      "457           52.777870                 1  \n",
      "458           55.173336                 1  \n",
      "459           56.793208                 1  \n",
      "460           59.523197                 1  \n",
      "461           61.931650                 2  \n",
      "462           63.593490                 2  \n",
      "463           67.973419                 2  \n",
      "Entries for Mouse ID: a251\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "464     a251    Infubinol  Female          21          25          0   \n",
      "465     a251    Infubinol  Female          21          25          5   \n",
      "466     a251    Infubinol  Female          21          25         10   \n",
      "467     a251    Infubinol  Female          21          25         15   \n",
      "468     a251    Infubinol  Female          21          25         20   \n",
      "469     a251    Infubinol  Female          21          25         25   \n",
      "470     a251    Infubinol  Female          21          25         30   \n",
      "471     a251    Infubinol  Female          21          25         35   \n",
      "472     a251    Infubinol  Female          21          25         40   \n",
      "473     a251    Infubinol  Female          21          25         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "464           45.000000                 0  \n",
      "465           46.982127                 0  \n",
      "466           48.591179                 1  \n",
      "467           50.534456                 1  \n",
      "468           54.462594                 1  \n",
      "469           57.414646                 1  \n",
      "470           59.861241                 1  \n",
      "471           60.903885                 1  \n",
      "472           63.095076                 1  \n",
      "473           65.525743                 1  \n",
      "Entries for Mouse ID: a262\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "474     a262      Placebo  Female          17          29          0   \n",
      "475     a262      Placebo  Female          17          29          5   \n",
      "476     a262      Placebo  Female          17          29         10   \n",
      "477     a262      Placebo  Female          17          29         15   \n",
      "478     a262      Placebo  Female          17          29         20   \n",
      "479     a262      Placebo  Female          17          29         25   \n",
      "480     a262      Placebo  Female          17          29         30   \n",
      "481     a262      Placebo  Female          17          29         35   \n",
      "482     a262      Placebo  Female          17          29         40   \n",
      "483     a262      Placebo  Female          17          29         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "474           45.000000                 0  \n",
      "475           48.717568                 1  \n",
      "476           49.595181                 1  \n",
      "477           53.827974                 2  \n",
      "478           57.013313                 2  \n",
      "479           60.131862                 2  \n",
      "480           64.958092                 3  \n",
      "481           66.561963                 4  \n",
      "482           69.592732                 4  \n",
      "483           70.717621                 4  \n",
      "Entries for Mouse ID: a275\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "484     a275     Ceftamin  Female          20          28          0   \n",
      "485     a275     Ceftamin  Female          20          28          5   \n",
      "486     a275     Ceftamin  Female          20          28         10   \n",
      "487     a275     Ceftamin  Female          20          28         15   \n",
      "488     a275     Ceftamin  Female          20          28         20   \n",
      "489     a275     Ceftamin  Female          20          28         25   \n",
      "490     a275     Ceftamin  Female          20          28         30   \n",
      "491     a275     Ceftamin  Female          20          28         35   \n",
      "492     a275     Ceftamin  Female          20          28         40   \n",
      "493     a275     Ceftamin  Female          20          28         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "484           45.000000                 0  \n",
      "485           46.795257                 0  \n",
      "486           47.371343                 0  \n",
      "487           49.734404                 0  \n",
      "488           50.513437                 1  \n",
      "489           53.576064                 1  \n",
      "490           54.444713                 2  \n",
      "491           56.353538                 2  \n",
      "492           60.921539                 3  \n",
      "493           62.999356                 3  \n",
      "Entries for Mouse ID: a366\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "494     a366     Stelasyn  Female          16          29          0   \n",
      "495     a366     Stelasyn  Female          16          29          5   \n",
      "496     a366     Stelasyn  Female          16          29         10   \n",
      "497     a366     Stelasyn  Female          16          29         15   \n",
      "498     a366     Stelasyn  Female          16          29         20   \n",
      "499     a366     Stelasyn  Female          16          29         25   \n",
      "500     a366     Stelasyn  Female          16          29         30   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "494           45.000000                 0  \n",
      "495           48.951368                 0  \n",
      "496           53.523990                 0  \n",
      "497           55.265582                 0  \n",
      "498           57.285987                 0  \n",
      "499           59.011728                 0  \n",
      "500           63.440686                 1  \n",
      "Entries for Mouse ID: a401\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "501     a401    Zoniferol  Female           8          25          0   \n",
      "502     a401    Zoniferol  Female           8          25          5   \n",
      "503     a401    Zoniferol  Female           8          25         10   \n",
      "504     a401    Zoniferol  Female           8          25         15   \n",
      "505     a401    Zoniferol  Female           8          25         20   \n",
      "506     a401    Zoniferol  Female           8          25         25   \n",
      "507     a401    Zoniferol  Female           8          25         30   \n",
      "508     a401    Zoniferol  Female           8          25         35   \n",
      "509     a401    Zoniferol  Female           8          25         40   \n",
      "510     a401    Zoniferol  Female           8          25         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "501           45.000000                 0  \n",
      "502           46.111986                 0  \n",
      "503           47.725937                 1  \n",
      "504           49.934725                 1  \n",
      "505           52.204511                 2  \n",
      "506           54.209836                 3  \n",
      "507           55.910162                 3  \n",
      "508           60.347145                 3  \n",
      "509           61.768605                 4  \n",
      "510           66.794156                 4  \n",
      "Entries for Mouse ID: a457\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "511     a457     Ketapril  Female          11          30          0   \n",
      "512     a457     Ketapril  Female          11          30          5   \n",
      "513     a457     Ketapril  Female          11          30         10   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "511           45.000000                 0  \n",
      "512           47.462891                 0  \n",
      "513           49.783419                 0  \n",
      "Entries for Mouse ID: a492\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "514     a492     Stelasyn  Male          20          25          0   \n",
      "515     a492     Stelasyn  Male          20          25          5   \n",
      "516     a492     Stelasyn  Male          20          25         10   \n",
      "517     a492     Stelasyn  Male          20          25         15   \n",
      "518     a492     Stelasyn  Male          20          25         20   \n",
      "519     a492     Stelasyn  Male          20          25         25   \n",
      "520     a492     Stelasyn  Male          20          25         30   \n",
      "521     a492     Stelasyn  Male          20          25         35   \n",
      "522     a492     Stelasyn  Male          20          25         40   \n",
      "523     a492     Stelasyn  Male          20          25         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "514           45.000000                 0  \n",
      "515           46.409143                 0  \n",
      "516           48.432197                 0  \n",
      "517           51.985263                 0  \n",
      "518           53.677193                 0  \n",
      "519           54.701229                 1  \n",
      "520           56.201041                 1  \n",
      "521           57.308554                 1  \n",
      "522           57.928499                 1  \n",
      "523           60.122011                 1  \n",
      "Entries for Mouse ID: a577\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "524     a577    Infubinol  Female           6          25          0   \n",
      "525     a577    Infubinol  Female           6          25          5   \n",
      "526     a577    Infubinol  Female           6          25         10   \n",
      "527     a577    Infubinol  Female           6          25         15   \n",
      "528     a577    Infubinol  Female           6          25         20   \n",
      "529     a577    Infubinol  Female           6          25         25   \n",
      "530     a577    Infubinol  Female           6          25         30   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "524           45.000000                 0  \n",
      "525           46.197720                 1  \n",
      "526           49.509639                 1  \n",
      "527           50.915007                 2  \n",
      "528           52.365185                 2  \n",
      "529           54.380932                 2  \n",
      "530           57.031862                 2  \n",
      "Entries for Mouse ID: a685\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "531     a685    Infubinol  Male           8          30          0   \n",
      "532     a685    Infubinol  Male           8          30          5   \n",
      "533     a685    Infubinol  Male           8          30         10   \n",
      "534     a685    Infubinol  Male           8          30         15   \n",
      "535     a685    Infubinol  Male           8          30         20   \n",
      "536     a685    Infubinol  Male           8          30         25   \n",
      "537     a685    Infubinol  Male           8          30         30   \n",
      "538     a685    Infubinol  Male           8          30         35   \n",
      "539     a685    Infubinol  Male           8          30         40   \n",
      "540     a685    Infubinol  Male           8          30         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "531           45.000000                 0  \n",
      "532           46.870483                 0  \n",
      "533           47.664753                 0  \n",
      "534           48.951474                 0  \n",
      "535           49.490559                 0  \n",
      "536           51.939951                 0  \n",
      "537           55.453855                 1  \n",
      "538           58.092629                 1  \n",
      "539           60.567904                 2  \n",
      "540           66.083066                 3  \n",
      "Entries for Mouse ID: a699\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "541     a699     Propriva  Female           5          28          0   \n",
      "542     a699     Propriva  Female           5          28          5   \n",
      "543     a699     Propriva  Female           5          28         10   \n",
      "544     a699     Propriva  Female           5          28         15   \n",
      "545     a699     Propriva  Female           5          28         20   \n",
      "546     a699     Propriva  Female           5          28         25   \n",
      "547     a699     Propriva  Female           5          28         30   \n",
      "548     a699     Propriva  Female           5          28         35   \n",
      "549     a699     Propriva  Female           5          28         40   \n",
      "550     a699     Propriva  Female           5          28         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "541           45.000000                 0  \n",
      "542           46.553090                 0  \n",
      "543           47.867376                 0  \n",
      "544           49.530401                 0  \n",
      "545           50.712423                 0  \n",
      "546           51.846381                 0  \n",
      "547           54.379345                 0  \n",
      "548           56.510682                 1  \n",
      "549           58.605448                 1  \n",
      "550           62.191414                 1  \n",
      "Entries for Mouse ID: a788\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "551     a788    Zoniferol  Male           5          30          0   \n",
      "552     a788    Zoniferol  Male           5          30          5   \n",
      "553     a788    Zoniferol  Male           5          30         10   \n",
      "554     a788    Zoniferol  Male           5          30         15   \n",
      "555     a788    Zoniferol  Male           5          30         20   \n",
      "556     a788    Zoniferol  Male           5          30         25   \n",
      "557     a788    Zoniferol  Male           5          30         30   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "551           45.000000                 0  \n",
      "552           47.006580                 0  \n",
      "553           50.159721                 1  \n",
      "554           52.539949                 1  \n",
      "555           54.060983                 1  \n",
      "556           56.770280                 1  \n",
      "557           60.413709                 1  \n",
      "Entries for Mouse ID: a818\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "558     a818     Naftisol  Female          12          28          0   \n",
      "559     a818     Naftisol  Female          12          28          5   \n",
      "560     a818     Naftisol  Female          12          28         10   \n",
      "561     a818     Naftisol  Female          12          28         15   \n",
      "562     a818     Naftisol  Female          12          28         20   \n",
      "563     a818     Naftisol  Female          12          28         25   \n",
      "564     a818     Naftisol  Female          12          28         30   \n",
      "565     a818     Naftisol  Female          12          28         35   \n",
      "566     a818     Naftisol  Female          12          28         40   \n",
      "567     a818     Naftisol  Female          12          28         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "558           45.000000                 0  \n",
      "559           45.696709                 0  \n",
      "560           49.790919                 0  \n",
      "561           51.227566                 0  \n",
      "562           54.834624                 0  \n",
      "563           56.966273                 0  \n",
      "564           60.072372                 0  \n",
      "565           63.298546                 0  \n",
      "566           69.273814                 1  \n",
      "567           74.997764                 2  \n",
      "Entries for Mouse ID: a897\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "568     a897      Placebo  Male           7          28          0   \n",
      "569     a897      Placebo  Male           7          28          5   \n",
      "570     a897      Placebo  Male           7          28         10   \n",
      "571     a897      Placebo  Male           7          28         15   \n",
      "572     a897      Placebo  Male           7          28         20   \n",
      "573     a897      Placebo  Male           7          28         25   \n",
      "574     a897      Placebo  Male           7          28         30   \n",
      "575     a897      Placebo  Male           7          28         35   \n",
      "576     a897      Placebo  Male           7          28         40   \n",
      "577     a897      Placebo  Male           7          28         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "568           45.000000                 0  \n",
      "569           45.691124                 1  \n",
      "570           47.972927                 1  \n",
      "571           52.343085                 2  \n",
      "572           54.595705                 3  \n",
      "573           56.413320                 3  \n",
      "574           59.916934                 3  \n",
      "575           64.052873                 3  \n",
      "576           67.211743                 4  \n",
      "577           72.255963                 4  \n",
      "Entries for Mouse ID: a963\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "578     a963     Stelasyn  Female          23          27          0   \n",
      "579     a963     Stelasyn  Female          23          27          5   \n",
      "580     a963     Stelasyn  Female          23          27         10   \n",
      "581     a963     Stelasyn  Female          23          27         15   \n",
      "582     a963     Stelasyn  Female          23          27         20   \n",
      "583     a963     Stelasyn  Female          23          27         25   \n",
      "584     a963     Stelasyn  Female          23          27         30   \n",
      "585     a963     Stelasyn  Female          23          27         35   \n",
      "586     a963     Stelasyn  Female          23          27         40   \n",
      "587     a963     Stelasyn  Female          23          27         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "578           45.000000                 0  \n",
      "579           46.233506                 0  \n",
      "580           47.150522                 0  \n",
      "581           47.836852                 0  \n",
      "582           51.463734                 0  \n",
      "583           52.129804                 0  \n",
      "584           53.401667                 1  \n",
      "585           56.813976                 1  \n",
      "586           58.463787                 1  \n",
      "587           62.765093                 1  \n",
      "Entries for Mouse ID: b313\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "588     b313    Zoniferol  Male          12          27          0   \n",
      "589     b313    Zoniferol  Male          12          27          5   \n",
      "590     b313    Zoniferol  Male          12          27         10   \n",
      "591     b313    Zoniferol  Male          12          27         15   \n",
      "592     b313    Zoniferol  Male          12          27         20   \n",
      "593     b313    Zoniferol  Male          12          27         25   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "588           45.000000                 0  \n",
      "589           47.154433                 0  \n",
      "590           48.319372                 1  \n",
      "591           49.188387                 1  \n",
      "592           53.979680                 1  \n",
      "593           55.745146                 1  \n",
      "Entries for Mouse ID: b487\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "595     b487     Ceftamin  Female           6          28          0   \n",
      "596     b487     Ceftamin  Female           6          28          5   \n",
      "597     b487     Ceftamin  Female           6          28         10   \n",
      "598     b487     Ceftamin  Female           6          28         15   \n",
      "599     b487     Ceftamin  Female           6          28         20   \n",
      "600     b487     Ceftamin  Female           6          28         25   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "595           45.000000                 0  \n",
      "596           46.213977                 0  \n",
      "597           47.664387                 0  \n",
      "598           51.683256                 0  \n",
      "599           53.427663                 0  \n",
      "600           56.057749                 1  \n",
      "Entries for Mouse ID: b559\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "601     b559     Naftisol  Male          20          26          0   \n",
      "602     b559     Naftisol  Male          20          26          5   \n",
      "603     b559     Naftisol  Male          20          26         10   \n",
      "604     b559     Naftisol  Male          20          26         15   \n",
      "605     b559     Naftisol  Male          20          26         20   \n",
      "606     b559     Naftisol  Male          20          26         25   \n",
      "607     b559     Naftisol  Male          20          26         30   \n",
      "608     b559     Naftisol  Male          20          26         35   \n",
      "609     b559     Naftisol  Male          20          26         40   \n",
      "610     b559     Naftisol  Male          20          26         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "601           45.000000                 0  \n",
      "602           47.409897                 0  \n",
      "603           48.036432                 0  \n",
      "604           51.378862                 0  \n",
      "605           55.654456                 1  \n",
      "606           57.043669                 1  \n",
      "607           61.190387                 1  \n",
      "608           65.705763                 1  \n",
      "609           69.969616                 1  \n",
      "610           73.051363                 1  \n",
      "Entries for Mouse ID: b759\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "611     b759     Ceftamin  Female          12          25          0   \n",
      "612     b759     Ceftamin  Female          12          25          5   \n",
      "613     b759     Ceftamin  Female          12          25         10   \n",
      "614     b759     Ceftamin  Female          12          25         15   \n",
      "615     b759     Ceftamin  Female          12          25         20   \n",
      "616     b759     Ceftamin  Female          12          25         25   \n",
      "617     b759     Ceftamin  Female          12          25         30   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "611           45.000000                 0  \n",
      "612           48.009190                 0  \n",
      "613           49.133355                 0  \n",
      "614           51.587799                 0  \n",
      "615           54.443035                 0  \n",
      "616           55.083632                 0  \n",
      "617           55.742829                 1  \n",
      "Entries for Mouse ID: b879\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "618     b879     Stelasyn  Female           4          26          0   \n",
      "619     b879     Stelasyn  Female           4          26          5   \n",
      "620     b879     Stelasyn  Female           4          26         10   \n",
      "621     b879     Stelasyn  Female           4          26         15   \n",
      "622     b879     Stelasyn  Female           4          26         20   \n",
      "623     b879     Stelasyn  Female           4          26         25   \n",
      "624     b879     Stelasyn  Female           4          26         30   \n",
      "625     b879     Stelasyn  Female           4          26         35   \n",
      "626     b879     Stelasyn  Female           4          26         40   \n",
      "627     b879     Stelasyn  Female           4          26         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "618           45.000000                 0  \n",
      "619           49.156156                 1  \n",
      "620           50.338946                 1  \n",
      "621           51.618387                 1  \n",
      "622           53.983436                 1  \n",
      "623           56.469987                 2  \n",
      "624           60.907615                 2  \n",
      "625           64.260886                 2  \n",
      "626           67.189127                 2  \n",
      "627           72.555239                 2  \n",
      "Entries for Mouse ID: c139\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "628     c139    Infubinol  Male          11          28          0   \n",
      "629     c139    Infubinol  Male          11          28          5   \n",
      "630     c139    Infubinol  Male          11          28         10   \n",
      "631     c139    Infubinol  Male          11          28         15   \n",
      "632     c139    Infubinol  Male          11          28         20   \n",
      "633     c139    Infubinol  Male          11          28         25   \n",
      "634     c139    Infubinol  Male          11          28         30   \n",
      "635     c139    Infubinol  Male          11          28         35   \n",
      "636     c139    Infubinol  Male          11          28         40   \n",
      "637     c139    Infubinol  Male          11          28         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "628           45.000000                 0  \n",
      "629           48.753112                 0  \n",
      "630           49.992954                 0  \n",
      "631           51.833225                 0  \n",
      "632           56.742007                 0  \n",
      "633           61.461970                 0  \n",
      "634           64.149871                 1  \n",
      "635           67.821420                 1  \n",
      "636           69.428141                 2  \n",
      "637           72.226731                 2  \n",
      "Entries for Mouse ID: c264\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "638     c264    Zoniferol  Female          11          27          0   \n",
      "639     c264    Zoniferol  Female          11          27          5   \n",
      "640     c264    Zoniferol  Female          11          27         10   \n",
      "641     c264    Zoniferol  Female          11          27         15   \n",
      "642     c264    Zoniferol  Female          11          27         20   \n",
      "643     c264    Zoniferol  Female          11          27         25   \n",
      "644     c264    Zoniferol  Female          11          27         30   \n",
      "645     c264    Zoniferol  Female          11          27         35   \n",
      "646     c264    Zoniferol  Female          11          27         40   \n",
      "647     c264    Zoniferol  Female          11          27         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "638           45.000000                 0  \n",
      "639           45.791704                 0  \n",
      "640           49.026592                 0  \n",
      "641           53.664942                 1  \n",
      "642           54.568196                 1  \n",
      "643           56.966769                 2  \n",
      "644           57.823916                 2  \n",
      "645           61.074795                 2  \n",
      "646           65.708323                 2  \n",
      "647           67.942121                 2  \n",
      "Entries for Mouse ID: c282\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "648     c282      Placebo  Male          12          27          0   \n",
      "649     c282      Placebo  Male          12          27          5   \n",
      "650     c282      Placebo  Male          12          27         10   \n",
      "651     c282      Placebo  Male          12          27         15   \n",
      "652     c282      Placebo  Male          12          27         20   \n",
      "653     c282      Placebo  Male          12          27         25   \n",
      "654     c282      Placebo  Male          12          27         30   \n",
      "655     c282      Placebo  Male          12          27         35   \n",
      "656     c282      Placebo  Male          12          27         40   \n",
      "657     c282      Placebo  Male          12          27         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "648           45.000000                 0  \n",
      "649           45.725690                 0  \n",
      "650           48.179506                 0  \n",
      "651           49.266079                 0  \n",
      "652           51.950574                 0  \n",
      "653           56.292200                 1  \n",
      "654           59.005902                 1  \n",
      "655           59.887655                 1  \n",
      "656           65.021799                 2  \n",
      "657           65.815165                 2  \n",
      "Entries for Mouse ID: c302\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "658     c302    Zoniferol  Female          10          29          0   \n",
      "659     c302    Zoniferol  Female          10          29          5   \n",
      "660     c302    Zoniferol  Female          10          29         10   \n",
      "661     c302    Zoniferol  Female          10          29         15   \n",
      "662     c302    Zoniferol  Female          10          29         20   \n",
      "663     c302    Zoniferol  Female          10          29         25   \n",
      "664     c302    Zoniferol  Female          10          29         30   \n",
      "665     c302    Zoniferol  Female          10          29         35   \n",
      "666     c302    Zoniferol  Female          10          29         40   \n",
      "667     c302    Zoniferol  Female          10          29         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "658           45.000000                 0  \n",
      "659           47.690680                 1  \n",
      "660           48.533567                 1  \n",
      "661           52.716635                 2  \n",
      "662           54.080908                 3  \n",
      "663           55.076229                 3  \n",
      "664           57.419744                 3  \n",
      "665           62.236572                 3  \n",
      "666           63.281071                 4  \n",
      "667           64.575222                 4  \n",
      "Entries for Mouse ID: c326\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "668     c326    Infubinol  Female          18          25          0   \n",
      "669     c326    Infubinol  Female          18          25          5   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "668           45.000000                 0  \n",
      "669           36.321346                 0  \n",
      "Entries for Mouse ID: c402\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "670     c402     Stelasyn  Female           1          27          0   \n",
      "671     c402     Stelasyn  Female           1          27          5   \n",
      "672     c402     Stelasyn  Female           1          27         10   \n",
      "673     c402     Stelasyn  Female           1          27         15   \n",
      "674     c402     Stelasyn  Female           1          27         20   \n",
      "675     c402     Stelasyn  Female           1          27         25   \n",
      "676     c402     Stelasyn  Female           1          27         30   \n",
      "677     c402     Stelasyn  Female           1          27         35   \n",
      "678     c402     Stelasyn  Female           1          27         40   \n",
      "679     c402     Stelasyn  Female           1          27         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "670           45.000000                 0  \n",
      "671           49.342630                 1  \n",
      "672           50.566894                 1  \n",
      "673           52.230719                 1  \n",
      "674           54.883320                 2  \n",
      "675           58.269889                 2  \n",
      "676           63.743194                 2  \n",
      "677           65.807963                 2  \n",
      "678           70.222297                 2  \n",
      "679           74.040390                 3  \n",
      "Entries for Mouse ID: c559\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "680     c559    Zoniferol  Female          19          28          0   \n",
      "681     c559    Zoniferol  Female          19          28          5   \n",
      "682     c559    Zoniferol  Female          19          28         10   \n",
      "683     c559    Zoniferol  Female          19          28         15   \n",
      "684     c559    Zoniferol  Female          19          28         20   \n",
      "685     c559    Zoniferol  Female          19          28         25   \n",
      "686     c559    Zoniferol  Female          19          28         30   \n",
      "687     c559    Zoniferol  Female          19          28         35   \n",
      "688     c559    Zoniferol  Female          19          28         40   \n",
      "689     c559    Zoniferol  Female          19          28         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "680           45.000000                 0  \n",
      "681           46.562638                 0  \n",
      "682           47.293260                 0  \n",
      "683           51.414904                 1  \n",
      "684           52.604367                 2  \n",
      "685           54.555442                 2  \n",
      "686           57.146144                 2  \n",
      "687           59.455041                 2  \n",
      "688           60.861844                 3  \n",
      "689           61.840058                 4  \n",
      "Entries for Mouse ID: c580\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "690     c580     Ketapril  Male          22          25          0   \n",
      "691     c580     Ketapril  Male          22          25          5   \n",
      "692     c580     Ketapril  Male          22          25         10   \n",
      "693     c580     Ketapril  Male          22          25         15   \n",
      "694     c580     Ketapril  Male          22          25         20   \n",
      "695     c580     Ketapril  Male          22          25         25   \n",
      "696     c580     Ketapril  Male          22          25         30   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "690           45.000000                 0  \n",
      "691           46.628455                 0  \n",
      "692           47.570174                 1  \n",
      "693           51.991708                 1  \n",
      "694           55.575322                 2  \n",
      "695           56.289062                 2  \n",
      "696           58.046569                 3  \n",
      "Entries for Mouse ID: c757\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "697     c757      Placebo  Male           9          27          0   \n",
      "698     c757      Placebo  Male           9          27          5   \n",
      "699     c757      Placebo  Male           9          27         10   \n",
      "700     c757      Placebo  Male           9          27         15   \n",
      "701     c757      Placebo  Male           9          27         20   \n",
      "702     c757      Placebo  Male           9          27         25   \n",
      "703     c757      Placebo  Male           9          27         30   \n",
      "704     c757      Placebo  Male           9          27         35   \n",
      "705     c757      Placebo  Male           9          27         40   \n",
      "706     c757      Placebo  Male           9          27         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "697           45.000000                 0  \n",
      "698           47.783280                 0  \n",
      "699           49.219317                 0  \n",
      "700           51.532603                 0  \n",
      "701           52.818634                 1  \n",
      "702           57.106418                 2  \n",
      "703           60.098572                 2  \n",
      "704           64.291164                 2  \n",
      "705           66.604368                 2  \n",
      "706           69.042841                 3  \n",
      "Entries for Mouse ID: c766\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "707     c766      Placebo  Female          13          26          0   \n",
      "708     c766      Placebo  Female          13          26          5   \n",
      "709     c766      Placebo  Female          13          26         10   \n",
      "710     c766      Placebo  Female          13          26         15   \n",
      "711     c766      Placebo  Female          13          26         20   \n",
      "712     c766      Placebo  Female          13          26         25   \n",
      "713     c766      Placebo  Female          13          26         30   \n",
      "714     c766      Placebo  Female          13          26         35   \n",
      "715     c766      Placebo  Female          13          26         40   \n",
      "716     c766      Placebo  Female          13          26         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "707           45.000000                 0  \n",
      "708           47.313055                 0  \n",
      "709           49.500271                 1  \n",
      "710           50.596633                 2  \n",
      "711           53.006865                 3  \n",
      "712           58.214624                 3  \n",
      "713           60.255924                 3  \n",
      "714           65.952368                 4  \n",
      "715           67.685295                 4  \n",
      "716           69.823146                 4  \n",
      "Entries for Mouse ID: c819\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "717     c819     Ketapril  Male          21          25          0   \n",
      "718     c819     Ketapril  Male          21          25          5   \n",
      "719     c819     Ketapril  Male          21          25         10   \n",
      "720     c819     Ketapril  Male          21          25         15   \n",
      "721     c819     Ketapril  Male          21          25         20   \n",
      "722     c819     Ketapril  Male          21          25         25   \n",
      "723     c819     Ketapril  Male          21          25         30   \n",
      "724     c819     Ketapril  Male          21          25         35   \n",
      "725     c819     Ketapril  Male          21          25         40   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "717           45.000000                 0  \n",
      "718           45.769249                 1  \n",
      "719           46.658395                 1  \n",
      "720           48.370999                 1  \n",
      "721           49.762415                 1  \n",
      "722           51.828357                 1  \n",
      "723           56.098998                 1  \n",
      "724           57.729535                 1  \n",
      "725           62.175705                 1  \n",
      "Entries for Mouse ID: c832\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "726     c832     Ketapril  Male          18          29          0   \n",
      "727     c832     Ketapril  Male          18          29          5   \n",
      "728     c832     Ketapril  Male          18          29         10   \n",
      "729     c832     Ketapril  Male          18          29         15   \n",
      "730     c832     Ketapril  Male          18          29         20   \n",
      "731     c832     Ketapril  Male          18          29         25   \n",
      "732     c832     Ketapril  Male          18          29         30   \n",
      "733     c832     Ketapril  Male          18          29         35   \n",
      "734     c832     Ketapril  Male          18          29         40   \n",
      "735     c832     Ketapril  Male          18          29         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "726           45.000000                 0  \n",
      "727           48.685461                 1  \n",
      "728           49.811413                 1  \n",
      "729           52.864534                 1  \n",
      "730           56.710234                 1  \n",
      "731           58.891816                 2  \n",
      "732           60.496376                 2  \n",
      "733           61.124487                 2  \n",
      "734           62.572318                 2  \n",
      "735           65.415955                 3  \n",
      "Entries for Mouse ID: c895\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "736     c895    Infubinol  Female           7          29          0   \n",
      "737     c895    Infubinol  Female           7          29          5   \n",
      "738     c895    Infubinol  Female           7          29         10   \n",
      "739     c895    Infubinol  Female           7          29         15   \n",
      "740     c895    Infubinol  Female           7          29         20   \n",
      "741     c895    Infubinol  Female           7          29         25   \n",
      "742     c895    Infubinol  Female           7          29         30   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "736           45.000000                 0  \n",
      "737           45.477544                 0  \n",
      "738           49.779015                 0  \n",
      "739           52.949465                 1  \n",
      "740           53.676840                 2  \n",
      "741           57.534193                 2  \n",
      "742           60.969711                 2  \n",
      "Entries for Mouse ID: c927\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "743     c927     Propriva  Female           4          26          0   \n",
      "744     c927     Propriva  Female           4          26          5   \n",
      "745     c927     Propriva  Female           4          26         10   \n",
      "746     c927     Propriva  Female           4          26         15   \n",
      "747     c927     Propriva  Female           4          26         20   \n",
      "748     c927     Propriva  Female           4          26         25   \n",
      "749     c927     Propriva  Female           4          26         30   \n",
      "750     c927     Propriva  Female           4          26         35   \n",
      "751     c927     Propriva  Female           4          26         40   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "743           45.000000                 0  \n",
      "744           46.351842                 0  \n",
      "745           50.965298                 1  \n",
      "746           53.266431                 1  \n",
      "747           55.481689                 1  \n",
      "748           56.545519                 2  \n",
      "749           60.753925                 2  \n",
      "750           61.872274                 3  \n",
      "751           64.183229                 4  \n",
      "Entries for Mouse ID: d164\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "753     d164    Zoniferol  Male          21          28          0   \n",
      "754     d164    Zoniferol  Male          21          28          5   \n",
      "755     d164    Zoniferol  Male          21          28         10   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "753           45.000000                 0  \n",
      "754           46.617671                 0  \n",
      "755           47.474645                 1  \n",
      "Entries for Mouse ID: d474\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "756     d474     Ketapril  Male          18          27          0   \n",
      "757     d474     Ketapril  Male          18          27          5   \n",
      "758     d474     Ketapril  Male          18          27         10   \n",
      "759     d474     Ketapril  Male          18          27         15   \n",
      "760     d474     Ketapril  Male          18          27         20   \n",
      "761     d474     Ketapril  Male          18          27         25   \n",
      "762     d474     Ketapril  Male          18          27         30   \n",
      "763     d474     Ketapril  Male          18          27         35   \n",
      "764     d474     Ketapril  Male          18          27         40   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "756           45.000000                 0  \n",
      "757           45.918352                 0  \n",
      "758           46.974963                 0  \n",
      "759           47.777936                 0  \n",
      "760           51.731494                 0  \n",
      "761           54.279325                 0  \n",
      "762           55.341342                 0  \n",
      "763           56.479113                 0  \n",
      "764           60.233733                 1  \n",
      "Entries for Mouse ID: e213\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "765     e213     Naftisol  Male           8          27          0   \n",
      "766     e213     Naftisol  Male           8          27          5   \n",
      "767     e213     Naftisol  Male           8          27         10   \n",
      "768     e213     Naftisol  Male           8          27         15   \n",
      "769     e213     Naftisol  Male           8          27         20   \n",
      "770     e213     Naftisol  Male           8          27         25   \n",
      "771     e213     Naftisol  Male           8          27         30   \n",
      "772     e213     Naftisol  Male           8          27         35   \n",
      "773     e213     Naftisol  Male           8          27         40   \n",
      "774     e213     Naftisol  Male           8          27         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "765           45.000000                 0  \n",
      "766           45.699250                 1  \n",
      "767           47.391571                 2  \n",
      "768           51.791695                 2  \n",
      "769           52.613763                 2  \n",
      "770           55.224476                 2  \n",
      "771           56.458729                 3  \n",
      "772           58.245854                 3  \n",
      "773           60.236548                 3  \n",
      "774           63.105696                 4  \n",
      "Entries for Mouse ID: e227\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "775     e227      Placebo  Male           1          30          0   \n",
      "776     e227      Placebo  Male           1          30          5   \n",
      "777     e227      Placebo  Male           1          30         10   \n",
      "778     e227      Placebo  Male           1          30         15   \n",
      "779     e227      Placebo  Male           1          30         20   \n",
      "780     e227      Placebo  Male           1          30         25   \n",
      "781     e227      Placebo  Male           1          30         30   \n",
      "782     e227      Placebo  Male           1          30         35   \n",
      "783     e227      Placebo  Male           1          30         40   \n",
      "784     e227      Placebo  Male           1          30         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "775           45.000000                 0  \n",
      "776           47.238011                 0  \n",
      "777           51.349757                 1  \n",
      "778           52.833942                 1  \n",
      "779           56.607552                 1  \n",
      "780           60.600292                 1  \n",
      "781           62.464385                 2  \n",
      "782           66.949121                 3  \n",
      "783           70.715218                 3  \n",
      "784           73.212939                 3  \n",
      "Entries for Mouse ID: e291\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "785     e291     Naftisol  Female          14          29          0   \n",
      "786     e291     Naftisol  Female          14          29          5   \n",
      "787     e291     Naftisol  Female          14          29         10   \n",
      "788     e291     Naftisol  Female          14          29         15   \n",
      "789     e291     Naftisol  Female          14          29         20   \n",
      "790     e291     Naftisol  Female          14          29         25   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "785           45.000000                 0  \n",
      "786           46.142505                 0  \n",
      "787           48.529741                 1  \n",
      "788           49.348426                 1  \n",
      "789           52.533765                 1  \n",
      "790           55.138953                 2  \n",
      "Entries for Mouse ID: e476\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "791     e476    Infubinol  Male          23          26          0   \n",
      "792     e476    Infubinol  Male          23          26          5   \n",
      "793     e476    Infubinol  Male          23          26         10   \n",
      "794     e476    Infubinol  Male          23          26         15   \n",
      "795     e476    Infubinol  Male          23          26         20   \n",
      "796     e476    Infubinol  Male          23          26         25   \n",
      "797     e476    Infubinol  Male          23          26         30   \n",
      "798     e476    Infubinol  Male          23          26         35   \n",
      "799     e476    Infubinol  Male          23          26         40   \n",
      "800     e476    Infubinol  Male          23          26         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "791           45.000000                 0  \n",
      "792           47.111801                 0  \n",
      "793           49.431685                 0  \n",
      "794           54.046213                 0  \n",
      "795           55.249273                 0  \n",
      "796           57.408638                 0  \n",
      "797           57.992797                 1  \n",
      "798           60.064340                 1  \n",
      "799           61.525276                 1  \n",
      "800           62.435404                 1  \n",
      "Entries for Mouse ID: e584\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "801     e584     Naftisol  Male           9          27          0   \n",
      "802     e584     Naftisol  Male           9          27          5   \n",
      "803     e584     Naftisol  Male           9          27         10   \n",
      "804     e584     Naftisol  Male           9          27         15   \n",
      "805     e584     Naftisol  Male           9          27         20   \n",
      "806     e584     Naftisol  Male           9          27         25   \n",
      "807     e584     Naftisol  Male           9          27         30   \n",
      "808     e584     Naftisol  Male           9          27         35   \n",
      "809     e584     Naftisol  Male           9          27         40   \n",
      "810     e584     Naftisol  Male           9          27         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "801           45.000000                 0  \n",
      "802           45.656979                 0  \n",
      "803           47.250641                 0  \n",
      "804           48.430411                 1  \n",
      "805           50.344921                 2  \n",
      "806           51.386419                 2  \n",
      "807           54.984408                 3  \n",
      "808           58.086560                 3  \n",
      "809           62.816871                 4  \n",
      "810           68.359777                 4  \n",
      "Entries for Mouse ID: f129\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "811     f129    Zoniferol  Female          11          29          0   \n",
      "812     f129    Zoniferol  Female          11          29          5   \n",
      "813     f129    Zoniferol  Female          11          29         10   \n",
      "814     f129    Zoniferol  Female          11          29         15   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "811           45.000000                 0  \n",
      "812           47.000594                 0  \n",
      "813           48.179719                 1  \n",
      "814           49.988302                 1  \n",
      "Entries for Mouse ID: f234\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "815     f234     Stelasyn  Male          14          28          0   \n",
      "816     f234     Stelasyn  Male          14          28          5   \n",
      "817     f234     Stelasyn  Male          14          28         10   \n",
      "818     f234     Stelasyn  Male          14          28         15   \n",
      "819     f234     Stelasyn  Male          14          28         20   \n",
      "820     f234     Stelasyn  Male          14          28         25   \n",
      "821     f234     Stelasyn  Male          14          28         30   \n",
      "822     f234     Stelasyn  Male          14          28         35   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "815           45.000000                 0  \n",
      "816           47.313491                 0  \n",
      "817           47.904324                 0  \n",
      "818           48.735197                 1  \n",
      "819           51.112713                 2  \n",
      "820           52.178602                 2  \n",
      "821           56.873817                 2  \n",
      "822           57.748758                 2  \n",
      "Entries for Mouse ID: f278\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "823     f278     Ketapril  Male          12          30          0   \n",
      "824     f278     Ketapril  Male          12          30          5   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "823           45.000000                 0  \n",
      "824           48.194578                 0  \n",
      "Entries for Mouse ID: f345\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "825     f345    Infubinol  Male          23          26          0   \n",
      "826     f345    Infubinol  Male          23          26          5   \n",
      "827     f345    Infubinol  Male          23          26         10   \n",
      "828     f345    Infubinol  Male          23          26         15   \n",
      "829     f345    Infubinol  Male          23          26         20   \n",
      "830     f345    Infubinol  Male          23          26         25   \n",
      "831     f345    Infubinol  Male          23          26         30   \n",
      "832     f345    Infubinol  Male          23          26         35   \n",
      "833     f345    Infubinol  Male          23          26         40   \n",
      "834     f345    Infubinol  Male          23          26         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "825           45.000000                 0  \n",
      "826           45.591147                 0  \n",
      "827           47.222446                 0  \n",
      "828           48.352239                 0  \n",
      "829           49.613383                 0  \n",
      "830           53.078894                 0  \n",
      "831           54.363797                 1  \n",
      "832           56.523327                 1  \n",
      "833           58.315593                 1  \n",
      "834           60.918767                 1  \n",
      "Entries for Mouse ID: f394\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "835     f394    Zoniferol  Male          19          30          0   \n",
      "836     f394    Zoniferol  Male          19          30          5   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "835             45.0000                 0  \n",
      "836             47.0331                 0  \n",
      "Entries for Mouse ID: f436\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "837     f436     Ceftamin  Female           3          25          0   \n",
      "838     f436     Ceftamin  Female           3          25          5   \n",
      "839     f436     Ceftamin  Female           3          25         10   \n",
      "840     f436     Ceftamin  Female           3          25         15   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "837           45.000000                 0  \n",
      "838           46.370798                 1  \n",
      "839           48.146978                 2  \n",
      "840           48.722078                 2  \n",
      "Entries for Mouse ID: f545\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "841     f545    Zoniferol  Female          20          26          0   \n",
      "842     f545    Zoniferol  Female          20          26          5   \n",
      "843     f545    Zoniferol  Female          20          26         10   \n",
      "844     f545    Zoniferol  Female          20          26         15   \n",
      "845     f545    Zoniferol  Female          20          26         20   \n",
      "846     f545    Zoniferol  Female          20          26         25   \n",
      "847     f545    Zoniferol  Female          20          26         30   \n",
      "848     f545    Zoniferol  Female          20          26         35   \n",
      "849     f545    Zoniferol  Female          20          26         40   \n",
      "850     f545    Zoniferol  Female          20          26         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "841           45.000000                 0  \n",
      "842           46.565813                 0  \n",
      "843           51.072512                 0  \n",
      "844           53.945544                 1  \n",
      "845           58.841189                 1  \n",
      "846           60.253481                 1  \n",
      "847           65.893986                 1  \n",
      "848           66.742924                 1  \n",
      "849           71.108118                 1  \n",
      "850           73.324432                 1  \n",
      "Entries for Mouse ID: f993\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "852     f993     Naftisol  Male          21          28          0   \n",
      "853     f993     Naftisol  Male          21          28          5   \n",
      "854     f993     Naftisol  Male          21          28         10   \n",
      "855     f993     Naftisol  Male          21          28         15   \n",
      "856     f993     Naftisol  Male          21          28         20   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "852           45.000000                 0  \n",
      "853           46.395760                 0  \n",
      "854           48.185373                 0  \n",
      "855           49.106975                 1  \n",
      "856           52.079510                 1  \n",
      "Entries for Mouse ID: g107\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "857     g107     Ketapril  Female           2          29          0   \n",
      "858     g107     Ketapril  Female           2          29          5   \n",
      "859     g107     Ketapril  Female           2          29         10   \n",
      "860     g107     Ketapril  Female           2          29         15   \n",
      "861     g107     Ketapril  Female           2          29         20   \n",
      "862     g107     Ketapril  Female           2          29         25   \n",
      "863     g107     Ketapril  Female           2          29         30   \n",
      "864     g107     Ketapril  Female           2          29         35   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "857           45.000000                 0  \n",
      "858           48.791665                 0  \n",
      "859           53.435987                 0  \n",
      "860           58.135545                 0  \n",
      "861           62.706031                 0  \n",
      "862           64.663626                 0  \n",
      "863           69.160520                 0  \n",
      "864           71.905117                 0  \n",
      "Entries for Mouse ID: g296\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "865     g296    Zoniferol  Female          14          29          0   \n",
      "866     g296    Zoniferol  Female          14          29          5   \n",
      "867     g296    Zoniferol  Female          14          29         10   \n",
      "868     g296    Zoniferol  Female          14          29         15   \n",
      "869     g296    Zoniferol  Female          14          29         20   \n",
      "870     g296    Zoniferol  Female          14          29         25   \n",
      "871     g296    Zoniferol  Female          14          29         30   \n",
      "872     g296    Zoniferol  Female          14          29         35   \n",
      "873     g296    Zoniferol  Female          14          29         40   \n",
      "874     g296    Zoniferol  Female          14          29         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "865           45.000000                 0  \n",
      "866           46.593233                 0  \n",
      "867           48.269509                 0  \n",
      "868           49.653244                 1  \n",
      "869           51.447118                 2  \n",
      "870           55.670107                 3  \n",
      "871           57.997706                 3  \n",
      "872           60.384520                 4  \n",
      "873           62.221915                 4  \n",
      "874           68.163195                 4  \n",
      "Entries for Mouse ID: g497\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "875     g497     Ketapril  Male          19          28          0   \n",
      "876     g497     Ketapril  Male          19          28          5   \n",
      "877     g497     Ketapril  Male          19          28         10   \n",
      "878     g497     Ketapril  Male          19          28         15   \n",
      "879     g497     Ketapril  Male          19          28         20   \n",
      "880     g497     Ketapril  Male          19          28         25   \n",
      "881     g497     Ketapril  Male          19          28         30   \n",
      "882     g497     Ketapril  Male          19          28         35   \n",
      "883     g497     Ketapril  Male          19          28         40   \n",
      "884     g497     Ketapril  Male          19          28         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "875           45.000000                 0  \n",
      "876           48.782069                 0  \n",
      "877           49.647087                 0  \n",
      "878           53.646168                 1  \n",
      "879           55.096994                 1  \n",
      "880           57.524446                 2  \n",
      "881           61.108186                 2  \n",
      "882           64.094889                 2  \n",
      "883           67.742814                 2  \n",
      "884           69.872251                 2  \n",
      "Entries for Mouse ID: g558\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "885     g558     Propriva  Male           8          29          0   \n",
      "886     g558     Propriva  Male           8          29          5   \n",
      "887     g558     Propriva  Male           8          29         10   \n",
      "888     g558     Propriva  Male           8          29         15   \n",
      "889     g558     Propriva  Male           8          29         20   \n",
      "890     g558     Propriva  Male           8          29         25   \n",
      "891     g558     Propriva  Male           8          29         30   \n",
      "892     g558     Propriva  Male           8          29         35   \n",
      "893     g558     Propriva  Male           8          29         40   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "885           45.000000                 0  \n",
      "886           46.188742                 0  \n",
      "887           50.094754                 0  \n",
      "888           51.007258                 0  \n",
      "889           55.090097                 1  \n",
      "890           55.754083                 2  \n",
      "891           58.952829                 3  \n",
      "892           60.862159                 4  \n",
      "893           61.774963                 4  \n",
      "Entries for Mouse ID: g570\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "894     g570     Propriva  Male          16          29          0   \n",
      "895     g570     Propriva  Male          16          29          5   \n",
      "896     g570     Propriva  Male          16          29         10   \n",
      "897     g570     Propriva  Male          16          29         15   \n",
      "898     g570     Propriva  Male          16          29         20   \n",
      "899     g570     Propriva  Male          16          29         25   \n",
      "900     g570     Propriva  Male          16          29         30   \n",
      "901     g570     Propriva  Male          16          29         35   \n",
      "902     g570     Propriva  Male          16          29         40   \n",
      "903     g570     Propriva  Male          16          29         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "894           45.000000                 0  \n",
      "895           47.656424                 1  \n",
      "896           49.188232                 1  \n",
      "897           52.682695                 1  \n",
      "898           54.643295                 1  \n",
      "899           56.849406                 1  \n",
      "900           60.328717                 1  \n",
      "901           62.330420                 2  \n",
      "902           68.525856                 2  \n",
      "903           70.492788                 2  \n",
      "Entries for Mouse ID: g867\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "904     g867     Stelasyn  Female           9          25          0   \n",
      "905     g867     Stelasyn  Female           9          25          5   \n",
      "906     g867     Stelasyn  Female           9          25         10   \n",
      "907     g867     Stelasyn  Female           9          25         15   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "904           45.000000                 0  \n",
      "905           46.880749                 0  \n",
      "906           48.183402                 0  \n",
      "907           51.060419                 1  \n",
      "Entries for Mouse ID: g989\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "908     g989     Propriva  Female          21          26          0   \n",
      "909     g989     Propriva  Female          21          26          0   \n",
      "910     g989     Propriva  Female          21          26          5   \n",
      "911     g989     Propriva  Female          21          26          5   \n",
      "912     g989     Propriva  Female          21          26         10   \n",
      "913     g989     Propriva  Female          21          26         10   \n",
      "914     g989     Propriva  Female          21          26         15   \n",
      "915     g989     Propriva  Female          21          26         15   \n",
      "916     g989     Propriva  Female          21          26         20   \n",
      "917     g989     Propriva  Female          21          26         20   \n",
      "918     g989     Propriva  Female          21          26         25   \n",
      "919     g989     Propriva  Female          21          26         30   \n",
      "920     g989     Propriva  Female          21          26         35   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "908           45.000000                 0  \n",
      "909           45.000000                 0  \n",
      "910           48.786801                 0  \n",
      "911           47.570392                 0  \n",
      "912           51.745156                 0  \n",
      "913           49.880528                 0  \n",
      "914           51.325852                 1  \n",
      "915           53.442020                 0  \n",
      "916           55.326122                 1  \n",
      "917           54.657650                 1  \n",
      "918           56.045564                 1  \n",
      "919           59.082294                 1  \n",
      "920           62.570880                 2  \n",
      "Entries for Mouse ID: h246\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "921     h246     Ketapril  Male          13          30          0   \n",
      "922     h246     Ketapril  Male          13          30          5   \n",
      "923     h246     Ketapril  Male          13          30         10   \n",
      "924     h246     Ketapril  Male          13          30         15   \n",
      "925     h246     Ketapril  Male          13          30         20   \n",
      "926     h246     Ketapril  Male          13          30         25   \n",
      "927     h246     Ketapril  Male          13          30         30   \n",
      "928     h246     Ketapril  Male          13          30         35   \n",
      "929     h246     Ketapril  Male          13          30         40   \n",
      "930     h246     Ketapril  Male          13          30         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "921           45.000000                 0  \n",
      "922           49.470417                 0  \n",
      "923           51.368862                 1  \n",
      "924           56.184327                 1  \n",
      "925           57.935912                 1  \n",
      "926           59.548854                 1  \n",
      "927           63.599610                 1  \n",
      "928           67.211270                 2  \n",
      "929           71.150835                 2  \n",
      "930           74.104086                 2  \n",
      "Entries for Mouse ID: h333\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "931     h333     Stelasyn  Male          21          27          0   \n",
      "932     h333     Stelasyn  Male          21          27          5   \n",
      "933     h333     Stelasyn  Male          21          27         10   \n",
      "934     h333     Stelasyn  Male          21          27         15   \n",
      "935     h333     Stelasyn  Male          21          27         20   \n",
      "936     h333     Stelasyn  Male          21          27         25   \n",
      "937     h333     Stelasyn  Male          21          27         30   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "931           45.000000                 0  \n",
      "932           45.751727                 0  \n",
      "933           46.233844                 1  \n",
      "934           50.692604                 2  \n",
      "935           51.997806                 2  \n",
      "936           53.730914                 2  \n",
      "937           55.455290                 2  \n",
      "Entries for Mouse ID: h531\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "939     h531     Ceftamin  Male           5          27          0   \n",
      "940     h531     Ceftamin  Male           5          27          5   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "939           45.000000                 0  \n",
      "940           47.784682                 0  \n",
      "Entries for Mouse ID: i386\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "941     i386    Infubinol  Female          23          29          0   \n",
      "942     i386    Infubinol  Female          23          29          5   \n",
      "943     i386    Infubinol  Female          23          29         10   \n",
      "944     i386    Infubinol  Female          23          29         15   \n",
      "945     i386    Infubinol  Female          23          29         20   \n",
      "946     i386    Infubinol  Female          23          29         25   \n",
      "947     i386    Infubinol  Female          23          29         30   \n",
      "948     i386    Infubinol  Female          23          29         35   \n",
      "949     i386    Infubinol  Female          23          29         40   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "941           45.000000                 0  \n",
      "942           46.853697                 1  \n",
      "943           49.861547                 2  \n",
      "944           51.736561                 2  \n",
      "945           55.087724                 2  \n",
      "946           56.687864                 3  \n",
      "947           59.133640                 3  \n",
      "948           64.925420                 3  \n",
      "949           67.289621                 4  \n",
      "Entries for Mouse ID: i477\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "950     i477      Placebo  Female           3          30          0   \n",
      "951     i477      Placebo  Female           3          30          5   \n",
      "952     i477      Placebo  Female           3          30         10   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "950           45.000000                 0  \n",
      "951           46.657385                 0  \n",
      "952           47.520632                 0  \n",
      "Entries for Mouse ID: i635\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "953     i635     Propriva  Male          21          26          0   \n",
      "954     i635     Propriva  Male          21          26          5   \n",
      "955     i635     Propriva  Male          21          26         10   \n",
      "956     i635     Propriva  Male          21          26         15   \n",
      "957     i635     Propriva  Male          21          26         20   \n",
      "958     i635     Propriva  Male          21          26         25   \n",
      "959     i635     Propriva  Male          21          26         30   \n",
      "960     i635     Propriva  Male          21          26         35   \n",
      "961     i635     Propriva  Male          21          26         40   \n",
      "962     i635     Propriva  Male          21          26         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "953           45.000000                 0  \n",
      "954           47.235937                 0  \n",
      "955           48.685756                 1  \n",
      "956           49.536898                 1  \n",
      "957           51.877062                 1  \n",
      "958           52.928823                 1  \n",
      "959           53.597038                 2  \n",
      "960           55.679997                 2  \n",
      "961           56.842435                 3  \n",
      "962           58.633404                 3  \n",
      "Entries for Mouse ID: i669\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "963     i669      Placebo  Female          18          27          0   \n",
      "964     i669      Placebo  Female          18          27          5   \n",
      "965     i669      Placebo  Female          18          27         10   \n",
      "966     i669      Placebo  Female          18          27         15   \n",
      "967     i669      Placebo  Female          18          27         20   \n",
      "968     i669      Placebo  Female          18          27         25   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "963           45.000000                 0  \n",
      "964           46.764668                 1  \n",
      "965           48.281633                 1  \n",
      "966           48.857601                 1  \n",
      "967           50.873690                 1  \n",
      "968           53.303185                 2  \n",
      "Entries for Mouse ID: i901\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "969     i901     Stelasyn  Male          23          29          0   \n",
      "970     i901     Stelasyn  Male          23          29          5   \n",
      "971     i901     Stelasyn  Male          23          29         10   \n",
      "972     i901     Stelasyn  Male          23          29         15   \n",
      "973     i901     Stelasyn  Male          23          29         20   \n",
      "974     i901     Stelasyn  Male          23          29         25   \n",
      "975     i901     Stelasyn  Male          23          29         30   \n",
      "976     i901     Stelasyn  Male          23          29         35   \n",
      "977     i901     Stelasyn  Male          23          29         40   \n",
      "978     i901     Stelasyn  Male          23          29         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "969           45.000000                 0  \n",
      "970           46.493024                 0  \n",
      "971           50.421250                 0  \n",
      "972           51.419642                 0  \n",
      "973           55.974405                 0  \n",
      "974           56.575195                 0  \n",
      "975           60.591858                 0  \n",
      "976           62.127336                 0  \n",
      "977           64.303455                 0  \n",
      "978           65.341811                 0  \n",
      "Entries for Mouse ID: j235\n",
      "    Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "979     j235      Placebo  Male           6          30          0   \n",
      "980     j235      Placebo  Male           6          30          5   \n",
      "981     j235      Placebo  Male           6          30         10   \n",
      "982     j235      Placebo  Male           6          30         15   \n",
      "983     j235      Placebo  Male           6          30         20   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "979           45.000000                 0  \n",
      "980           46.588820                 0  \n",
      "981           48.018788                 1  \n",
      "982           51.161138                 1  \n",
      "983           52.942902                 1  \n",
      "Entries for Mouse ID: j296\n",
      "    Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "984     j296     Ceftamin  Female          24          30          0   \n",
      "985     j296     Ceftamin  Female          24          30          5   \n",
      "986     j296     Ceftamin  Female          24          30         10   \n",
      "987     j296     Ceftamin  Female          24          30         15   \n",
      "988     j296     Ceftamin  Female          24          30         20   \n",
      "989     j296     Ceftamin  Female          24          30         25   \n",
      "990     j296     Ceftamin  Female          24          30         30   \n",
      "991     j296     Ceftamin  Female          24          30         35   \n",
      "992     j296     Ceftamin  Female          24          30         40   \n",
      "993     j296     Ceftamin  Female          24          30         45   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "984           45.000000                 0  \n",
      "985           46.799256                 1  \n",
      "986           48.529978                 2  \n",
      "987           50.701280                 2  \n",
      "988           54.005342                 3  \n",
      "989           55.767148                 3  \n",
      "990           56.803061                 3  \n",
      "991           58.714483                 3  \n",
      "992           60.072688                 3  \n",
      "993           61.849023                 3  \n",
      "Entries for Mouse ID: j365\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "994      j365    Zoniferol  Male          24          28          0   \n",
      "995      j365    Zoniferol  Male          24          28          5   \n",
      "996      j365    Zoniferol  Male          24          28         10   \n",
      "997      j365    Zoniferol  Male          24          28         15   \n",
      "998      j365    Zoniferol  Male          24          28         20   \n",
      "999      j365    Zoniferol  Male          24          28         25   \n",
      "1000     j365    Zoniferol  Male          24          28         30   \n",
      "1001     j365    Zoniferol  Male          24          28         35   \n",
      "1002     j365    Zoniferol  Male          24          28         40   \n",
      "1003     j365    Zoniferol  Male          24          28         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "994            45.000000                 0  \n",
      "995            46.711261                 0  \n",
      "996            48.349320                 0  \n",
      "997            49.588263                 0  \n",
      "998            50.939353                 1  \n",
      "999            51.810320                 1  \n",
      "1000           54.404882                 1  \n",
      "1001           56.961200                 2  \n",
      "1002           62.327171                 2  \n",
      "1003           64.294085                 2  \n",
      "Entries for Mouse ID: j755\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1004     j755     Naftisol  Male          23          27          0   \n",
      "1005     j755     Naftisol  Male          23          27          5   \n",
      "1006     j755     Naftisol  Male          23          27         10   \n",
      "1007     j755     Naftisol  Male          23          27         15   \n",
      "1008     j755     Naftisol  Male          23          27         20   \n",
      "1009     j755     Naftisol  Male          23          27         25   \n",
      "1010     j755     Naftisol  Male          23          27         30   \n",
      "1011     j755     Naftisol  Male          23          27         35   \n",
      "1012     j755     Naftisol  Male          23          27         40   \n",
      "1013     j755     Naftisol  Male          23          27         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1004           45.000000                 0  \n",
      "1005           47.242844                 0  \n",
      "1006           48.167061                 0  \n",
      "1007           51.453974                 0  \n",
      "1008           55.496608                 1  \n",
      "1009           58.055818                 1  \n",
      "1010           60.007210                 1  \n",
      "1011           62.732858                 1  \n",
      "1012           67.207710                 1  \n",
      "1013           69.563621                 1  \n",
      "Entries for Mouse ID: j984\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1014     j984     Stelasyn  Female           2          30          0   \n",
      "1015     j984     Stelasyn  Female           2          30          5   \n",
      "1016     j984     Stelasyn  Female           2          30         10   \n",
      "1017     j984     Stelasyn  Female           2          30         15   \n",
      "1018     j984     Stelasyn  Female           2          30         20   \n",
      "1019     j984     Stelasyn  Female           2          30         25   \n",
      "1020     j984     Stelasyn  Female           2          30         30   \n",
      "1021     j984     Stelasyn  Female           2          30         35   \n",
      "1022     j984     Stelasyn  Female           2          30         40   \n",
      "1023     j984     Stelasyn  Female           2          30         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1014           45.000000                 0  \n",
      "1015           48.410721                 1  \n",
      "1016           50.141084                 1  \n",
      "1017           51.166757                 1  \n",
      "1018           54.372516                 1  \n",
      "1019           57.064355                 1  \n",
      "1020           61.240506                 1  \n",
      "1021           64.055399                 1  \n",
      "1022           67.777080                 1  \n",
      "1023           70.653832                 1  \n",
      "Entries for Mouse ID: k210\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1024     k210     Ceftamin  Male          15          28          0   \n",
      "1025     k210     Ceftamin  Male          15          28          5   \n",
      "1026     k210     Ceftamin  Male          15          28         10   \n",
      "1027     k210     Ceftamin  Male          15          28         15   \n",
      "1028     k210     Ceftamin  Male          15          28         20   \n",
      "1029     k210     Ceftamin  Male          15          28         25   \n",
      "1030     k210     Ceftamin  Male          15          28         30   \n",
      "1031     k210     Ceftamin  Male          15          28         35   \n",
      "1032     k210     Ceftamin  Male          15          28         40   \n",
      "1033     k210     Ceftamin  Male          15          28         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1024           45.000000                 0  \n",
      "1025           47.918998                 0  \n",
      "1026           49.379932                 0  \n",
      "1027           51.073558                 0  \n",
      "1028           51.997619                 0  \n",
      "1029           54.613973                 0  \n",
      "1030           59.989510                 1  \n",
      "1031           63.329330                 1  \n",
      "1032           66.622836                 2  \n",
      "1033           68.923185                 3  \n",
      "Entries for Mouse ID: k382\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1034     k382     Ketapril  Male          22          29          0   \n",
      "1035     k382     Ketapril  Male          22          29          5   \n",
      "1036     k382     Ketapril  Male          22          29         10   \n",
      "1037     k382     Ketapril  Male          22          29         15   \n",
      "1038     k382     Ketapril  Male          22          29         20   \n",
      "1039     k382     Ketapril  Male          22          29         25   \n",
      "1040     k382     Ketapril  Male          22          29         30   \n",
      "1041     k382     Ketapril  Male          22          29         35   \n",
      "1042     k382     Ketapril  Male          22          29         40   \n",
      "1043     k382     Ketapril  Male          22          29         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1034           45.000000                 0  \n",
      "1035           46.274997                 1  \n",
      "1036           50.180968                 1  \n",
      "1037           54.429168                 1  \n",
      "1038           57.824351                 2  \n",
      "1039           59.503904                 3  \n",
      "1040           63.469442                 4  \n",
      "1041           66.079185                 4  \n",
      "1042           67.420955                 4  \n",
      "1043           73.715619                 4  \n",
      "Entries for Mouse ID: k483\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1044     k483    Infubinol  Female          20          30          0   \n",
      "1045     k483    Infubinol  Female          20          30          5   \n",
      "1046     k483    Infubinol  Female          20          30         10   \n",
      "1047     k483    Infubinol  Female          20          30         15   \n",
      "1048     k483    Infubinol  Female          20          30         20   \n",
      "1049     k483    Infubinol  Female          20          30         25   \n",
      "1050     k483    Infubinol  Female          20          30         30   \n",
      "1051     k483    Infubinol  Female          20          30         35   \n",
      "1052     k483    Infubinol  Female          20          30         40   \n",
      "1053     k483    Infubinol  Female          20          30         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1044           45.000000                 0  \n",
      "1045           46.611056                 0  \n",
      "1046           50.296041                 1  \n",
      "1047           53.244458                 1  \n",
      "1048           54.778961                 1  \n",
      "1049           57.432007                 2  \n",
      "1050           59.747077                 2  \n",
      "1051           60.541562                 2  \n",
      "1052           64.138725                 3  \n",
      "1053           66.196912                 3  \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Entries for Mouse ID: k510\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1054     k510     Stelasyn  Female           8          27          0   \n",
      "1055     k510     Stelasyn  Female           8          27          5   \n",
      "1056     k510     Stelasyn  Female           8          27         10   \n",
      "1057     k510     Stelasyn  Female           8          27         15   \n",
      "1058     k510     Stelasyn  Female           8          27         20   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1054           45.000000                 0  \n",
      "1055           46.608467                 0  \n",
      "1056           47.658250                 1  \n",
      "1057           49.687052                 1  \n",
      "1058           52.105574                 1  \n",
      "Entries for Mouse ID: k603\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1059     k603     Propriva  Male           2          27          0   \n",
      "1060     k603     Propriva  Male           2          27          5   \n",
      "1061     k603     Propriva  Male           2          27         10   \n",
      "1062     k603     Propriva  Male           2          27         15   \n",
      "1063     k603     Propriva  Male           2          27         20   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1059           45.000000                 0  \n",
      "1060           46.042116                 0  \n",
      "1061           46.606947                 0  \n",
      "1062           48.775286                 0  \n",
      "1063           50.180109                 0  \n",
      "Entries for Mouse ID: k754\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1064     k754    Zoniferol  Female           8          26          0   \n",
      "1065     k754    Zoniferol  Female           8          26          5   \n",
      "1066     k754    Zoniferol  Female           8          26         10   \n",
      "1067     k754    Zoniferol  Female           8          26         15   \n",
      "1068     k754    Zoniferol  Female           8          26         20   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1064           45.000000                 0  \n",
      "1065           45.727760                 0  \n",
      "1066           49.746117                 0  \n",
      "1067           51.323570                 0  \n",
      "1068           52.693423                 1  \n",
      "Entries for Mouse ID: k804\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1069     k804    Infubinol  Female          23          29          0   \n",
      "1070     k804    Infubinol  Female          23          29          5   \n",
      "1071     k804    Infubinol  Female          23          29         10   \n",
      "1072     k804    Infubinol  Female          23          29         15   \n",
      "1073     k804    Infubinol  Female          23          29         20   \n",
      "1074     k804    Infubinol  Female          23          29         25   \n",
      "1075     k804    Infubinol  Female          23          29         30   \n",
      "1076     k804    Infubinol  Female          23          29         35   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1069           45.000000                 0  \n",
      "1070           48.266204                 0  \n",
      "1071           49.471244                 0  \n",
      "1072           50.477618                 0  \n",
      "1073           54.484519                 0  \n",
      "1074           55.674808                 1  \n",
      "1075           59.240615                 2  \n",
      "1076           62.117279                 2  \n",
      "Entries for Mouse ID: k862\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1077     k862     Stelasyn  Female          13          25          0   \n",
      "1078     k862     Stelasyn  Female          13          25          5   \n",
      "1079     k862     Stelasyn  Female          13          25         10   \n",
      "1080     k862     Stelasyn  Female          13          25         15   \n",
      "1081     k862     Stelasyn  Female          13          25         20   \n",
      "1082     k862     Stelasyn  Female          13          25         25   \n",
      "1083     k862     Stelasyn  Female          13          25         30   \n",
      "1084     k862     Stelasyn  Female          13          25         35   \n",
      "1085     k862     Stelasyn  Female          13          25         40   \n",
      "1086     k862     Stelasyn  Female          13          25         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1077           45.000000                 0  \n",
      "1078           49.203058                 0  \n",
      "1079           50.523550                 1  \n",
      "1080           54.474534                 1  \n",
      "1081           57.057848                 1  \n",
      "1082           58.719297                 2  \n",
      "1083           60.605440                 3  \n",
      "1084           66.580722                 3  \n",
      "1085           67.571341                 4  \n",
      "1086           69.299149                 4  \n",
      "Entries for Mouse ID: k894\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1087     k894    Zoniferol  Female          13          29          0   \n",
      "1088     k894    Zoniferol  Female          13          29          5   \n",
      "1089     k894    Zoniferol  Female          13          29         10   \n",
      "1090     k894    Zoniferol  Female          13          29         15   \n",
      "1091     k894    Zoniferol  Female          13          29         20   \n",
      "1092     k894    Zoniferol  Female          13          29         25   \n",
      "1093     k894    Zoniferol  Female          13          29         30   \n",
      "1094     k894    Zoniferol  Female          13          29         35   \n",
      "1095     k894    Zoniferol  Female          13          29         40   \n",
      "1096     k894    Zoniferol  Female          13          29         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1087           45.000000                 0  \n",
      "1088           47.645687                 0  \n",
      "1089           49.272870                 1  \n",
      "1090           49.987766                 1  \n",
      "1091           50.981639                 1  \n",
      "1092           52.325838                 2  \n",
      "1093           54.400123                 3  \n",
      "1094           55.362662                 4  \n",
      "1095           58.647056                 4  \n",
      "1096           60.752704                 4  \n",
      "Entries for Mouse ID: l215\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1097     l215     Propriva  Male          10          29          0   \n",
      "1098     l215     Propriva  Male          10          29          5   \n",
      "1099     l215     Propriva  Male          10          29         10   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1097           45.000000                 0  \n",
      "1098           49.481949                 1  \n",
      "1099           53.653970                 1  \n",
      "Entries for Mouse ID: l264\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1100     l264     Ketapril  Female          15          30          0   \n",
      "1101     l264     Ketapril  Female          15          30          5   \n",
      "1102     l264     Ketapril  Female          15          30         10   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1100           45.000000                 0  \n",
      "1101           46.668766                 0  \n",
      "1102           50.659581                 0  \n",
      "Entries for Mouse ID: l471\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1103     l471     Ceftamin  Female           7          28          0   \n",
      "1104     l471     Ceftamin  Female           7          28          5   \n",
      "1105     l471     Ceftamin  Female           7          28         10   \n",
      "1106     l471     Ceftamin  Female           7          28         15   \n",
      "1107     l471     Ceftamin  Female           7          28         20   \n",
      "1108     l471     Ceftamin  Female           7          28         25   \n",
      "1109     l471     Ceftamin  Female           7          28         30   \n",
      "1110     l471     Ceftamin  Female           7          28         35   \n",
      "1111     l471     Ceftamin  Female           7          28         40   \n",
      "1112     l471     Ceftamin  Female           7          28         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1103           45.000000                 0  \n",
      "1104           46.251872                 0  \n",
      "1105           48.182063                 0  \n",
      "1106           49.406879                 0  \n",
      "1107           52.228327                 0  \n",
      "1108           52.847559                 1  \n",
      "1109           58.093604                 1  \n",
      "1110           61.405999                 1  \n",
      "1111           63.844858                 1  \n",
      "1112           67.748662                 1  \n",
      "Entries for Mouse ID: l490\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1113     l490     Ceftamin  Male          24          26          0   \n",
      "1114     l490     Ceftamin  Male          24          26          5   \n",
      "1115     l490     Ceftamin  Male          24          26         10   \n",
      "1116     l490     Ceftamin  Male          24          26         15   \n",
      "1117     l490     Ceftamin  Male          24          26         20   \n",
      "1118     l490     Ceftamin  Male          24          26         25   \n",
      "1119     l490     Ceftamin  Male          24          26         30   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1113           45.000000                 0  \n",
      "1114           45.612539                 1  \n",
      "1115           47.259606                 1  \n",
      "1116           50.524813                 1  \n",
      "1117           51.905447                 1  \n",
      "1118           55.810034                 2  \n",
      "1119           57.918381                 3  \n",
      "Entries for Mouse ID: l558\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1120     l558     Ceftamin  Female          13          30          0   \n",
      "1121     l558     Ceftamin  Female          13          30          5   \n",
      "1122     l558     Ceftamin  Female          13          30         10   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1120           45.000000                 0  \n",
      "1121           45.809089                 0  \n",
      "1122           46.784535                 0  \n",
      "Entries for Mouse ID: l661\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1123     l661     Ceftamin  Male          18          26          0   \n",
      "1124     l661     Ceftamin  Male          18          26          5   \n",
      "1125     l661     Ceftamin  Male          18          26         10   \n",
      "1126     l661     Ceftamin  Male          18          26         15   \n",
      "1127     l661     Ceftamin  Male          18          26         20   \n",
      "1128     l661     Ceftamin  Male          18          26         25   \n",
      "1129     l661     Ceftamin  Male          18          26         30   \n",
      "1130     l661     Ceftamin  Male          18          26         35   \n",
      "1131     l661     Ceftamin  Male          18          26         40   \n",
      "1132     l661     Ceftamin  Male          18          26         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1123           45.000000                 0  \n",
      "1124           46.268799                 0  \n",
      "1125           49.683620                 0  \n",
      "1126           50.947545                 1  \n",
      "1127           52.617490                 1  \n",
      "1128           53.180657                 2  \n",
      "1129           55.329099                 2  \n",
      "1130           56.474129                 2  \n",
      "1131           59.205669                 3  \n",
      "1132           59.851956                 3  \n",
      "Entries for Mouse ID: l700\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1133     l700     Naftisol  Female          18          27          0   \n",
      "1134     l700     Naftisol  Female          18          27          5   \n",
      "1135     l700     Naftisol  Female          18          27         10   \n",
      "1136     l700     Naftisol  Female          18          27         15   \n",
      "1137     l700     Naftisol  Female          18          27         20   \n",
      "1138     l700     Naftisol  Female          18          27         25   \n",
      "1139     l700     Naftisol  Female          18          27         30   \n",
      "1140     l700     Naftisol  Female          18          27         35   \n",
      "1141     l700     Naftisol  Female          18          27         40   \n",
      "1142     l700     Naftisol  Female          18          27         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1133           45.000000                 0  \n",
      "1134           45.918372                 0  \n",
      "1135           47.013567                 1  \n",
      "1136           49.040225                 1  \n",
      "1137           50.734768                 1  \n",
      "1138           54.234502                 1  \n",
      "1139           56.653215                 1  \n",
      "1140           61.462604                 1  \n",
      "1141           62.986678                 1  \n",
      "1142           63.946640                 1  \n",
      "Entries for Mouse ID: l725\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1143     l725     Naftisol  Female           8          26          0   \n",
      "1144     l725     Naftisol  Female           8          26          5   \n",
      "1145     l725     Naftisol  Female           8          26         10   \n",
      "1146     l725     Naftisol  Female           8          26         15   \n",
      "1147     l725     Naftisol  Female           8          26         20   \n",
      "1148     l725     Naftisol  Female           8          26         25   \n",
      "1149     l725     Naftisol  Female           8          26         30   \n",
      "1150     l725     Naftisol  Female           8          26         35   \n",
      "1151     l725     Naftisol  Female           8          26         40   \n",
      "1152     l725     Naftisol  Female           8          26         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1143           45.000000                 0  \n",
      "1144           48.736319                 1  \n",
      "1145           50.823912                 2  \n",
      "1146           54.244563                 2  \n",
      "1147           59.615155                 2  \n",
      "1148           65.008829                 2  \n",
      "1149           66.599545                 3  \n",
      "1150           69.125702                 3  \n",
      "1151           73.693494                 3  \n",
      "1152           76.668817                 3  \n",
      "Entries for Mouse ID: l733\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1153     l733     Ceftamin  Female           4          30          0   \n",
      "1154     l733     Ceftamin  Female           4          30          5   \n",
      "1155     l733     Ceftamin  Female           4          30         10   \n",
      "1156     l733     Ceftamin  Female           4          30         15   \n",
      "1157     l733     Ceftamin  Female           4          30         20   \n",
      "1158     l733     Ceftamin  Female           4          30         25   \n",
      "1159     l733     Ceftamin  Female           4          30         30   \n",
      "1160     l733     Ceftamin  Female           4          30         35   \n",
      "1161     l733     Ceftamin  Female           4          30         40   \n",
      "1162     l733     Ceftamin  Female           4          30         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1153           45.000000                 0  \n",
      "1154           46.174226                 0  \n",
      "1155           48.354952                 0  \n",
      "1156           49.285195                 0  \n",
      "1157           53.244312                 1  \n",
      "1158           54.951668                 1  \n",
      "1159           56.319065                 1  \n",
      "1160           57.600798                 1  \n",
      "1161           59.443506                 1  \n",
      "1162           64.299830                 1  \n",
      "Entries for Mouse ID: m133\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1164     m133     Naftisol  Female           2          26          0   \n",
      "1165     m133     Naftisol  Female           2          26          5   \n",
      "1166     m133     Naftisol  Female           2          26         10   \n",
      "1167     m133     Naftisol  Female           2          26         15   \n",
      "1168     m133     Naftisol  Female           2          26         20   \n",
      "1169     m133     Naftisol  Female           2          26         25   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1164           45.000000                 0  \n",
      "1165           46.621301                 0  \n",
      "1166           47.503338                 0  \n",
      "1167           48.665207                 1  \n",
      "1168           52.636882                 1  \n",
      "1169           54.082437                 2  \n",
      "Entries for Mouse ID: m269\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1170     m269     Stelasyn  Female          22          28          0   \n",
      "1171     m269     Stelasyn  Female          22          28          5   \n",
      "1172     m269     Stelasyn  Female          22          28         10   \n",
      "1173     m269     Stelasyn  Female          22          28         15   \n",
      "1174     m269     Stelasyn  Female          22          28         20   \n",
      "1175     m269     Stelasyn  Female          22          28         25   \n",
      "1176     m269     Stelasyn  Female          22          28         30   \n",
      "1177     m269     Stelasyn  Female          22          28         35   \n",
      "1178     m269     Stelasyn  Female          22          28         40   \n",
      "1179     m269     Stelasyn  Female          22          28         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1170           45.000000                 0  \n",
      "1171           49.011180                 0  \n",
      "1172           50.860130                 0  \n",
      "1173           55.905344                 0  \n",
      "1174           61.145866                 0  \n",
      "1175           64.893020                 0  \n",
      "1176           67.712510                 1  \n",
      "1177           68.689917                 1  \n",
      "1178           70.214644                 1  \n",
      "1179           75.123690                 1  \n",
      "Entries for Mouse ID: m331\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1180     m331    Zoniferol  Female          19          26          0   \n",
      "1181     m331    Zoniferol  Female          19          26          5   \n",
      "1182     m331    Zoniferol  Female          19          26         10   \n",
      "1183     m331    Zoniferol  Female          19          26         15   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1180           45.000000                 0  \n",
      "1181           45.523014                 1  \n",
      "1182           47.646877                 1  \n",
      "1183           52.110088                 1  \n",
      "Entries for Mouse ID: m550\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1184     m550     Ketapril  Male          18          28          0   \n",
      "1185     m550     Ketapril  Male          18          28          5   \n",
      "1186     m550     Ketapril  Male          18          28         10   \n",
      "1187     m550     Ketapril  Male          18          28         15   \n",
      "1188     m550     Ketapril  Male          18          28         20   \n",
      "1189     m550     Ketapril  Male          18          28         25   \n",
      "1190     m550     Ketapril  Male          18          28         30   \n",
      "1191     m550     Ketapril  Male          18          28         35   \n",
      "1192     m550     Ketapril  Male          18          28         40   \n",
      "1193     m550     Ketapril  Male          18          28         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1184           45.000000                 0  \n",
      "1185           49.054097                 1  \n",
      "1186           50.548035                 2  \n",
      "1187           51.166065                 3  \n",
      "1188           53.757945                 3  \n",
      "1189           57.620682                 4  \n",
      "1190           60.856543                 4  \n",
      "1191           62.539154                 4  \n",
      "1192           68.210720                 4  \n",
      "1193           69.253503                 4  \n",
      "Entries for Mouse ID: m650\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1194     m650     Ketapril  Male          15          27          0   \n",
      "1195     m650     Ketapril  Male          15          27          5   \n",
      "1196     m650     Ketapril  Male          15          27         10   \n",
      "1197     m650     Ketapril  Male          15          27         15   \n",
      "1198     m650     Ketapril  Male          15          27         20   \n",
      "1199     m650     Ketapril  Male          15          27         25   \n",
      "1200     m650     Ketapril  Male          15          27         30   \n",
      "1201     m650     Ketapril  Male          15          27         35   \n",
      "1202     m650     Ketapril  Male          15          27         40   \n",
      "1203     m650     Ketapril  Male          15          27         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1194           45.000000                 0  \n",
      "1195           48.562495                 1  \n",
      "1196           50.968998                 1  \n",
      "1197           53.149559                 1  \n",
      "1198           56.777939                 2  \n",
      "1199           62.253597                 2  \n",
      "1200           64.901888                 3  \n",
      "1201           69.265747                 4  \n",
      "1202           70.797068                 4  \n",
      "1203           73.901399                 4  \n",
      "Entries for Mouse ID: m756\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1204     m756    Infubinol  Male          19          30          0   \n",
      "1205     m756    Infubinol  Male          19          30          5   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1204           45.000000                 0  \n",
      "1205           47.010364                 1  \n",
      "Entries for Mouse ID: n304\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1206     n304     Naftisol  Male           9          26          0   \n",
      "1207     n304     Naftisol  Male           9          26          5   \n",
      "1208     n304     Naftisol  Male           9          26         10   \n",
      "1209     n304     Naftisol  Male           9          26         15   \n",
      "1210     n304     Naftisol  Male           9          26         20   \n",
      "1211     n304     Naftisol  Male           9          26         25   \n",
      "1212     n304     Naftisol  Male           9          26         30   \n",
      "1213     n304     Naftisol  Male           9          26         35   \n",
      "1214     n304     Naftisol  Male           9          26         40   \n",
      "1215     n304     Naftisol  Male           9          26         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1206           45.000000                 0  \n",
      "1207           46.431216                 0  \n",
      "1208           47.201251                 0  \n",
      "1209           48.477979                 0  \n",
      "1210           49.253309                 1  \n",
      "1211           53.970859                 2  \n",
      "1212           55.039020                 3  \n",
      "1213           57.122419                 4  \n",
      "1214           59.830507                 4  \n",
      "1215           63.586395                 4  \n",
      "Entries for Mouse ID: n630\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1217     n630     Propriva  Female          15          29          0   \n",
      "1218     n630     Propriva  Female          15          29          5   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1217             45.0000                 0  \n",
      "1218             46.0991                 0  \n",
      "Entries for Mouse ID: n671\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1219     n671    Infubinol  Male          18          25          0   \n",
      "1220     n671    Infubinol  Male          18          25          5   \n",
      "1221     n671    Infubinol  Male          18          25         10   \n",
      "1222     n671    Infubinol  Male          18          25         15   \n",
      "1223     n671    Infubinol  Male          18          25         20   \n",
      "1224     n671    Infubinol  Male          18          25         25   \n",
      "1225     n671    Infubinol  Male          18          25         30   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1219           45.000000                 0  \n",
      "1220           47.353889                 0  \n",
      "1221           51.039357                 0  \n",
      "1222           54.216064                 0  \n",
      "1223           54.822521                 0  \n",
      "1224           56.174458                 0  \n",
      "1225           60.165180                 0  \n",
      "Entries for Mouse ID: n678\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1226     n678     Propriva  Male           5          29          0   \n",
      "1227     n678     Propriva  Male           5          29          5   \n",
      "1228     n678     Propriva  Male           5          29         10   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1226           45.000000                 0  \n",
      "1227           47.554284                 0  \n",
      "1228           49.145709                 1  \n",
      "Entries for Mouse ID: n763\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1229     n763      Placebo  Female          16          25          0   \n",
      "1230     n763      Placebo  Female          16          25          5   \n",
      "1231     n763      Placebo  Female          16          25         10   \n",
      "1232     n763      Placebo  Female          16          25         15   \n",
      "1233     n763      Placebo  Female          16          25         20   \n",
      "1234     n763      Placebo  Female          16          25         25   \n",
      "1235     n763      Placebo  Female          16          25         30   \n",
      "1236     n763      Placebo  Female          16          25         35   \n",
      "1237     n763      Placebo  Female          16          25         40   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1229           45.000000                 0  \n",
      "1230           46.085981                 0  \n",
      "1231           46.817315                 1  \n",
      "1232           47.798100                 1  \n",
      "1233           49.258126                 1  \n",
      "1234           53.405871                 2  \n",
      "1235           55.413660                 3  \n",
      "1236           57.382413                 3  \n",
      "1237           58.011146                 4  \n",
      "Entries for Mouse ID: n923\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1238     n923     Ketapril  Male          19          30          0   \n",
      "1239     n923     Ketapril  Male          19          30          5   \n",
      "1240     n923     Ketapril  Male          19          30         10   \n",
      "1241     n923     Ketapril  Male          19          30         15   \n",
      "1242     n923     Ketapril  Male          19          30         20   \n",
      "1243     n923     Ketapril  Male          19          30         25   \n",
      "1244     n923     Ketapril  Male          19          30         30   \n",
      "1245     n923     Ketapril  Male          19          30         35   \n",
      "1246     n923     Ketapril  Male          19          30         40   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1238           45.000000                 0  \n",
      "1239           45.824881                 0  \n",
      "1240           48.791950                 1  \n",
      "1241           51.738706                 1  \n",
      "1242           52.599206                 1  \n",
      "1243           56.855465                 2  \n",
      "1244           59.632561                 3  \n",
      "1245           60.356294                 3  \n",
      "1246           66.229606                 3  \n",
      "Entries for Mouse ID: n967\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1247     n967    Zoniferol  Male          11          27          0   \n",
      "1248     n967    Zoniferol  Male          11          27          5   \n",
      "1249     n967    Zoniferol  Male          11          27         10   \n",
      "1250     n967    Zoniferol  Male          11          27         15   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1247           45.000000                 0  \n",
      "1248           46.077192                 1  \n",
      "1249           47.471723                 1  \n",
      "1250           49.825004                 1  \n",
      "Entries for Mouse ID: o287\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1251     o287     Ceftamin  Male           2          28          0   \n",
      "1252     o287     Ceftamin  Male           2          28          5   \n",
      "1253     o287     Ceftamin  Male           2          28         10   \n",
      "1254     o287     Ceftamin  Male           2          28         15   \n",
      "1255     o287     Ceftamin  Male           2          28         20   \n",
      "1256     o287     Ceftamin  Male           2          28         25   \n",
      "1257     o287     Ceftamin  Male           2          28         30   \n",
      "1258     o287     Ceftamin  Male           2          28         35   \n",
      "1259     o287     Ceftamin  Male           2          28         40   \n",
      "1260     o287     Ceftamin  Male           2          28         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1251           45.000000                 0  \n",
      "1252           45.586804                 0  \n",
      "1253           47.360201                 1  \n",
      "1254           48.679453                 1  \n",
      "1255           50.856141                 2  \n",
      "1256           52.068486                 3  \n",
      "1257           54.503001                 3  \n",
      "1258           55.118290                 4  \n",
      "1259           57.197193                 4  \n",
      "1260           59.741901                 4  \n",
      "Entries for Mouse ID: o302\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1261     o302      Placebo  Female           2          29          0   \n",
      "1262     o302      Placebo  Female           2          29          5   \n",
      "1263     o302      Placebo  Female           2          29         10   \n",
      "1264     o302      Placebo  Female           2          29         15   \n",
      "1265     o302      Placebo  Female           2          29         20   \n",
      "1266     o302      Placebo  Female           2          29         25   \n",
      "1267     o302      Placebo  Female           2          29         30   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1261           45.000000                 0  \n",
      "1262           48.937012                 0  \n",
      "1263           49.701450                 0  \n",
      "1264           51.381489                 0  \n",
      "1265           56.177611                 0  \n",
      "1266           60.517103                 0  \n",
      "1267           62.030594                 1  \n",
      "Entries for Mouse ID: o331\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1268     o331     Ketapril  Male          24          30          0   \n",
      "1269     o331     Ketapril  Male          24          30          5   \n",
      "1270     o331     Ketapril  Male          24          30         10   \n",
      "1271     o331     Ketapril  Male          24          30         15   \n",
      "1272     o331     Ketapril  Male          24          30         20   \n",
      "1273     o331     Ketapril  Male          24          30         25   \n",
      "1274     o331     Ketapril  Male          24          30         30   \n",
      "1275     o331     Ketapril  Male          24          30         35   \n",
      "1276     o331     Ketapril  Male          24          30         40   \n",
      "1277     o331     Ketapril  Male          24          30         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1268           45.000000                 0  \n",
      "1269           47.059664                 1  \n",
      "1270           50.128455                 1  \n",
      "1271           54.789768                 1  \n",
      "1272           58.965720                 1  \n",
      "1273           61.102306                 1  \n",
      "1274           66.330663                 1  \n",
      "1275           70.126238                 2  \n",
      "1276           71.447743                 3  \n",
      "1277           78.567014                 4  \n",
      "Entries for Mouse ID: o523\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1278     o523     Propriva  Female           6          25          0   \n",
      "1279     o523     Propriva  Female           6          25          5   \n",
      "1280     o523     Propriva  Female           6          25         10   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1278           45.000000                 0  \n",
      "1279           45.544700                 0  \n",
      "1280           47.081086                 1  \n",
      "Entries for Mouse ID: o562\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1281     o562     Propriva  Female           4          25          0   \n",
      "1282     o562     Propriva  Female           4          25          5   \n",
      "1283     o562     Propriva  Female           4          25         10   \n",
      "1284     o562     Propriva  Female           4          25         15   \n",
      "1285     o562     Propriva  Female           4          25         20   \n",
      "1286     o562     Propriva  Female           4          25         25   \n",
      "1287     o562     Propriva  Female           4          25         30   \n",
      "1288     o562     Propriva  Female           4          25         35   \n",
      "1289     o562     Propriva  Female           4          25         40   \n",
      "1290     o562     Propriva  Female           4          25         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1281           45.000000                 0  \n",
      "1282           46.514950                 1  \n",
      "1283           47.147670                 1  \n",
      "1284           51.505086                 1  \n",
      "1285           53.616863                 1  \n",
      "1286           54.742733                 1  \n",
      "1287           59.653525                 1  \n",
      "1288           65.360767                 1  \n",
      "1289           71.172463                 1  \n",
      "1290           72.455421                 2  \n",
      "Entries for Mouse ID: o725\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1291     o725     Naftisol  Male           4          26          0   \n",
      "1292     o725     Naftisol  Male           4          26          5   \n",
      "1293     o725     Naftisol  Male           4          26         10   \n",
      "1294     o725     Naftisol  Male           4          26         15   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1291           45.000000                 0  \n",
      "1292           46.889821                 0  \n",
      "1293           48.199452                 0  \n",
      "1294           50.015079                 1  \n",
      "Entries for Mouse ID: o795\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1295     o795      Placebo  Female          20          26          0   \n",
      "1296     o795      Placebo  Female          20          26          5   \n",
      "1297     o795      Placebo  Female          20          26         10   \n",
      "1298     o795      Placebo  Female          20          26         15   \n",
      "1299     o795      Placebo  Female          20          26         20   \n",
      "1300     o795      Placebo  Female          20          26         25   \n",
      "1301     o795      Placebo  Female          20          26         30   \n",
      "1302     o795      Placebo  Female          20          26         35   \n",
      "1303     o795      Placebo  Female          20          26         40   \n",
      "1304     o795      Placebo  Female          20          26         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1295           45.000000                 0  \n",
      "1296           46.760927                 1  \n",
      "1297           51.123704                 1  \n",
      "1298           55.886338                 2  \n",
      "1299           60.610059                 3  \n",
      "1300           65.741777                 4  \n",
      "1301           68.217070                 4  \n",
      "1302           69.085094                 4  \n",
      "1303           70.266479                 4  \n",
      "1304           73.059454                 4  \n",
      "Entries for Mouse ID: o809\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1305     o809    Infubinol  Male           3          25          0   \n",
      "1306     o809    Infubinol  Male           3          25          5   \n",
      "1307     o809    Infubinol  Male           3          25         10   \n",
      "1308     o809    Infubinol  Male           3          25         15   \n",
      "1309     o809    Infubinol  Male           3          25         20   \n",
      "1310     o809    Infubinol  Male           3          25         25   \n",
      "1311     o809    Infubinol  Male           3          25         30   \n",
      "1312     o809    Infubinol  Male           3          25         35   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1305           45.000000                 0  \n",
      "1306           46.877243                 0  \n",
      "1307           48.670732                 0  \n",
      "1308           49.683445                 1  \n",
      "1309           50.336553                 1  \n",
      "1310           52.318174                 1  \n",
      "1311           54.832629                 1  \n",
      "1312           55.629428                 1  \n",
      "Entries for Mouse ID: o813\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1313     o813    Infubinol  Male          24          28          0   \n",
      "1314     o813    Infubinol  Male          24          28          5   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1313           45.000000                 0  \n",
      "1314           45.699331                 0  \n",
      "Entries for Mouse ID: o926\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1316     o926    Zoniferol  Male          15          29          0   \n",
      "1317     o926    Zoniferol  Male          15          29          5   \n",
      "1318     o926    Zoniferol  Male          15          29         10   \n",
      "1319     o926    Zoniferol  Male          15          29         15   \n",
      "1320     o926    Zoniferol  Male          15          29         20   \n",
      "1321     o926    Zoniferol  Male          15          29         25   \n",
      "1322     o926    Zoniferol  Male          15          29         30   \n",
      "1323     o926    Zoniferol  Male          15          29         35   \n",
      "1324     o926    Zoniferol  Male          15          29         40   \n",
      "1325     o926    Zoniferol  Male          15          29         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1316           45.000000                 0  \n",
      "1317           46.761164                 0  \n",
      "1318           47.565674                 1  \n",
      "1319           48.254248                 1  \n",
      "1320           51.826638                 2  \n",
      "1321           54.763339                 3  \n",
      "1322           56.917398                 3  \n",
      "1323           58.593993                 3  \n",
      "1324           59.903044                 3  \n",
      "1325           62.327966                 4  \n",
      "Entries for Mouse ID: o973\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1326     o973     Ketapril  Female          11          29          0   \n",
      "1327     o973     Ketapril  Female          11          29          5   \n",
      "1328     o973     Ketapril  Female          11          29         10   \n",
      "1329     o973     Ketapril  Female          11          29         15   \n",
      "1330     o973     Ketapril  Female          11          29         20   \n",
      "1331     o973     Ketapril  Female          11          29         25   \n",
      "1332     o973     Ketapril  Female          11          29         30   \n",
      "1333     o973     Ketapril  Female          11          29         35   \n",
      "1334     o973     Ketapril  Female          11          29         40   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1326           45.000000                 0  \n",
      "1327           46.717877                 0  \n",
      "1328           48.245790                 0  \n",
      "1329           49.871936                 0  \n",
      "1330           51.956993                 1  \n",
      "1331           53.179815                 1  \n",
      "1332           57.769960                 1  \n",
      "1333           60.242219                 1  \n",
      "1334           64.487812                 2  \n",
      "Entries for Mouse ID: p136\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1335     p136    Zoniferol  Female           5          28          0   \n",
      "1336     p136    Zoniferol  Female           5          28          5   \n",
      "1337     p136    Zoniferol  Female           5          28         10   \n",
      "1338     p136    Zoniferol  Female           5          28         15   \n",
      "1339     p136    Zoniferol  Female           5          28         20   \n",
      "1340     p136    Zoniferol  Female           5          28         25   \n",
      "1341     p136    Zoniferol  Female           5          28         30   \n",
      "1342     p136    Zoniferol  Female           5          28         35   \n",
      "1343     p136    Zoniferol  Female           5          28         40   \n",
      "1344     p136    Zoniferol  Female           5          28         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1335           45.000000                 0  \n",
      "1336           49.273971                 0  \n",
      "1337           50.907890                 0  \n",
      "1338           51.991416                 1  \n",
      "1339           54.913799                 1  \n",
      "1340           56.281477                 1  \n",
      "1341           57.052805                 1  \n",
      "1342           57.630782                 1  \n",
      "1343           61.380249                 1  \n",
      "1344           63.488697                 2  \n",
      "Entries for Mouse ID: p189\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1345     p189     Ketapril  Male           8          28          0   \n",
      "1346     p189     Ketapril  Male           8          28          5   \n",
      "1347     p189     Ketapril  Male           8          28         10   \n",
      "1348     p189     Ketapril  Male           8          28         15   \n",
      "1349     p189     Ketapril  Male           8          28         20   \n",
      "1350     p189     Ketapril  Male           8          28         25   \n",
      "1351     p189     Ketapril  Male           8          28         30   \n",
      "1352     p189     Ketapril  Male           8          28         35   \n",
      "1353     p189     Ketapril  Male           8          28         40   \n",
      "1354     p189     Ketapril  Male           8          28         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1345           45.000000                 0  \n",
      "1346           49.048707                 1  \n",
      "1347           51.582162                 2  \n",
      "1348           53.675542                 2  \n",
      "1349           56.530204                 3  \n",
      "1350           62.108960                 3  \n",
      "1351           67.104537                 4  \n",
      "1352           67.873777                 4  \n",
      "1353           74.106091                 4  \n",
      "1354           75.294936                 4  \n",
      "Entries for Mouse ID: p310\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1355     p310     Propriva  Male           6          26          0   \n",
      "1356     p310     Propriva  Male           6          26          5   \n",
      "1357     p310     Propriva  Male           6          26         10   \n",
      "1358     p310     Propriva  Male           6          26         15   \n",
      "1359     p310     Propriva  Male           6          26         20   \n",
      "1360     p310     Propriva  Male           6          26         25   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1355           45.000000                 0  \n",
      "1356           46.558532                 1  \n",
      "1357           48.665607                 1  \n",
      "1358           49.770741                 1  \n",
      "1359           54.205181                 1  \n",
      "1360           55.341834                 2  \n",
      "Entries for Mouse ID: p387\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1361     p387     Stelasyn  Male           3          30          0   \n",
      "1362     p387     Stelasyn  Male           3          30          5   \n",
      "1363     p387     Stelasyn  Male           3          30         10   \n",
      "1364     p387     Stelasyn  Male           3          30         15   \n",
      "1365     p387     Stelasyn  Male           3          30         20   \n",
      "1366     p387     Stelasyn  Male           3          30         25   \n",
      "1367     p387     Stelasyn  Male           3          30         30   \n",
      "1368     p387     Stelasyn  Male           3          30         35   \n",
      "1369     p387     Stelasyn  Male           3          30         40   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1361           45.000000                 0  \n",
      "1362           48.667631                 0  \n",
      "1363           53.362963                 0  \n",
      "1364           55.251380                 0  \n",
      "1365           56.587617                 0  \n",
      "1366           58.098489                 0  \n",
      "1367           63.269246                 0  \n",
      "1368           66.492204                 1  \n",
      "1369           69.038876                 1  \n",
      "Entries for Mouse ID: p438\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1370     p438     Ceftamin  Female          11          26          0   \n",
      "1371     p438     Ceftamin  Female          11          26          5   \n",
      "1372     p438     Ceftamin  Female          11          26         10   \n",
      "1373     p438     Ceftamin  Female          11          26         15   \n",
      "1374     p438     Ceftamin  Female          11          26         20   \n",
      "1375     p438     Ceftamin  Female          11          26         25   \n",
      "1376     p438     Ceftamin  Female          11          26         30   \n",
      "1377     p438     Ceftamin  Female          11          26         35   \n",
      "1378     p438     Ceftamin  Female          11          26         40   \n",
      "1379     p438     Ceftamin  Female          11          26         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1370           45.000000                 0  \n",
      "1371           46.827934                 0  \n",
      "1372           50.517498                 0  \n",
      "1373           52.198368                 0  \n",
      "1374           52.905299                 0  \n",
      "1375           54.510575                 0  \n",
      "1376           56.406422                 0  \n",
      "1377           57.538555                 1  \n",
      "1378           59.305288                 1  \n",
      "1379           61.433892                 1  \n",
      "Entries for Mouse ID: p981\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1380     p981     Stelasyn  Male          20          29          0   \n",
      "1381     p981     Stelasyn  Male          20          29          5   \n",
      "1382     p981     Stelasyn  Male          20          29         10   \n",
      "1383     p981     Stelasyn  Male          20          29         15   \n",
      "1384     p981     Stelasyn  Male          20          29         20   \n",
      "1385     p981     Stelasyn  Male          20          29         25   \n",
      "1386     p981     Stelasyn  Male          20          29         30   \n",
      "1387     p981     Stelasyn  Male          20          29         35   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1380           45.000000                 0  \n",
      "1381           47.000627                 0  \n",
      "1382           47.545846                 0  \n",
      "1383           49.657710                 0  \n",
      "1384           50.358069                 0  \n",
      "1385           52.544705                 1  \n",
      "1386           56.339104                 1  \n",
      "1387           59.131023                 1  \n",
      "Entries for Mouse ID: q119\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1388     q119     Ketapril  Male          17          30          0   \n",
      "1389     q119     Ketapril  Male          17          30          5   \n",
      "1390     q119     Ketapril  Male          17          30         10   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1388           45.000000                 0  \n",
      "1389           47.864440                 0  \n",
      "1390           51.236606                 0  \n",
      "Entries for Mouse ID: q132\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1391     q132    Infubinol  Female           1          30          0   \n",
      "1392     q132    Infubinol  Female           1          30          5   \n",
      "1393     q132    Infubinol  Female           1          30         10   \n",
      "1394     q132    Infubinol  Female           1          30         15   \n",
      "1395     q132    Infubinol  Female           1          30         20   \n",
      "1396     q132    Infubinol  Female           1          30         25   \n",
      "1397     q132    Infubinol  Female           1          30         30   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1391           45.000000                 0  \n",
      "1392           46.716398                 1  \n",
      "1393           47.953844                 2  \n",
      "1394           49.159749                 3  \n",
      "1395           51.909025                 4  \n",
      "1396           52.780489                 4  \n",
      "1397           54.656549                 4  \n",
      "Entries for Mouse ID: q483\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1398     q483     Ceftamin  Male           6          26          0   \n",
      "1399     q483     Ceftamin  Male           6          26          5   \n",
      "1400     q483     Ceftamin  Male           6          26         10   \n",
      "1401     q483     Ceftamin  Male           6          26         15   \n",
      "1402     q483     Ceftamin  Male           6          26         20   \n",
      "1403     q483     Ceftamin  Male           6          26         25   \n",
      "1404     q483     Ceftamin  Male           6          26         30   \n",
      "1405     q483     Ceftamin  Male           6          26         35   \n",
      "1406     q483     Ceftamin  Male           6          26         40   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1398           45.000000                 0  \n",
      "1399           46.776816                 1  \n",
      "1400           47.839101                 1  \n",
      "1401           48.468483                 1  \n",
      "1402           50.239856                 1  \n",
      "1403           52.430066                 1  \n",
      "1404           54.952226                 1  \n",
      "1405           59.253484                 1  \n",
      "1406           64.192341                 1  \n",
      "Entries for Mouse ID: q511\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1407     q511    Zoniferol  Female           2          28          0   \n",
      "1408     q511    Zoniferol  Female           2          28          5   \n",
      "1409     q511    Zoniferol  Female           2          28         10   \n",
      "1410     q511    Zoniferol  Female           2          28         15   \n",
      "1411     q511    Zoniferol  Female           2          28         20   \n",
      "1412     q511    Zoniferol  Female           2          28         25   \n",
      "1413     q511    Zoniferol  Female           2          28         30   \n",
      "1414     q511    Zoniferol  Female           2          28         35   \n",
      "1415     q511    Zoniferol  Female           2          28         40   \n",
      "1416     q511    Zoniferol  Female           2          28         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1407           45.000000                 0  \n",
      "1408           45.832654                 0  \n",
      "1409           50.311647                 0  \n",
      "1410           52.133081                 0  \n",
      "1411           52.672712                 0  \n",
      "1412           57.257583                 0  \n",
      "1413           59.364353                 1  \n",
      "1414           60.838661                 1  \n",
      "1415           63.194428                 2  \n",
      "1416           68.611061                 3  \n",
      "Entries for Mouse ID: q582\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1417     q582      Placebo  Male           5          30          0   \n",
      "1418     q582      Placebo  Male           5          30          5   \n",
      "1419     q582      Placebo  Male           5          30         10   \n",
      "1420     q582      Placebo  Male           5          30         15   \n",
      "1421     q582      Placebo  Male           5          30         20   \n",
      "1422     q582      Placebo  Male           5          30         25   \n",
      "1423     q582      Placebo  Male           5          30         30   \n",
      "1424     q582      Placebo  Male           5          30         35   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1417           45.000000                 0  \n",
      "1418           45.955399                 1  \n",
      "1419           47.013575                 1  \n",
      "1420           48.322640                 2  \n",
      "1421           51.185976                 2  \n",
      "1422           51.968211                 2  \n",
      "1423           52.648893                 2  \n",
      "1424           53.713158                 2  \n",
      "Entries for Mouse ID: q633\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1425     q633    Zoniferol  Male          12          25          0   \n",
      "1426     q633    Zoniferol  Male          12          25          5   \n",
      "1427     q633    Zoniferol  Male          12          25         10   \n",
      "1428     q633    Zoniferol  Male          12          25         15   \n",
      "1429     q633    Zoniferol  Male          12          25         20   \n",
      "1430     q633    Zoniferol  Male          12          25         25   \n",
      "1431     q633    Zoniferol  Male          12          25         30   \n",
      "1432     q633    Zoniferol  Male          12          25         35   \n",
      "1433     q633    Zoniferol  Male          12          25         40   \n",
      "1434     q633    Zoniferol  Male          12          25         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1425           45.000000                 0  \n",
      "1426           47.183802                 0  \n",
      "1427           49.001866                 0  \n",
      "1428           50.583557                 1  \n",
      "1429           53.287287                 1  \n",
      "1430           55.683102                 1  \n",
      "1431           58.057253                 1  \n",
      "1432           63.125659                 1  \n",
      "1433           68.498639                 2  \n",
      "1434           70.827796                 2  \n",
      "Entries for Mouse ID: q787\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1435     q787      Placebo  Male          17          27          0   \n",
      "1436     q787      Placebo  Male          17          27          5   \n",
      "1437     q787      Placebo  Male          17          27         10   \n",
      "1438     q787      Placebo  Male          17          27         15   \n",
      "1439     q787      Placebo  Male          17          27         20   \n",
      "1440     q787      Placebo  Male          17          27         25   \n",
      "1441     q787      Placebo  Male          17          27         30   \n",
      "1442     q787      Placebo  Male          17          27         35   \n",
      "1443     q787      Placebo  Male          17          27         40   \n",
      "1444     q787      Placebo  Male          17          27         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1435           45.000000                 0  \n",
      "1436           47.116616                 0  \n",
      "1437           48.593862                 1  \n",
      "1438           49.217732                 2  \n",
      "1439           50.229934                 2  \n",
      "1440           52.713188                 2  \n",
      "1441           55.036206                 2  \n",
      "1442           60.333852                 3  \n",
      "1443           62.034127                 3  \n",
      "1444           66.096475                 3  \n",
      "Entries for Mouse ID: r107\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1445     r107     Propriva  Female           2          28          0   \n",
      "1446     r107     Propriva  Female           2          28          5   \n",
      "1447     r107     Propriva  Female           2          28         10   \n",
      "1448     r107     Propriva  Female           2          28         15   \n",
      "1449     r107     Propriva  Female           2          28         20   \n",
      "1450     r107     Propriva  Female           2          28         25   \n",
      "1451     r107     Propriva  Female           2          28         30   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1445           45.000000                 0  \n",
      "1446           48.513420                 0  \n",
      "1447           49.186011                 0  \n",
      "1448           53.090335                 0  \n",
      "1449           55.263858                 0  \n",
      "1450           57.706667                 1  \n",
      "1451           58.406473                 1  \n",
      "Entries for Mouse ID: r157\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1452     r157    Capomulin  Male          22          25          0   \n",
      "1453     r157    Capomulin  Male          22          25          5   \n",
      "1454     r157    Capomulin  Male          22          25         10   \n",
      "1455     r157    Capomulin  Male          22          25         15   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1452           45.000000                 0  \n",
      "1453           45.597064                 0  \n",
      "1454           46.059608                 0  \n",
      "1455           46.539206                 0  \n",
      "Entries for Mouse ID: r604\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1456     r604     Naftisol  Male           7          30          0   \n",
      "1457     r604     Naftisol  Male           7          30          5   \n",
      "1458     r604     Naftisol  Male           7          30         10   \n",
      "1459     r604     Naftisol  Male           7          30         15   \n",
      "1460     r604     Naftisol  Male           7          30         20   \n",
      "1461     r604     Naftisol  Male           7          30         25   \n",
      "1462     r604     Naftisol  Male           7          30         30   \n",
      "1463     r604     Naftisol  Male           7          30         35   \n",
      "1464     r604     Naftisol  Male           7          30         40   \n",
      "1465     r604     Naftisol  Male           7          30         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1456           45.000000                 0  \n",
      "1457           47.067744                 1  \n",
      "1458           48.786560                 1  \n",
      "1459           51.074521                 1  \n",
      "1460           51.902753                 1  \n",
      "1461           52.936858                 1  \n",
      "1462           54.688215                 2  \n",
      "1463           59.217000                 2  \n",
      "1464           60.186115                 2  \n",
      "1465           62.670759                 3  \n",
      "Entries for Mouse ID: r701\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1466     r701     Naftisol  Male          21          25          0   \n",
      "1467     r701     Naftisol  Male          21          25          5   \n",
      "1468     r701     Naftisol  Male          21          25         10   \n",
      "1469     r701     Naftisol  Male          21          25         15   \n",
      "1470     r701     Naftisol  Male          21          25         20   \n",
      "1471     r701     Naftisol  Male          21          25         25   \n",
      "1472     r701     Naftisol  Male          21          25         30   \n",
      "1473     r701     Naftisol  Male          21          25         35   \n",
      "1474     r701     Naftisol  Male          21          25         40   \n",
      "1475     r701     Naftisol  Male          21          25         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1466           45.000000                 0  \n",
      "1467           46.886971                 0  \n",
      "1468           49.654596                 0  \n",
      "1469           52.484804                 0  \n",
      "1470           54.114137                 0  \n",
      "1471           57.898490                 1  \n",
      "1472           60.341819                 1  \n",
      "1473           64.730010                 1  \n",
      "1474           66.640722                 1  \n",
      "1475           69.778544                 1  \n",
      "Entries for Mouse ID: r850\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1476     r850      Placebo  Male           5          30          0   \n",
      "1477     r850      Placebo  Male           5          30          5   \n",
      "1478     r850      Placebo  Male           5          30         10   \n",
      "1479     r850      Placebo  Male           5          30         15   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1476           45.000000                 0  \n",
      "1477           46.862912                 0  \n",
      "1478           48.515091                 1  \n",
      "1479           50.218605                 1  \n",
      "Entries for Mouse ID: s121\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1480     s121    Infubinol  Male          23          26          0   \n",
      "1481     s121    Infubinol  Male          23          26          5   \n",
      "1482     s121    Infubinol  Male          23          26         10   \n",
      "1483     s121    Infubinol  Male          23          26         15   \n",
      "1484     s121    Infubinol  Male          23          26         20   \n",
      "1485     s121    Infubinol  Male          23          26         25   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1480           45.000000                 0  \n",
      "1481           45.635662                 1  \n",
      "1482           49.048835                 1  \n",
      "1483           50.824560                 2  \n",
      "1484           52.005066                 2  \n",
      "1485           55.650681                 2  \n",
      "Entries for Mouse ID: s141\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1486     s141     Propriva  Male           8          25          0   \n",
      "1487     s141     Propriva  Male           8          25          5   \n",
      "1488     s141     Propriva  Male           8          25         10   \n",
      "1489     s141     Propriva  Male           8          25         15   \n",
      "1490     s141     Propriva  Male           8          25         20   \n",
      "1491     s141     Propriva  Male           8          25         25   \n",
      "1492     s141     Propriva  Male           8          25         30   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1486           45.000000                 0  \n",
      "1487           45.831134                 0  \n",
      "1488           47.235692                 0  \n",
      "1489           49.232345                 1  \n",
      "1490           51.621646                 1  \n",
      "1491           53.804370                 1  \n",
      "1492           55.841410                 1  \n",
      "Entries for Mouse ID: s152\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1493     s152      Placebo  Female           4          30          0   \n",
      "1494     s152      Placebo  Female           4          30          5   \n",
      "1495     s152      Placebo  Female           4          30         10   \n",
      "1496     s152      Placebo  Female           4          30         15   \n",
      "1497     s152      Placebo  Female           4          30         20   \n",
      "1498     s152      Placebo  Female           4          30         25   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1493           45.000000                 0  \n",
      "1494           47.459053                 1  \n",
      "1495           52.181644                 2  \n",
      "1496           57.224981                 2  \n",
      "1497           62.351609                 2  \n",
      "1498           64.119142                 2  \n",
      "Entries for Mouse ID: s166\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1499     s166      Placebo  Male          19          27          0   \n",
      "1500     s166      Placebo  Male          19          27          5   \n",
      "1501     s166      Placebo  Male          19          27         10   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1499           45.000000                 0  \n",
      "1500           47.186788                 0  \n",
      "1501           49.000125                 0  \n",
      "Entries for Mouse ID: s187\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1502     s187     Propriva  Male          22          25          0   \n",
      "1503     s187     Propriva  Male          22          25          5   \n",
      "1504     s187     Propriva  Male          22          25         10   \n",
      "1505     s187     Propriva  Male          22          25         15   \n",
      "1506     s187     Propriva  Male          22          25         20   \n",
      "1507     s187     Propriva  Male          22          25         25   \n",
      "1508     s187     Propriva  Male          22          25         30   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1502           45.000000                 0  \n",
      "1503           47.576718                 1  \n",
      "1504           48.146351                 1  \n",
      "1505           52.081632                 1  \n",
      "1506           53.744734                 1  \n",
      "1507           56.485220                 1  \n",
      "1508           60.008783                 2  \n",
      "Entries for Mouse ID: s337\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1509     s337    Zoniferol  Male          14          27          0   \n",
      "1510     s337    Zoniferol  Male          14          27          5   \n",
      "1511     s337    Zoniferol  Male          14          27         10   \n",
      "1512     s337    Zoniferol  Male          14          27         15   \n",
      "1513     s337    Zoniferol  Male          14          27         20   \n",
      "1514     s337    Zoniferol  Male          14          27         25   \n",
      "1515     s337    Zoniferol  Male          14          27         30   \n",
      "1516     s337    Zoniferol  Male          14          27         35   \n",
      "1517     s337    Zoniferol  Male          14          27         40   \n",
      "1518     s337    Zoniferol  Male          14          27         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1509           45.000000                 0  \n",
      "1510           46.849852                 0  \n",
      "1511           47.894441                 0  \n",
      "1512           48.571516                 0  \n",
      "1513           49.202054                 1  \n",
      "1514           50.970689                 2  \n",
      "1515           52.747718                 3  \n",
      "1516           54.810813                 3  \n",
      "1517           56.994816                 4  \n",
      "1518           62.109651                 4  \n",
      "Entries for Mouse ID: s565\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1519     s565     Stelasyn  Female           3          29          0   \n",
      "1520     s565     Stelasyn  Female           3          29          5   \n",
      "1521     s565     Stelasyn  Female           3          29         10   \n",
      "1522     s565     Stelasyn  Female           3          29         15   \n",
      "1523     s565     Stelasyn  Female           3          29         20   \n",
      "1524     s565     Stelasyn  Female           3          29         25   \n",
      "1525     s565     Stelasyn  Female           3          29         30   \n",
      "1526     s565     Stelasyn  Female           3          29         35   \n",
      "1527     s565     Stelasyn  Female           3          29         40   \n",
      "1528     s565     Stelasyn  Female           3          29         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1519           45.000000                 0  \n",
      "1520           48.242552                 0  \n",
      "1521           52.777527                 0  \n",
      "1522           54.328317                 1  \n",
      "1523           57.046189                 1  \n",
      "1524           58.553611                 1  \n",
      "1525           63.668967                 1  \n",
      "1526           64.776579                 2  \n",
      "1527           67.221007                 2  \n",
      "1528           72.588964                 2  \n",
      "Entries for Mouse ID: s619\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1529     s619     Stelasyn  Male          22          30          0   \n",
      "1530     s619     Stelasyn  Male          22          30          5   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1529           45.000000                 0  \n",
      "1530           46.602269                 0  \n",
      "Entries for Mouse ID: t198\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1531     t198     Propriva  Male          22          26          0   \n",
      "1532     t198     Propriva  Male          22          26          5   \n",
      "1533     t198     Propriva  Male          22          26         10   \n",
      "1534     t198     Propriva  Male          22          26         15   \n",
      "1535     t198     Propriva  Male          22          26         20   \n",
      "1536     t198     Propriva  Male          22          26         25   \n",
      "1537     t198     Propriva  Male          22          26         30   \n",
      "1538     t198     Propriva  Male          22          26         35   \n",
      "1539     t198     Propriva  Male          22          26         40   \n",
      "1540     t198     Propriva  Male          22          26         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1531           45.000000                 0  \n",
      "1532           47.461261                 0  \n",
      "1533           49.000810                 1  \n",
      "1534           49.781181                 2  \n",
      "1535           51.490740                 3  \n",
      "1536           56.184664                 3  \n",
      "1537           56.924974                 3  \n",
      "1538           57.735941                 3  \n",
      "1539           59.129960                 4  \n",
      "1540           64.911363                 4  \n",
      "Entries for Mouse ID: t451\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1541     t451     Stelasyn  Male           8          29          0   \n",
      "1542     t451     Stelasyn  Male           8          29          5   \n",
      "1543     t451     Stelasyn  Male           8          29         10   \n",
      "1544     t451     Stelasyn  Male           8          29         15   \n",
      "1545     t451     Stelasyn  Male           8          29         20   \n",
      "1546     t451     Stelasyn  Male           8          29         25   \n",
      "1547     t451     Stelasyn  Male           8          29         30   \n",
      "1548     t451     Stelasyn  Male           8          29         35   \n",
      "1549     t451     Stelasyn  Male           8          29         40   \n",
      "1550     t451     Stelasyn  Male           8          29         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1541           45.000000                 0  \n",
      "1542           48.047139                 0  \n",
      "1543           48.957919                 0  \n",
      "1544           49.652788                 0  \n",
      "1545           51.063678                 0  \n",
      "1546           55.527553                 0  \n",
      "1547           59.275823                 0  \n",
      "1548           63.756990                 0  \n",
      "1549           67.654796                 1  \n",
      "1550           68.711630                 1  \n",
      "Entries for Mouse ID: t718\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1552     t718      Placebo  Female          10          30          0   \n",
      "1553     t718      Placebo  Female          10          30          5   \n",
      "1554     t718      Placebo  Female          10          30         10   \n",
      "1555     t718      Placebo  Female          10          30         15   \n",
      "1556     t718      Placebo  Female          10          30         20   \n",
      "1557     t718      Placebo  Female          10          30         25   \n",
      "1558     t718      Placebo  Female          10          30         30   \n",
      "1559     t718      Placebo  Female          10          30         35   \n",
      "1560     t718      Placebo  Female          10          30         40   \n",
      "1561     t718      Placebo  Female          10          30         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1552           45.000000                 0  \n",
      "1553           45.921253                 1  \n",
      "1554           46.392688                 1  \n",
      "1555           48.085126                 1  \n",
      "1556           52.636700                 2  \n",
      "1557           55.876588                 3  \n",
      "1558           57.704114                 3  \n",
      "1559           60.463899                 3  \n",
      "1560           61.530399                 3  \n",
      "1561           63.423695                 4  \n",
      "Entries for Mouse ID: t724\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1562     t724     Naftisol  Female           2          25          0   \n",
      "1563     t724     Naftisol  Female           2          25          5   \n",
      "1564     t724     Naftisol  Female           2          25         10   \n",
      "1565     t724     Naftisol  Female           2          25         15   \n",
      "1566     t724     Naftisol  Female           2          25         20   \n",
      "1567     t724     Naftisol  Female           2          25         25   \n",
      "1568     t724     Naftisol  Female           2          25         30   \n",
      "1569     t724     Naftisol  Female           2          25         35   \n",
      "1570     t724     Naftisol  Female           2          25         40   \n",
      "1571     t724     Naftisol  Female           2          25         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1562           45.000000                 0  \n",
      "1563           46.359258                 0  \n",
      "1564           50.703900                 0  \n",
      "1565           55.584617                 0  \n",
      "1566           57.229409                 0  \n",
      "1567           59.826068                 1  \n",
      "1568           64.234595                 2  \n",
      "1569           67.744328                 2  \n",
      "1570           69.728326                 2  \n",
      "1571           75.113288                 2  \n",
      "Entries for Mouse ID: t994\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1572     t994      Placebo  Male          14          30          0   \n",
      "1573     t994      Placebo  Male          14          30          5   \n",
      "1574     t994      Placebo  Male          14          30         10   \n",
      "1575     t994      Placebo  Male          14          30         15   \n",
      "1576     t994      Placebo  Male          14          30         20   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1572           45.000000                 0  \n",
      "1573           47.891487                 0  \n",
      "1574           52.614163                 1  \n",
      "1575           53.458639                 1  \n",
      "1576           56.527952                 1  \n",
      "Entries for Mouse ID: u149\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1577     u149     Ceftamin  Male          24          29          0   \n",
      "1578     u149     Ceftamin  Male          24          29          5   \n",
      "1579     u149     Ceftamin  Male          24          29         10   \n",
      "1580     u149     Ceftamin  Male          24          29         15   \n",
      "1581     u149     Ceftamin  Male          24          29         20   \n",
      "1582     u149     Ceftamin  Male          24          29         25   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1577           45.000000                 0  \n",
      "1578           45.792068                 0  \n",
      "1579           47.404834                 0  \n",
      "1580           48.522373                 0  \n",
      "1581           50.378058                 0  \n",
      "1582           52.925348                 0  \n",
      "Entries for Mouse ID: u327\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1584     u327     Ketapril  Male          17          25          0   \n",
      "1585     u327     Ketapril  Male          17          25          5   \n",
      "1586     u327     Ketapril  Male          17          25         10   \n",
      "1587     u327     Ketapril  Male          17          25         15   \n",
      "1588     u327     Ketapril  Male          17          25         20   \n",
      "1589     u327     Ketapril  Male          17          25         25   \n",
      "1590     u327     Ketapril  Male          17          25         30   \n",
      "1591     u327     Ketapril  Male          17          25         35   \n",
      "1592     u327     Ketapril  Male          17          25         40   \n",
      "1593     u327     Ketapril  Male          17          25         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1584           45.000000                 0  \n",
      "1585           45.694188                 0  \n",
      "1586           49.235259                 0  \n",
      "1587           50.659964                 0  \n",
      "1588           53.189879                 0  \n",
      "1589           56.059634                 0  \n",
      "1590           57.314072                 0  \n",
      "1591           58.089028                 1  \n",
      "1592           60.466545                 1  \n",
      "1593           66.268801                 2  \n",
      "Entries for Mouse ID: u946\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1594     u946     Propriva  Male           5          30          0   \n",
      "1595     u946     Propriva  Male           5          30          5   \n",
      "1596     u946     Propriva  Male           5          30         10   \n",
      "1597     u946     Propriva  Male           5          30         15   \n",
      "1598     u946     Propriva  Male           5          30         20   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1594           45.000000                 0  \n",
      "1595           45.991808                 1  \n",
      "1596           46.730506                 1  \n",
      "1597           47.673029                 1  \n",
      "1598           49.110050                 1  \n",
      "Entries for Mouse ID: v289\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1600     v289     Ketapril  Female           3          26          0   \n",
      "1601     v289     Ketapril  Female           3          26          5   \n",
      "1602     v289     Ketapril  Female           3          26         10   \n",
      "1603     v289     Ketapril  Female           3          26         15   \n",
      "1604     v289     Ketapril  Female           3          26         20   \n",
      "1605     v289     Ketapril  Female           3          26         25   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1600           45.000000                 0  \n",
      "1601           46.204460                 0  \n",
      "1602           48.133482                 0  \n",
      "1603           52.602166                 0  \n",
      "1604           54.250054                 0  \n",
      "1605           56.720095                 0  \n",
      "Entries for Mouse ID: v295\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1606     v295     Naftisol  Female           2          27          0   \n",
      "1607     v295     Naftisol  Female           2          27          5   \n",
      "1608     v295     Naftisol  Female           2          27         10   \n",
      "1609     v295     Naftisol  Female           2          27         15   \n",
      "1610     v295     Naftisol  Female           2          27         20   \n",
      "1611     v295     Naftisol  Female           2          27         25   \n",
      "1612     v295     Naftisol  Female           2          27         30   \n",
      "1613     v295     Naftisol  Female           2          27         35   \n",
      "1614     v295     Naftisol  Female           2          27         40   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1606           45.000000                 0  \n",
      "1607           46.111818                 1  \n",
      "1608           47.539462                 2  \n",
      "1609           50.666054                 2  \n",
      "1610           55.731375                 3  \n",
      "1611           57.691859                 3  \n",
      "1612           59.333772                 3  \n",
      "1613           61.893153                 3  \n",
      "1614           65.466074                 3  \n",
      "Entries for Mouse ID: v339\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1615     v339    Infubinol  Male          20          26          0   \n",
      "1616     v339    Infubinol  Male          20          26          5   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1615           45.000000                 0  \n",
      "1616           46.250112                 0  \n",
      "Entries for Mouse ID: v409\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1617     v409      Placebo  Female          16          25          0   \n",
      "1618     v409      Placebo  Female          16          25          5   \n",
      "1619     v409      Placebo  Female          16          25         10   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1617           45.000000                 0  \n",
      "1618           46.220796                 0  \n",
      "1619           50.649038                 1  \n",
      "Entries for Mouse ID: v603\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1620     v603     Ketapril  Female          22          30          0   \n",
      "1621     v603     Ketapril  Female          22          30          5   \n",
      "1622     v603     Ketapril  Female          22          30         10   \n",
      "1623     v603     Ketapril  Female          22          30         15   \n",
      "1624     v603     Ketapril  Female          22          30         20   \n",
      "1625     v603     Ketapril  Female          22          30         25   \n",
      "1626     v603     Ketapril  Female          22          30         30   \n",
      "1627     v603     Ketapril  Female          22          30         35   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1620           45.000000                 0  \n",
      "1621           46.016006                 0  \n",
      "1622           47.830557                 0  \n",
      "1623           52.102947                 0  \n",
      "1624           53.721242                 0  \n",
      "1625           56.075230                 1  \n",
      "1626           57.990554                 1  \n",
      "1627           63.189432                 1  \n",
      "Entries for Mouse ID: v719\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1628     v719    Infubinol  Female          17          30          0   \n",
      "1629     v719    Infubinol  Female          17          30          5   \n",
      "1630     v719    Infubinol  Female          17          30         10   \n",
      "1631     v719    Infubinol  Female          17          30         15   \n",
      "1632     v719    Infubinol  Female          17          30         20   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1628           45.000000                 0  \n",
      "1629           47.188363                 0  \n",
      "1630           51.497054                 1  \n",
      "1631           52.609108                 1  \n",
      "1632           54.048608                 1  \n",
      "Entries for Mouse ID: v764\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1633     v764     Stelasyn  Female           5          30          0   \n",
      "1634     v764     Stelasyn  Female           5          30          5   \n",
      "1635     v764     Stelasyn  Female           5          30         10   \n",
      "1636     v764     Stelasyn  Female           5          30         15   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1633           45.000000                 0  \n",
      "1634           47.054185                 0  \n",
      "1635           48.189001                 1  \n",
      "1636           49.412624                 2  \n",
      "Entries for Mouse ID: v766\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1637     v766    Infubinol  Male          16          27          0   \n",
      "1638     v766    Infubinol  Male          16          27          5   \n",
      "1639     v766    Infubinol  Male          16          27         10   \n",
      "1640     v766    Infubinol  Male          16          27         15   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1637           45.000000                 0  \n",
      "1638           48.151251                 1  \n",
      "1639           50.363110                 1  \n",
      "1640           51.542431                 1  \n",
      "Entries for Mouse ID: v835\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1641     v835     Naftisol  Male           7          29          0   \n",
      "1642     v835     Naftisol  Male           7          29          5   \n",
      "1643     v835     Naftisol  Male           7          29         10   \n",
      "1644     v835     Naftisol  Male           7          29         15   \n",
      "1645     v835     Naftisol  Male           7          29         20   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1641           45.000000                 0  \n",
      "1642           47.156011                 0  \n",
      "1643           48.965918                 0  \n",
      "1644           50.545206                 1  \n",
      "1645           51.296543                 2  \n",
      "Entries for Mouse ID: v989\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1646     v989      Placebo  Male           4          25          0   \n",
      "1647     v989      Placebo  Male           4          25          5   \n",
      "1648     v989      Placebo  Male           4          25         10   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1646           45.000000                 0  \n",
      "1647           48.858135                 0  \n",
      "1648           52.614689                 1  \n",
      "Entries for Mouse ID: v991\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1649     v991     Propriva  Female          10          30          0   \n",
      "1650     v991     Propriva  Female          10          30          5   \n",
      "1651     v991     Propriva  Female          10          30         10   \n",
      "1652     v991     Propriva  Female          10          30         15   \n",
      "1653     v991     Propriva  Female          10          30         20   \n",
      "1654     v991     Propriva  Female          10          30         25   \n",
      "1655     v991     Propriva  Female          10          30         30   \n",
      "1656     v991     Propriva  Female          10          30         35   \n",
      "1657     v991     Propriva  Female          10          30         40   \n",
      "1658     v991     Propriva  Female          10          30         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1649           45.000000                 0  \n",
      "1650           49.214328                 1  \n",
      "1651           52.644906                 1  \n",
      "1652           54.588591                 1  \n",
      "1653           57.740695                 2  \n",
      "1654           60.016747                 2  \n",
      "1655           62.743643                 3  \n",
      "1656           63.895313                 4  \n",
      "1657           64.851129                 4  \n",
      "1658           70.167749                 4  \n",
      "Entries for Mouse ID: w140\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1659     w140    Zoniferol  Female          19          30          0   \n",
      "1660     w140    Zoniferol  Female          19          30          5   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1659           45.000000                 0  \n",
      "1660           47.717952                 0  \n",
      "Entries for Mouse ID: w151\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1661     w151     Ceftamin  Male          24          25          0   \n",
      "1662     w151     Ceftamin  Male          24          25          5   \n",
      "1663     w151     Ceftamin  Male          24          25         10   \n",
      "1664     w151     Ceftamin  Male          24          25         15   \n",
      "1665     w151     Ceftamin  Male          24          25         20   \n",
      "1666     w151     Ceftamin  Male          24          25         25   \n",
      "1667     w151     Ceftamin  Male          24          25         30   \n",
      "1668     w151     Ceftamin  Male          24          25         35   \n",
      "1669     w151     Ceftamin  Male          24          25         40   \n",
      "1670     w151     Ceftamin  Male          24          25         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1661           45.000000                 0  \n",
      "1662           45.546076                 1  \n",
      "1663           46.501476                 1  \n",
      "1664           47.242929                 1  \n",
      "1665           49.554263                 2  \n",
      "1666           51.869059                 2  \n",
      "1667           56.767158                 2  \n",
      "1668           58.339141                 2  \n",
      "1669           62.187950                 2  \n",
      "1670           67.527482                 3  \n",
      "Entries for Mouse ID: w167\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1671     w167      Placebo  Female           6          28          0   \n",
      "1672     w167      Placebo  Female           6          28          5   \n",
      "1673     w167      Placebo  Female           6          28         10   \n",
      "1674     w167      Placebo  Female           6          28         15   \n",
      "1675     w167      Placebo  Female           6          28         20   \n",
      "1676     w167      Placebo  Female           6          28         25   \n",
      "1677     w167      Placebo  Female           6          28         30   \n",
      "1678     w167      Placebo  Female           6          28         35   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1671           45.000000                 0  \n",
      "1672           48.786272                 0  \n",
      "1673           51.826410                 0  \n",
      "1674           53.900489                 0  \n",
      "1675           57.548157                 0  \n",
      "1676           61.868577                 0  \n",
      "1677           67.197872                 0  \n",
      "1678           68.134288                 0  \n",
      "Entries for Mouse ID: w193\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1679     w193    Infubinol  Male          22          30          0   \n",
      "1680     w193    Infubinol  Male          22          30          5   \n",
      "1681     w193    Infubinol  Male          22          30         10   \n",
      "1682     w193    Infubinol  Male          22          30         15   \n",
      "1683     w193    Infubinol  Male          22          30         20   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1679           45.000000                 0  \n",
      "1680           45.493858                 0  \n",
      "1681           48.346550                 0  \n",
      "1682           49.385574                 0  \n",
      "1683           50.005138                 0  \n",
      "Entries for Mouse ID: w350\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1684     w350     Propriva  Male           7          26          0   \n",
      "1685     w350     Propriva  Male           7          26          5   \n",
      "1686     w350     Propriva  Male           7          26         10   \n",
      "1687     w350     Propriva  Male           7          26         15   \n",
      "1688     w350     Propriva  Male           7          26         20   \n",
      "1689     w350     Propriva  Male           7          26         25   \n",
      "1690     w350     Propriva  Male           7          26         30   \n",
      "1691     w350     Propriva  Male           7          26         35   \n",
      "1692     w350     Propriva  Male           7          26         40   \n",
      "1693     w350     Propriva  Male           7          26         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1684           45.000000                 0  \n",
      "1685           48.232113                 0  \n",
      "1686           48.899552                 0  \n",
      "1687           50.854632                 1  \n",
      "1688           52.132321                 1  \n",
      "1689           52.805915                 1  \n",
      "1690           55.879909                 1  \n",
      "1691           56.683558                 1  \n",
      "1692           62.324348                 2  \n",
      "1693           64.957562                 2  \n",
      "Entries for Mouse ID: w422\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1694     w422     Ketapril  Female          18          26          0   \n",
      "1695     w422     Ketapril  Female          18          26          5   \n",
      "1696     w422     Ketapril  Female          18          26         10   \n",
      "1697     w422     Ketapril  Female          18          26         15   \n",
      "1698     w422     Ketapril  Female          18          26         20   \n",
      "1699     w422     Ketapril  Female          18          26         25   \n",
      "1700     w422     Ketapril  Female          18          26         30   \n",
      "1701     w422     Ketapril  Female          18          26         35   \n",
      "1702     w422     Ketapril  Female          18          26         40   \n",
      "1703     w422     Ketapril  Female          18          26         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1694           45.000000                 0  \n",
      "1695           48.457459                 0  \n",
      "1696           49.935970                 0  \n",
      "1697           52.246310                 0  \n",
      "1698           53.676243                 1  \n",
      "1699           56.957917                 2  \n",
      "1700           60.096635                 3  \n",
      "1701           61.409620                 4  \n",
      "1702           63.072585                 4  \n",
      "1703           67.989530                 4  \n",
      "Entries for Mouse ID: w540\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1704     w540     Stelasyn  Female           8          26          0   \n",
      "1705     w540     Stelasyn  Female           8          26          5   \n",
      "1706     w540     Stelasyn  Female           8          26         10   \n",
      "1707     w540     Stelasyn  Female           8          26         15   \n",
      "1708     w540     Stelasyn  Female           8          26         20   \n",
      "1709     w540     Stelasyn  Female           8          26         25   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1704           45.000000                 0  \n",
      "1705           45.885370                 1  \n",
      "1706           47.459067                 1  \n",
      "1707           48.250146                 2  \n",
      "1708           50.672727                 2  \n",
      "1709           52.600270                 2  \n",
      "Entries for Mouse ID: w575\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1710     w575    Zoniferol  Female          16          28          0   \n",
      "1711     w575    Zoniferol  Female          16          28          5   \n",
      "1712     w575    Zoniferol  Female          16          28         10   \n",
      "1713     w575    Zoniferol  Female          16          28         15   \n",
      "1714     w575    Zoniferol  Female          16          28         20   \n",
      "1715     w575    Zoniferol  Female          16          28         25   \n",
      "1716     w575    Zoniferol  Female          16          28         30   \n",
      "1717     w575    Zoniferol  Female          16          28         35   \n",
      "1718     w575    Zoniferol  Female          16          28         40   \n",
      "1719     w575    Zoniferol  Female          16          28         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1710           45.000000                 0  \n",
      "1711           48.913860                 1  \n",
      "1712           50.135955                 1  \n",
      "1713           50.867452                 1  \n",
      "1714           55.591816                 1  \n",
      "1715           58.587322                 1  \n",
      "1716           60.153065                 1  \n",
      "1717           63.686445                 2  \n",
      "1718           64.938406                 3  \n",
      "1719           68.401286                 3  \n",
      "Entries for Mouse ID: w584\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1720     w584    Infubinol  Male           3          29          0   \n",
      "1721     w584    Infubinol  Male           3          29          5   \n",
      "1722     w584    Infubinol  Male           3          29         10   \n",
      "1723     w584    Infubinol  Male           3          29         15   \n",
      "1724     w584    Infubinol  Male           3          29         20   \n",
      "1725     w584    Infubinol  Male           3          29         25   \n",
      "1726     w584    Infubinol  Male           3          29         30   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1720           45.000000                 0  \n",
      "1721           46.051931                 0  \n",
      "1722           47.298508                 0  \n",
      "1723           51.265440                 0  \n",
      "1724           53.323507                 1  \n",
      "1725           55.650838                 1  \n",
      "1726           58.268442                 1  \n",
      "Entries for Mouse ID: w697\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1727     w697     Stelasyn  Female          14          30          0   \n",
      "1728     w697     Stelasyn  Female          14          30          5   \n",
      "1729     w697     Stelasyn  Female          14          30         10   \n",
      "1730     w697     Stelasyn  Female          14          30         15   \n",
      "1731     w697     Stelasyn  Female          14          30         20   \n",
      "1732     w697     Stelasyn  Female          14          30         25   \n",
      "1733     w697     Stelasyn  Female          14          30         30   \n",
      "1734     w697     Stelasyn  Female          14          30         35   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1727           45.000000                 0  \n",
      "1728           48.301823                 1  \n",
      "1729           48.925056                 2  \n",
      "1730           52.657265                 2  \n",
      "1731           54.228091                 3  \n",
      "1732           57.610394                 3  \n",
      "1733           60.720636                 3  \n",
      "1734           63.689042                 3  \n",
      "Entries for Mouse ID: w746\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1735     w746     Propriva  Male           1          26          0   \n",
      "1736     w746     Propriva  Male           1          26          5   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1735            45.00000                 0  \n",
      "1736            49.45327                 0  \n",
      "Entries for Mouse ID: x111\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1737     x111     Propriva  Female          24          27          0   \n",
      "1738     x111     Propriva  Female          24          27          5   \n",
      "1739     x111     Propriva  Female          24          27         10   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1737           45.000000                 0  \n",
      "1738           46.941015                 1  \n",
      "1739           49.122969                 1  \n",
      "Entries for Mouse ID: x209\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1740     x209     Propriva  Female           7          29          0   \n",
      "1741     x209     Propriva  Female           7          29          5   \n",
      "1742     x209     Propriva  Female           7          29         10   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1740           45.000000                 0  \n",
      "1741           46.754269                 0  \n",
      "1742           48.929895                 0  \n",
      "Entries for Mouse ID: x264\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1744     x264     Naftisol  Female          21          27          0   \n",
      "1745     x264     Naftisol  Female          21          27          5   \n",
      "1746     x264     Naftisol  Female          21          27         10   \n",
      "1747     x264     Naftisol  Female          21          27         15   \n",
      "1748     x264     Naftisol  Female          21          27         20   \n",
      "1749     x264     Naftisol  Female          21          27         25   \n",
      "1750     x264     Naftisol  Female          21          27         30   \n",
      "1751     x264     Naftisol  Female          21          27         35   \n",
      "1752     x264     Naftisol  Female          21          27         40   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1744           45.000000                 0  \n",
      "1745           47.038415                 0  \n",
      "1746           47.887128                 1  \n",
      "1747           50.002314                 1  \n",
      "1748           53.074270                 1  \n",
      "1749           56.891053                 2  \n",
      "1750           58.158694                 3  \n",
      "1751           61.299608                 4  \n",
      "1752           63.283288                 4  \n",
      "Entries for Mouse ID: x402\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1754     x402     Stelasyn  Male          21          28          0   \n",
      "1755     x402     Stelasyn  Male          21          28          5   \n",
      "1756     x402     Stelasyn  Male          21          28         10   \n",
      "1757     x402     Stelasyn  Male          21          28         15   \n",
      "1758     x402     Stelasyn  Male          21          28         20   \n",
      "1759     x402     Stelasyn  Male          21          28         25   \n",
      "1760     x402     Stelasyn  Male          21          28         30   \n",
      "1761     x402     Stelasyn  Male          21          28         35   \n",
      "1762     x402     Stelasyn  Male          21          28         40   \n",
      "1763     x402     Stelasyn  Male          21          28         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1754           45.000000                 0  \n",
      "1755           46.327570                 1  \n",
      "1756           46.886962                 1  \n",
      "1757           49.119948                 1  \n",
      "1758           50.414750                 2  \n",
      "1759           52.431737                 2  \n",
      "1760           54.351585                 3  \n",
      "1761           55.240962                 3  \n",
      "1762           56.691723                 3  \n",
      "1763           61.619606                 3  \n",
      "Entries for Mouse ID: x581\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1764     x581     Ceftamin  Female          19          28          0   \n",
      "1765     x581     Ceftamin  Female          19          28          5   \n",
      "1766     x581     Ceftamin  Female          19          28         10   \n",
      "1767     x581     Ceftamin  Female          19          28         15   \n",
      "1768     x581     Ceftamin  Female          19          28         20   \n",
      "1769     x581     Ceftamin  Female          19          28         25   \n",
      "1770     x581     Ceftamin  Female          19          28         30   \n",
      "1771     x581     Ceftamin  Female          19          28         35   \n",
      "1772     x581     Ceftamin  Female          19          28         40   \n",
      "1773     x581     Ceftamin  Female          19          28         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1764           45.000000                 0  \n",
      "1765           47.196927                 0  \n",
      "1766           49.067028                 1  \n",
      "1767           49.746427                 2  \n",
      "1768           51.207969                 3  \n",
      "1769           51.935283                 3  \n",
      "1770           55.492826                 3  \n",
      "1771           58.077583                 3  \n",
      "1772           60.280405                 3  \n",
      "1773           64.634949                 3  \n",
      "Entries for Mouse ID: x613\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1774     x613    Zoniferol  Female           2          29          0   \n",
      "1775     x613    Zoniferol  Female           2          29          5   \n",
      "1776     x613    Zoniferol  Female           2          29         10   \n",
      "1777     x613    Zoniferol  Female           2          29         15   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1774           45.000000                 0  \n",
      "1775           46.097041                 0  \n",
      "1776           46.818176                 0  \n",
      "1777           48.077646                 0  \n",
      "Entries for Mouse ID: x773\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1778     x773      Placebo  Female          21          30          0   \n",
      "1779     x773      Placebo  Female          21          30          5   \n",
      "1780     x773      Placebo  Female          21          30         10   \n",
      "1781     x773      Placebo  Female          21          30         15   \n",
      "1782     x773      Placebo  Female          21          30         20   \n",
      "1783     x773      Placebo  Female          21          30         25   \n",
      "1784     x773      Placebo  Female          21          30         30   \n",
      "1785     x773      Placebo  Female          21          30         35   \n",
      "1786     x773      Placebo  Female          21          30         40   \n",
      "1787     x773      Placebo  Female          21          30         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1778           45.000000                 0  \n",
      "1779           45.850831                 1  \n",
      "1780           47.189206                 2  \n",
      "1781           47.671236                 3  \n",
      "1782           49.739713                 3  \n",
      "1783           51.104421                 3  \n",
      "1784           52.813115                 4  \n",
      "1785           55.192736                 4  \n",
      "1786           55.987676                 4  \n",
      "1787           58.634971                 4  \n",
      "Entries for Mouse ID: x822\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1788     x822     Ceftamin  Male           3          29          0   \n",
      "1789     x822     Ceftamin  Male           3          29          5   \n",
      "1790     x822     Ceftamin  Male           3          29         10   \n",
      "1791     x822     Ceftamin  Male           3          29         15   \n",
      "1792     x822     Ceftamin  Male           3          29         20   \n",
      "1793     x822     Ceftamin  Male           3          29         25   \n",
      "1794     x822     Ceftamin  Male           3          29         30   \n",
      "1795     x822     Ceftamin  Male           3          29         35   \n",
      "1796     x822     Ceftamin  Male           3          29         40   \n",
      "1797     x822     Ceftamin  Male           3          29         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1788           45.000000                 0  \n",
      "1789           45.671104                 1  \n",
      "1790           48.983717                 1  \n",
      "1791           49.694665                 1  \n",
      "1792           51.914910                 2  \n",
      "1793           54.041333                 2  \n",
      "1794           55.445155                 2  \n",
      "1795           56.796567                 2  \n",
      "1796           59.555685                 2  \n",
      "1797           61.386660                 3  \n",
      "Entries for Mouse ID: x930\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1798     x930     Naftisol  Male          13          26          0   \n",
      "1799     x930     Naftisol  Male          13          26          5   \n",
      "1800     x930     Naftisol  Male          13          26         10   \n",
      "1801     x930     Naftisol  Male          13          26         15   \n",
      "1802     x930     Naftisol  Male          13          26         20   \n",
      "1803     x930     Naftisol  Male          13          26         25   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1798           45.000000                 0  \n",
      "1799           46.078234                 0  \n",
      "1800           50.260694                 0  \n",
      "1801           51.973769                 0  \n",
      "1802           52.556066                 0  \n",
      "1803           53.726101                 0  \n",
      "Entries for Mouse ID: y163\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1804     y163    Infubinol  Female          17          27          0   \n",
      "1805     y163    Infubinol  Female          17          27          5   \n",
      "1806     y163    Infubinol  Female          17          27         10   \n",
      "1807     y163    Infubinol  Female          17          27         15   \n",
      "1808     y163    Infubinol  Female          17          27         20   \n",
      "1809     y163    Infubinol  Female          17          27         25   \n",
      "1810     y163    Infubinol  Female          17          27         30   \n",
      "1811     y163    Infubinol  Female          17          27         35   \n",
      "1812     y163    Infubinol  Female          17          27         40   \n",
      "1813     y163    Infubinol  Female          17          27         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1804           45.000000                 0  \n",
      "1805           48.284970                 0  \n",
      "1806           49.112399                 1  \n",
      "1807           51.523068                 1  \n",
      "1808           54.571076                 1  \n",
      "1809           56.176385                 1  \n",
      "1810           59.412537                 2  \n",
      "1811           61.730196                 2  \n",
      "1812           63.620680                 2  \n",
      "1813           67.685569                 3  \n",
      "Entries for Mouse ID: y260\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1814     y260     Ketapril  Female           7          25          0   \n",
      "1815     y260     Ketapril  Female           7          25          5   \n",
      "1816     y260     Ketapril  Female           7          25         10   \n",
      "1817     y260     Ketapril  Female           7          25         15   \n",
      "1818     y260     Ketapril  Female           7          25         20   \n",
      "1819     y260     Ketapril  Female           7          25         25   \n",
      "1820     y260     Ketapril  Female           7          25         30   \n",
      "1821     y260     Ketapril  Female           7          25         35   \n",
      "1822     y260     Ketapril  Female           7          25         40   \n",
      "1823     y260     Ketapril  Female           7          25         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1814           45.000000                 0  \n",
      "1815           46.799839                 0  \n",
      "1816           48.081807                 1  \n",
      "1817           50.196152                 2  \n",
      "1818           50.729582                 3  \n",
      "1819           54.437562                 4  \n",
      "1820           58.582676                 4  \n",
      "1821           59.603558                 4  \n",
      "1822           60.914176                 4  \n",
      "1823           62.909441                 4  \n",
      "Entries for Mouse ID: y478\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1824     y478      Placebo  Female           3          25          0   \n",
      "1825     y478      Placebo  Female           3          25          5   \n",
      "1826     y478      Placebo  Female           3          25         10   \n",
      "1827     y478      Placebo  Female           3          25         15   \n",
      "1828     y478      Placebo  Female           3          25         20   \n",
      "1829     y478      Placebo  Female           3          25         25   \n",
      "1830     y478      Placebo  Female           3          25         30   \n",
      "1831     y478      Placebo  Female           3          25         35   \n",
      "1832     y478      Placebo  Female           3          25         40   \n",
      "1833     y478      Placebo  Female           3          25         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1824           45.000000                 0  \n",
      "1825           48.641078                 1  \n",
      "1826           52.288934                 1  \n",
      "1827           53.610406                 1  \n",
      "1828           56.848850                 1  \n",
      "1829           57.826976                 1  \n",
      "1830           59.374615                 1  \n",
      "1831           61.888027                 1  \n",
      "1832           65.971120                 1  \n",
      "1833           66.842635                 1  \n",
      "Entries for Mouse ID: y601\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1834     y601     Naftisol  Female          23          25          0   \n",
      "1835     y601     Naftisol  Female          23          25          5   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1834           45.000000                 0  \n",
      "1835           48.475003                 1  \n",
      "Entries for Mouse ID: y769\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1836     y769     Ceftamin  Female           6          27          0   \n",
      "1837     y769     Ceftamin  Female           6          27          5   \n",
      "1838     y769     Ceftamin  Female           6          27         10   \n",
      "1839     y769     Ceftamin  Female           6          27         15   \n",
      "1840     y769     Ceftamin  Female           6          27         20   \n",
      "1841     y769     Ceftamin  Female           6          27         25   \n",
      "1842     y769     Ceftamin  Female           6          27         30   \n",
      "1843     y769     Ceftamin  Female           6          27         35   \n",
      "1844     y769     Ceftamin  Female           6          27         40   \n",
      "1845     y769     Ceftamin  Female           6          27         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1836           45.000000                 0  \n",
      "1837           46.422652                 1  \n",
      "1838           48.015163                 1  \n",
      "1839           52.761021                 2  \n",
      "1840           55.025724                 2  \n",
      "1841           58.335959                 3  \n",
      "1842           61.071949                 3  \n",
      "1843           63.430632                 3  \n",
      "1844           64.251028                 4  \n",
      "1845           68.594745                 4  \n",
      "Entries for Mouse ID: y865\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1846     y865     Ceftamin  Male          23          26          0   \n",
      "1847     y865     Ceftamin  Male          23          26          5   \n",
      "1848     y865     Ceftamin  Male          23          26         10   \n",
      "1849     y865     Ceftamin  Male          23          26         15   \n",
      "1850     y865     Ceftamin  Male          23          26         20   \n",
      "1851     y865     Ceftamin  Male          23          26         25   \n",
      "1852     y865     Ceftamin  Male          23          26         30   \n",
      "1853     y865     Ceftamin  Male          23          26         35   \n",
      "1854     y865     Ceftamin  Male          23          26         40   \n",
      "1855     y865     Ceftamin  Male          23          26         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1846           45.000000                 0  \n",
      "1847           46.735006                 1  \n",
      "1848           49.522740                 1  \n",
      "1849           50.806519                 1  \n",
      "1850           52.361982                 1  \n",
      "1851           57.173538                 2  \n",
      "1852           59.033275                 3  \n",
      "1853           61.153140                 3  \n",
      "1854           63.469549                 3  \n",
      "1855           64.729837                 3  \n",
      "Entries for Mouse ID: z234\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1856     z234     Naftisol  Female          19          27          0   \n",
      "1857     z234     Naftisol  Female          19          27          5   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1856           45.000000                 0  \n",
      "1857           46.129357                 1  \n",
      "Entries for Mouse ID: z314\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1858     z314     Stelasyn  Female          21          28          0   \n",
      "1859     z314     Stelasyn  Female          21          28          5   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1858           45.000000                 0  \n",
      "1859           45.934712                 0  \n",
      "Entries for Mouse ID: z435\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1860     z435     Propriva  Female          12          26          0   \n",
      "1861     z435     Propriva  Female          12          26          5   \n",
      "1862     z435     Propriva  Female          12          26         10   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1860           45.000000                 0  \n",
      "1861           47.115980                 0  \n",
      "1862           48.710661                 0  \n",
      "Entries for Mouse ID: z581\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1863     z581    Infubinol  Female          24          25          0   \n",
      "1864     z581    Infubinol  Female          24          25          5   \n",
      "1865     z581    Infubinol  Female          24          25         10   \n",
      "1866     z581    Infubinol  Female          24          25         15   \n",
      "1867     z581    Infubinol  Female          24          25         20   \n",
      "1868     z581    Infubinol  Female          24          25         25   \n",
      "1869     z581    Infubinol  Female          24          25         30   \n",
      "1870     z581    Infubinol  Female          24          25         35   \n",
      "1871     z581    Infubinol  Female          24          25         40   \n",
      "1872     z581    Infubinol  Female          24          25         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1863           45.000000                 0  \n",
      "1864           49.273092                 1  \n",
      "1865           50.478750                 2  \n",
      "1866           51.196304                 2  \n",
      "1867           51.807944                 2  \n",
      "1868           54.316407                 2  \n",
      "1869           56.286750                 2  \n",
      "1870           58.628399                 3  \n",
      "1871           60.053740                 3  \n",
      "1872           62.754451                 3  \n",
      "Entries for Mouse ID: z795\n",
      "     Mouse ID Drug Regimen     Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1873     z795     Naftisol  Female          13          29          0   \n",
      "1874     z795     Naftisol  Female          13          29          5   \n",
      "1875     z795     Naftisol  Female          13          29         10   \n",
      "1876     z795     Naftisol  Female          13          29         15   \n",
      "1877     z795     Naftisol  Female          13          29         20   \n",
      "1878     z795     Naftisol  Female          13          29         25   \n",
      "1879     z795     Naftisol  Female          13          29         30   \n",
      "1880     z795     Naftisol  Female          13          29         35   \n",
      "1881     z795     Naftisol  Female          13          29         40   \n",
      "1882     z795     Naftisol  Female          13          29         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1873           45.000000                 0  \n",
      "1874           46.833475                 0  \n",
      "1875           48.030804                 0  \n",
      "1876           49.368132                 1  \n",
      "1877           53.280657                 1  \n",
      "1878           57.947100                 2  \n",
      "1879           59.789636                 2  \n",
      "1880           60.435654                 2  \n",
      "1881           62.376639                 3  \n",
      "1882           65.741070                 3  \n",
      "Entries for Mouse ID: z969\n",
      "     Mouse ID Drug Regimen   Sex  Age_months  Weight (g)  Timepoint  \\\n",
      "1883     z969     Naftisol  Male           9          30          0   \n",
      "1884     z969     Naftisol  Male           9          30          5   \n",
      "1885     z969     Naftisol  Male           9          30         10   \n",
      "1886     z969     Naftisol  Male           9          30         15   \n",
      "1887     z969     Naftisol  Male           9          30         20   \n",
      "1888     z969     Naftisol  Male           9          30         25   \n",
      "1889     z969     Naftisol  Male           9          30         30   \n",
      "1890     z969     Naftisol  Male           9          30         35   \n",
      "1891     z969     Naftisol  Male           9          30         40   \n",
      "1892     z969     Naftisol  Male           9          30         45   \n",
      "\n",
      "      Tumor Volume (mm3)  Metastatic Sites  \n",
      "1883           45.000000                 0  \n",
      "1884           49.332999                 0  \n",
      "1885           52.656081                 1  \n",
      "1886           54.713005                 2  \n",
      "1887           57.898778                 2  \n",
      "1888           63.145652                 2  \n",
      "1889           65.841013                 3  \n",
      "1890           69.176246                 4  \n",
      "1891           70.314904                 4  \n",
      "1892           73.867845                 4  \n"
     ]
    }
   ],
   "source": [
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Summary Statistics"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "                   Mean     Median   Variance  Standard Deviation       SEM\n",
      "Drug Regimen                                                               \n",
      "Capomulin     40.675741  41.557809  24.947764            4.994774  0.329346\n",
      "Ceftamin      52.591172  51.776157  39.290177            6.268188  0.469821\n",
      "Infubinol     52.884795  51.820584  43.128684            6.567243  0.492236\n",
      "Ketapril      55.235638  53.698743  68.553577            8.279709  0.603860\n",
      "Naftisol      54.331565  52.509285  66.173479            8.134708  0.596466\n",
      "Placebo       54.033581  52.288934  61.168083            7.821003  0.581331\n",
      "Propriva      52.320930  50.446266  43.852013            6.622085  0.544332\n",
      "Ramicane      40.216745  40.673236  23.486704            4.846308  0.320955\n",
      "Stelasyn      54.233149  52.431737  59.450562            7.710419  0.573111\n",
      "Zoniferol     53.236507  51.818479  48.533355            6.966589  0.516398\n"
     ]
    }
   ],
   "source": [
    "# Generate a summary statistics table of mean, median, variance, standard deviation, and SEM of the tumor volume for each regimen\n",
    "\n",
    "# Use groupby and summary statistical methods to calculate the following properties of each drug regimen: \n",
    "# mean, median, variance, standard deviation, and SEM of the tumor volume. \n",
    "# Assemble the resulting series into a single summary DataFrame.\n",
    "\n",
    "# Group the data by 'Drug Regimen' and calculate the desired statistics\n",
    "summary_stats = cleaned_data.groupby('Drug Regimen')['Tumor Volume (mm3)'].agg(['mean', 'median', 'var', 'std', 'sem'])\n",
    "\n",
    "# Rename the columns for clarity\n",
    "summary_stats.columns = ['Mean', 'Median', 'Variance', 'Standard Deviation', 'SEM']\n",
    "\n",
    "# Display the summary statistics table\n",
    "print(summary_stats)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [],
   "source": [
    "# A more advanced method to generate a summary statistics table of mean, median, variance, standard deviation,\n",
    "# and SEM of the tumor volume for each regimen (only one method is required in the solution)\n",
    "\n",
    "# Using the aggregation method, produce the same summary statistics in a single line\n",
    "summary_stats = cleaned_data.groupby('Drug Regimen')['Tumor Volume (mm3)'].agg(\n",
    "    Mean='mean',\n",
    "    Median='median',\n",
    "    Variance='var',\n",
    "    Standard_Deviation='std',\n",
    "    SEM=lambda x: x.sem()\n",
    ")\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Bar and Pie Charts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Generate a bar plot showing the total number of rows (Mouse ID/Timepoints) for each drug regimen using Pandas.\n",
    "# Group the data by 'Drug Regimen' and count the number of rows in each group\n",
    "rows_per_regimen = cleaned_data.groupby('Drug Regimen').size()\n",
    "\n",
    "# Create a bar plot\n",
    "rows_per_regimen.plot(kind='bar', figsize=(10, 6), color='skyblue', alpha=0.75)\n",
    "\n",
    "# Add labels and title\n",
    "plt.title('Total Number of Rows (Mouse ID/Timepoints) for Each Drug Regimen')\n",
    "plt.xlabel('Drug Regimen')\n",
    "plt.ylabel('Number of Rows')\n",
    "plt.xticks(rotation=45, ha='right')  # Rotate x-axis labels for better readability\n",
    "plt.tight_layout()\n",
    "\n",
    "# Show the plot\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA90AAAJOCAYAAACqS2TfAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjcuMiwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy8pXeV/AAAACXBIWXMAAA9hAAAPYQGoP6dpAACWNElEQVR4nOzdd3iN9//H8fcRGUaSGhlCJPaKTW1BrNirVu1Qo1WU2rOKojbVQY3aVXyr9iiqKGrVnrVqr5iZ798f+Z27OZKQaO5G9Pm4rlyXc5/7nPM+t3OP1/353J/boqoqAAAAAAAg0aVI6gIAAAAAAHhTEboBAAAAADAJoRsAAAAAAJMQugEAAAAAMAmhGwAAAAAAkxC6AQAAAAAwCaEbAAAAAACTELoBAAAAADAJoRsAAAAAAJMQuoFkxmKxxOtv27ZtL32v0aNHy6pVq/5xPcOHD4933Z999lmM5+bOnSsWi0X279//j2p5Vb6+vlKnTp0k+exXMXjwYMmaNaukTJlS3nrrrTjnGz58uM1vwt7eXrJmzSqdOnWS69ev/3sF/0P379+XjBkzypIlS4xp1u+WIkUKOX/+fIzXPH78WFxcXMRisUi7du3+xWoT37Zt28Riscjy5cuNadZ1xvrn5OQknp6eUrlyZRkzZozcvHkzzve7e/eu2NvbS+HCheO1LalUqZL8+eefYrFYZO7cuf/CNzbfP/0+/2TbOWTIEClWrJhERkbGa/7Q0FDp0qWLZMqUSezs7KRIkSKv9Lnx1a5duxf+HszyT7fD0Wu0s7OTdOnSSeHChaVz586yZ8+eRKw0cT2/fF1cXKRs2bKyePFi0z/buh35888/Tf8s4L8uZVIXACBhdu/ebfN45MiR8vPPP8vWrVttpufPn/+l7zV69Ghp0qSJNGjQIDFLfKHPPvtM3nvvPUmfPv2/9plvkv/9738yatQoGTRokAQGBoqjo+NLX7N+/XpxdXWVR48eycaNG2XChAmya9cuOXTokNjb2/8LVf8zI0aMEC8vL2nWrFmM59KmTStz5syRkSNH2kz//vvvJSwsLFl8v39izpw5kjdvXgkLC5ObN2/Kzp07ZezYsfL555/L0qVLpWrVqjFe87///U8cHBzkp59+kqtXrxrTr127Jo0aNZLu3btLy5YtjekuLi6SKVMm2b17t+TIkeNf+V5m+6ff559sO/v06SPTp0+XefPmSfv27V86/8yZM+Wrr76SadOmSfHixSVt2rSvUHHCpEqVKsY+JTlo0qSJ9O7dW1RVgoOD5ejRozJ//nz5+uuv5cMPP5QpU6YkdYmxil73hQsXZPTo0dKyZUtRVZt1MbHVrl1bdu/eLZkyZTLtMwBEIXQDyUzp0qVtHru5uUmKFCliTH8dVa1aVbZt2yajRo2SCRMmJHU5/ypVlWfPnkmqVKn+0fscPXpUREQ+/PBDcXd3j9drihcvLhkzZhSRqP+D27dvy5w5c2Tnzp1SuXLlf1SP2e7evStfffWVTJo0KdZWtmbNmsm8efNkxIgRkiLF3523Zs+eLQ0bNpQff/zx3yz3X+fn5yclSpQwHjdu3Fh69eol5cuXl0aNGsmZM2fEw8PD5jXLly+XWrVqibe3t3h7exvTra1dWbNmjXV7khy2MfHl6OiYZN/H1dVVWrVqJZ999pnRqvwiR48elVSpUskHH3yQaDU8ffr0hdui5LJPeZ6Hh4dN3TVq1JCePXvKe++9J1OnTpW8efNK165d43x9WFiYWCwWSZny3z08jl53mTJlpFy5cuLr6ytfffWVqaHbzc1N3NzcTHt/AH+jeznwBrp7965069ZNMmfOLA4ODpI9e3YZNGiQhISEGPNYLBZ5/PixzJs3z6YbqYjIrVu3pFu3bpI/f35JmzatuLu7S5UqVeSXX375R3XlyZNHgoKCZMaMGXLx4sUXzlupUiWjnujatWsnvr6+xmNrN9Hx48fL2LFjxdfXV1KlSiWVKlWS06dPS1hYmPTv31+8vLzE1dVVGjZsGGfX25UrV0qhQoXEyclJsmfPLlOnTo0xT3BwsPTp00eyZcsmDg4OkjlzZunZs6c8fvzYZj6LxSIffPCBfPnll5IvXz5xdHSUefPmxfl9IyMjZdy4cZI3b15xdHQUd3d3adOmjVy5csWYx9fXVwYPHiwiUQdp8e3a/zxrSLtx44bN9G+//VYKFy4sTk5Okj59emnYsKGcOHHCeH7NmjVisVhk3759xrQffvhBLBaL1K5d2+a9ChUqJI0bNzYef//991KqVClxdXWV1KlTS/bs2aVDhw4vrXXu3LkSHh4eayu3iEiHDh3k8uXLsmnTJmPa6dOnZefOnXG+/6VLl6RVq1bi7u4ujo6Oki9fPpkwYYJNd19rl+7nL9OIrVvy+fPnpXnz5uLl5SWOjo7i4eEhAQEBcujQIZvXLl26VMqUKSNp0qSRtGnTSo0aNeTgwYMvXQYJlTVrVpkwYYI8fPhQvvrqK5vngoODZfPmzTb/N/ER2/e2dvE/cuSIvPPOO+Lq6irp06eXjz76SMLDw+XUqVNSs2ZNcXZ2Fl9fXxk3blyM903o+vTVV19J7ty5xdHRUfLnz29zyYHV0aNHpX79+pIuXTpxcnKSIkWKxFj3XvR9jh07Ji1atBBXV1fx8PCQDh06yIMHD2xqiWvb+eTJE+P7WNejEiVKxOgq3Lp1azl9+rT8/PPPL1zuFotFZs2aJU+fPjU+y1rzs2fPZMCAATbL7v3335f79+/bvIe12/aKFSukaNGi4uTkJCNGjHjh58bHs2fPpHfv3lKkSBHj/75MmTLyv//9L8a8kZGRMm3aNClSpIikSpVK3nrrLSldunSsJ8XWr18vxYoVk1SpUknevHnl22+//Ud12tnZyfTp0yVjxowyfvx4Y7p1Hf/uu++kd+/ekjlzZnF0dJSzZ88av4XnxdYdOyQkRHr37i2enp6SOnVqqVixovz+++/i6+v7ype2+Pj4iJubW4xtdHzXl/v370tQUJCkT59e0qZNK7Vr15bz58/H2GfE9n0qVaokfn5+snv3bilbtqykSpVKfH19Zc6cOSIStR8oVqyYpE6dWgoWLCjr16+PUf+ZM2ekZcuWNtvYGTNm2MxjXf6LFy+WQYMGiZeXl7i4uEjVqlXl1KlTr7TcgNcZLd3AG+bZs2dSuXJlOXfunIwYMUIKFSokv/zyi4wZM0YOHToka9asEZGobupVqlSRypUry5AhQ0QkqhupSFRoFxEZNmyYeHp6yqNHj2TlypVSqVIl2bJlS6xhOL6GDx8u3333nQwZMkTmz5//z75sNDNmzJBChQrJjBkz5P79+9K7d2+pW7eulCpVSuzt7eXbb7+VixcvSp8+faRjx44xDvYOHTokPXv2lOHDh4unp6csXLhQevToIaGhodKnTx8RiTqg9vf3lytXrsjAgQOlUKFCcuzYMRk6dKj88ccfsnnzZpsDtVWrVskvv/wiQ4cOFU9Pzxe2THft2lW+/vpr+eCDD6ROnTry559/ypAhQ2Tbtm1y4MAByZgxo6xcuVJmzJghs2fPNrqMZ8mSJcHL6sKFCyIikjt3bmPamDFjZODAgdKiRQsZM2aM3LlzR4YPHy5lypSRffv2Sa5cucTf31/s7e1l8+bNUrJkSRER2bx5s6RKlUq2b99udOe+efOmHD161GhR2r17tzRr1kyaNWsmw4cPFycnJ7l48WK8uq+uWbNGihYtGue167ly5ZIKFSrIt99+KzVq1BCRqJMHvr6+EhAQEGP+W7duSdmyZSU0NFRGjhwpvr6+8tNPP0mfPn3k3Llz8sUXXyRoWYqI1KpVSyIiImTcuHGSNWtWuX37tuzatcsm/IwePVoGDx4s7du3l8GDB0toaKiMHz9eKlSoIHv37o3X5SAJrcnOzk527NhhM3316tWxniT5J5o2bSqtWrWSzp07y6ZNm2TcuHESFhYmmzdvlm7dukmfPn1k0aJF0q9fP8mZM6c0atRIRBK+Pv3444/y888/yyeffCJp0qSRL774Qlq0aCEpU6aUJk2aiIjIqVOnpGzZsuLu7i5Tp06VDBkyyIIFC6Rdu3Zy48YN6du370u/T+PGjaVZs2YSFBQkf/zxhwwYMEBExAh/L9p2fvTRR/Ldd9/Jp59+KkWLFpXHjx/L0aNH5c6dOzafYe0mvmbNGqlSpUqctezevTvGJUQ5cuQQVZUGDRrIli1bZMCAAVKhQgU5cuSIDBs2THbv3i27d++2ufTkwIEDcuLECRk8eLBky5ZN0qRJ89LlEB4eHmNaihQpjB4lISEhcvfuXenTp49kzpxZQkNDZfPmzdKoUSOZM2eOtGnTxnhdu3btZMGCBRIUFCSffPKJODg4yIEDB2JcS3z48GHp3bu39O/fXzw8PGTWrFkSFBQkOXPmlIoVK7605rikSpVKqlatKkuWLJErV67YbDcHDBggZcqUkS+//FJSpEgR7x5EVu3bt5elS5dK3759pUqVKnL8+HFp2LChBAcHv3K9Dx48kLt379q02sd3fYmMjJS6devK/v37Zfjw4VKsWDHZvXu31KxZM96ff/36dWnfvr307dtXsmTJItOmTTNOcC5fvlwGDhworq6u8sknn0iDBg3k/Pnz4uXlJSIix48fl7Jlyxon/zw9PWXDhg3y4Ycfyu3bt2XYsGE2nzVw4EApV66czJo1S4KDg6Vfv35St25dOXHihNjZ2b3yMgReOwogWWvbtq2mSZPGePzll1+qiOiyZcts5hs7dqyKiG7cuNGYliZNGm3btu1LPyM8PFzDwsI0ICBAGzZsaPOciOiwYcNe+h4iou+//76qqg4aNEhTpEihhw8fVlXVOXPmqIjovn37jPn9/f3V398/xvu0bdtWfXx8jMcXLlxQEdHChQtrRESEMX3y5MkqIlqvXj2b1/fs2VNFRB88eGBM8/HxUYvFoocOHbKZt1q1auri4qKPHz9WVdUxY8ZoihQpbOpUVV2+fLmKiK5du9bm+7q6uurdu3dfumxOnDihIqLdunWzmf7bb7+piOjAgQONacOGDVMR0Vu3br30fa3zXr9+XcPCwvTevXu6bNkyTZMmjbZo0cKY7969e5oqVSqtVauWzesvXbqkjo6O2rJlS2Na+fLltUqVKsbjnDlz6scff6wpUqTQ7du3q6rqwoULVUT09OnTqqr6+eefq4jo/fv3X1rz81KnTq1dunSJ87vdunVL58yZo46Ojnrnzh0NDw/XTJky6fDhw1U15m+8f//+KiL622+/2bxf165d1WKx6KlTp1RV9eeff1YR0Z9//tlmPuvvbc6cOaqqevv2bRURnTx5cpzf4dKlS5oyZUrt3r27zfSHDx+qp6enNm3a9IXLwFrL999/b0yLbZ15noeHh+bLl89mWoMGDbRu3bqxzm/9buPHj4/zOev3Vv37/2DChAk28xYpUkRFRFesWGFMCwsLUzc3N23UqJExLaHrU6pUqfT69evGtPDwcM2bN6/mzJnTmNa8eXN1dHTUS5cu2bxnYGCgpk6d2vgNvuj7jBs3zua13bp1UycnJ42MjDSmxbXt9PPz0wYNGsSYHpty5cppqVKlXjrf89t4VdX169fHWuvSpUtVRPTrr782pvn4+KidnZ3x247P54lIrH8BAQFxvs66nwgKCtKiRYsa03fs2KEiooMGDXrh5/r4+KiTk5NevHjRmPb06VNNnz69du7c+aV1R9/HxKZfv3426751vapYsWKMea2/hedZ17sLFy6oquqxY8dURLRfv3428y1evFhFJF77V+u2PywsTENDQ/X06dNar149dXZ21v379xvzxXd9WbNmjYqIzpw502a+MWPGxNhfP/99VKP2vSJi89l37txROzs7TZUqlV69etWYfujQIRURnTp1qjGtRo0amiVLFpt9rKrqBx98oE5OTsY+0br8n9/vLFu2TEVEd+/e/dJlByQndC8H3jBbt26VNGnSGC0/VtZublu2bInX+3z55ZdSrFgxcXJykpQpU4q9vb1s2bLFprvxq+rbt6+kT59e+vXr94/fy6pWrVo21/Tmy5dPRCRGi551+qVLl2ymFyhQQAoXLmwzrWXLlhIcHCwHDhwQEZGffvpJ/Pz8pEiRIhIeHm781ahRI9auyFWqVJF06dK9tHZrF9PnuyK+/fbbki9fvnj/n8XF09NT7O3tJV26dNK0aVMpXry4TXfb3bt3y9OnT2N8vre3t1SpUsXm8wMCAuTXX3+Vp0+fysWLF+Xs2bPSvHlzKVKkiNHFe/PmzZI1a1bJlSuXiIjRKt60aVNZtmyZzeBdL3L//n158uTJS1ue3nnnHXFwcJCFCxfK2rVr5fr163F269y6davkz59f3n77bZvp7dq1E1VN8OBR6dOnlxw5csj48eNl4sSJcvDgwRijUm/YsEHCw8OlTZs2Nr8bJycn8ff3j9edBl6Fqto8fvz4sWzYsCHBXctf5vkRp/PlyycWi0UCAwONaSlTppScOXPaXFaS0PUpICDA5vp0Ozs7adasmZw9e9a4DGPr1q0SEBBgc626SNT/75MnT2IMRBmbevXq2TwuVKiQPHv27IUjwlu9/fbbsm7dOunfv79s27ZNnj59Gue87u7u8V4Xnmf9nT7/O3/nnXckTZo0MbYZhQoVsunZ8jKpUqWSffv2xfh7vifI999/L+XKlZO0adMa+4nZs2fb7CfWrVsnIiLvv//+Sz+3SJEikjVrVuOxk5OT5M6d+6WXI8XH8+uD1T9ZH7Zv3y4iUdu26Jo0aZKg68K/+OILsbe3FwcHB8mdO7esW7dOFi9eLMWLFzfmie/6EldNLVq0iHc9mTJlsvns9OnTi7u7uxQpUsRo0Rb5e39q/f959uyZbNmyRRo2bCipU6e2qbNWrVry7NmzGCPJx7a+RX9P4E1B6AbeMHfu3BFPT88Y16O5u7tLypQpY3RzjM3EiROla9euUqpUKfnhhx9kz549sm/fPqlZs+YLDyLjy8XFRQYPHizr169/6TWN8fX8aOgODg4vnP7s2TOb6Z6enjHe0zrNusxu3LghR44cEXt7e5s/Z2dnUVW5ffu2zevjOyKs9f1jm9/Lyyte/2cvsnnzZtm3b58RuHbs2CHdu3d/pc+vWrWqhISEyM6dO2XTpk2SMWNGKVq0qFStWlU2b94sIlEndqKPml2xYkVZtWqVETyzZMkifn5+L70ljvW35uTk9ML50qRJI82aNZNvv/1WZs+eLVWrVhUfH59Y571z506c39P6fEJYLBbZsmWL1KhRQ8aNGyfFihUTNzc3+fDDD+Xhw4ci8ve18yVLlozx21m6dGmM301iePz4sdy5c8fmAHnNmjUSFhYW4yD3n4ptHUudOnWM/zcHBweb9S6h61N81tHE+P/NkCGDzWNrN+34bPumTp0q/fr1k1WrVknlypUlffr00qBBAzlz5kyMeZ2cnF55e3rnzh1JmTJljEGwLBaLeHp6xvieCR2dOkWKFFKiRIkYf9GD+4oVK6Rp06aSOXNmWbBggezevVv27dsnHTp0sPl/vnXrltjZ2cX6//e855e9SNTyT4z9jjXERV8nRBK+bKKzLufnBytMmTJlrN8lLk2bNpV9+/bJrl275KuvvhJnZ2dp3ry5ze8mvuuL9bfx/Hr5fI0vEtvdRRwcHF66P71z546Eh4fLtGnTYtRZq1YtEZEY6/U/Wd+A5IRruoE3TIYMGeS3334TVbUJ3jdv3pTw8HBjFOsXWbBggVSqVElmzpxpM90aIhJD165dZcqUKdKvX79YR5N1cnKyGbzIyoyAIiKx3rfaOs16UJAxY0ZJlSpVnAP7PL9s43tPW+v7X7t2LcY12n/99Ve8/s9epHDhwsZ7VKtWTWrUqCFff/21BAUFScmSJW0+/3nPf36pUqUkbdq0snnzZvnzzz8lICBALBaLBAQEyIQJE2Tfvn1y6dKlGLeqql+/vtSvX19CQkJkz549MmbMGGnZsqX4+vpKmTJlYq3bWpd1jIEX6dChg8yaNUuOHDkiCxcujHO+DBkyxPk9Rf7+P7QGxuiDD4rE/vvz8fGR2bNni0jUIG7Lli2T4cOHS2hoqHz55ZfGey5fvjzOkwGJbc2aNRIREWEz/sIPP/wQ794X/4aErk/xWUfj+/9rljRp0siIESNkxIgRcuPGDaPVu27dunLy5Embee/evfvK9WTIkEHCw8Pl1q1bNsFbVeX69etG7xIrM+6vvWDBAsmWLZssXbrU5v2fX2fc3NwkIiJCrl+/nmS3pnr69Kls3rxZcuTIEWMbG9uyib7+R782Pq7AeOPGDcmcObMxPTw8PEEn8Nzc3IwBLsuUKSP58uUTf39/6dWrl/z0008iEv/1xfrbuHv3rk1Ijm39SWzp0qUTOzs7ad26dZw9G7Jly2Z6HcDriJZu4A0TEBAgjx49klWrVtlMtw5aFn1wqbhaECwWS4z7Px85ciReXTPjy8HBQT799FPZt2+ffP/99zGe9/X1ldOnT9scwN25c0d27dqVaDVEd+zYMTl8+LDNtEWLFomzs7MUK1ZMRKK60Z47d04yZMgQaytQ9FHVE8I6kNKCBQtspu/bt09OnDgR64Bgr8pisciMGTPEzs7OGAm9TJkykipVqhiff+XKFaO7rpW9vb1UrFhRNm3aJFu3bpVq1aqJiEiFChUkZcqUMnjwYCOEx8bR0VH8/f1l7NixIiIvHL3bOvL+uXPnXvq9ypQpIx06dJCGDRtKw4YN45wvICBAjh8/blwyYDV//nyxWCzGLdSs/5dHjhyxme9ltyDLnTu3DB48WAoWLGh8Ro0aNSRlypRy7ty5WH830W/5lRguXbokffr0EVdXV+ncubOIRLVErV27NtG7lv8TCV2ftmzZYjOac0REhCxdutQmSAUEBMjWrVuNkG01f/58SZ06daLdBis+ra8eHh7Srl07adGihZw6dUqePHli8/z58+dfeQA96/r1/Dr7ww8/yOPHjxN1mxEXi8UiDg4ONqH1+vXrMUYvt15m8PxJ3H9LRESEfPDBB3Lnzp14X9IU1/q/evVqm8fWwd2WLl1qM3358uWxDkQXXxUqVJA2bdrImjVrjP1ufNcXf3//WGuKbaT/xJY6dWqpXLmyHDx4UAoVKhRrnQnpAQC8SWjpBt4wbdq0kRkzZkjbtm3lzz//lIIFC8rOnTtl9OjRUqtWLZsWyIIFC8q2bdtk9erVkilTJnF2dpY8efJInTp1ZOTIkTJs2DDx9/eXU6dOySeffCLZsmX7RwcSz2vRooV8/vnnxjV/0bVu3Vq++uoradWqlXTq1Enu3Lkj48aNM0YJTmxeXl5Sr149GT58uGTKlEkWLFggmzZtkrFjx0rq1KlFRKRnz57yww8/SMWKFaVXr15SqFAhiYyMlEuXLsnGjRuld+/eUqpUqQR/dp48eeS9996TadOmSYoUKSQwMNAYvdzb21t69eqVqN81V65c8t5778kXX3whO3fulPLly8uQIUNk4MCB0qZNG2nRooXcuXNHRowYIU5OTjFGmw0ICJDevXuLiBi/p1SpUknZsmVl48aNUqhQIZvrsIcOHSpXrlyRgIAAyZIli9y/f1+mTJki9vb2xgFiXCpVqhTr7yM21tbmF+nVq5fMnz9fateuLZ988on4+PjImjVr5IsvvpCuXbsa3Wc9PT2latWqMmbMGEmXLp34+PjIli1bZMWKFTbvd+TIEfnggw/knXfekVy5comDg4Ns3bpVjhw5Iv379xeRqAP4Tz75RAYNGiTnz5+XmjVrSrp06eTGjRuyd+9eo3X0VRw9etS4ZvLmzZvyyy+/yJw5c8TOzk5WrlxptIKuX79enjx5Ig0aNHilzzFDQtenjBkzSpUqVWTIkCHG6OUnT560CRPDhg2Tn376SSpXrixDhw6V9OnTy8KFC2XNmjUybtw4cXV1TZTa49p2lipVSurUqSOFChWSdOnSyYkTJ+S7776TMmXKGNsRkagTiGfOnLG5zCMhrD1W+vXrJ8HBwVKuXDlj9PKiRYtK69at/9H3i4yMjHHtrVXRokXF0dHRuA1Zt27dpEmTJnL58mUZOXKkZMqUyaZbdIUKFaR169by6aefyo0bN6ROnTri6OgoBw8elNSpU7/yMojNjRs3ZM+ePaKq8vDhQzl69KjMnz9fDh8+LL169ZJOnTrF631q1aol6dOnN0ZbT5kypcydO1cuX75sM1+BAgWkRYsWMmHCBLGzs5MqVarIsWPHZMKECeLq6mozzkhCjRw5UpYuXSpDhgyRzZs3x3t9qVmzppQrV0569+4twcHBUrx4cdm9e7dx4v2f1BQfU6ZMkfLly0uFChWka9eu4uvrKw8fPpSzZ8/K6tWrEzxuBvDGSLIh3AAkithGtr1z54526dJFM2XKpClTplQfHx8dMGCAPnv2zGa+Q4cOably5TR16tQqIsZo4SEhIdqnTx/NnDmzOjk5abFixXTVqlUxRg5XfbXRy6PbuHGjMTLu86Oyzps3T/Ply6dOTk6aP39+Xbp0aZyjlz8/4nJsIz6rxj7qs4+Pj9auXVuXL1+uBQoUUAcHB/X19dWJEyfGqPfRo0c6ePBgzZMnjzo4OKirq6sWLFhQe/XqZTOyclzfNy4RERE6duxYzZ07t9rb22vGjBm1VatWevnyZZv5XmX08tjmvXHjhqZNm1YrV65sTJs1a5YWKlTI+F7169fXY8eOxXjt4cOHVUQ0V65cNtNHjRqlIqIfffSRzfSffvpJAwMDNXPmzOrg4KDu7u5aq1Yt/eWXX176HbZs2aIionv37o33d4sutlGmL168qC1bttQMGTKovb295smTR8ePH28z+r2q6rVr17RJkyaaPn16dXV11VatWun+/fttRr2+ceOGtmvXTvPmzatp0qTRtGnTaqFChXTSpEkaHh5u836rVq3SypUrq4uLizo6OqqPj482adJEN2/e/MLv8KLRy61/1uXq7++vo0eP1ps3b9q8R6tWrWK9G0B0rzp6+fP/B7Ftk1SjRkUuUKCAzbSErk9ffPGF5siRQ+3t7TVv3ry6cOHCGJ/zxx9/aN26ddXV1VUdHBy0cOHCNnUn9PvENsJzXNvO/v37a4kSJTRdunTq6Oio2bNn1169eunt27dt3nP27Nlqb29v8x3jEtfyfPr0qfbr1099fHzU3t5eM2XKpF27dtV79+7ZzGfdvsXXi0YvFxE9c+aMMe9nn32mvr6+6ujoqPny5dNvvvkm1pG/IyIidNKkSern52f8P5cpU0ZXr1790jrjupPF86LXmCJFCnVxcdGCBQvqe++9F+tI2HHtI6z27t2rZcuW1TRp0mjmzJl12LBhOmvWrBi/hWfPnulHH32k7u7u6uTkpKVLl9bdu3erq6ur9urVK151x7Wv+Pjjj1VEjDtDxHd9uXv3rrZv317feustTZ06tVarVk337NmjIqJTpkwx5otr9PLn11PVuP9/Yqv/woUL2qFDB82cObPa29urm5ubli1bVj/99FNjnriWf2zrJvAmsKjGMZwjAACvgUKFCkm5cuWSrHtqchcaGiru7u4ycuTIRG1V/DdZLBZ5//33Zfr06UldSqKoUKGCZM2a9YXjDyD52rVrl5QrV04WLlwoLVu2TOpyRCTqcql3331Xfv31VylbtmxSlwP859C9HADwWhs3bpw0bNhQBg0aFGMQJLycg4OD3L9/P6nLwP/bsWOH7Nu3z+a2fUi+Nm3aJLt375bixYtLqlSp5PDhw/LZZ59Jrly5pFGjRklS0+LFi+Xq1atSsGBBSZEihezZs0fGjx8vFStWJHADSYTQDQB4rdWsWVPGjx8vFy5cIHQj2btz547Mnz9fsmfPntSlIBG4uLjIxo0bZfLkyfLw4UPJmDGjBAYGypgxY156u0OzODs7y5IlS+TTTz+Vx48fS6ZMmaRdu3by6aefJkk9AEToXg4AAAAAgEm4ZRgAAAAAACYhdAMAAAAAYBJCNwAAAAAAJmEgNRGJjIyUv/76S5ydncVisSR1OQAAAACA15yqysOHD8XLy0tSpIi7PZvQLSJ//fWXeHt7J3UZAAAAAIBk5vLlyy+8wwqhW6JurSAStbBcXFySuBoAAAAAwOsuODhYvL29jTwZF0K3iNGl3MXFhdANAAAAAIi3l12izEBqAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYJGVSF4D4W3TmQVKX8Fppmcs1qUsAAAAAgBeipRsAAAAAAJMQugEAAAAAMAmhGwAAAAAAk3BNNwAAAN54jI1ji7FxgH8PLd0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJkjR0jxkzRkqWLCnOzs7i7u4uDRo0kFOnTtnMo6oyfPhw8fLyklSpUkmlSpXk2LFjNvOEhIRI9+7dJWPGjJImTRqpV6+eXLly5d/8KgAAAAAAxJCkoXv79u3y/vvvy549e2TTpk0SHh4u1atXl8ePHxvzjBs3TiZOnCjTp0+Xffv2iaenp1SrVk0ePnxozNOzZ09ZuXKlLFmyRHbu3CmPHj2SOnXqSERERFJ8LQAAAAAARETEoqqa1EVY3bp1S9zd3WX79u1SsWJFUVXx8vKSnj17Sr9+/UQkqlXbw8NDxo4dK507d5YHDx6Im5ubfPfdd9KsWTMREfnrr7/E29tb1q5dKzVq1Hjp5wYHB4urq6s8ePBAXFxcTP2O/8SiMw+SuoTXSstcrkldAgAASCY4jrLFcRTwz8U3R75W13Q/eBC1MUyfPr2IiFy4cEGuX78u1atXN+ZxdHQUf39/2bVrl4iI/P777xIWFmYzj5eXl/j5+RnzPC8kJESCg4Nt/gAAAAAASGyvTehWVfnoo4+kfPny4ufnJyIi169fFxERDw8Pm3k9PDyM565fvy4ODg6SLl26OOd53pgxY8TV1dX48/b2TuyvAwAAAADA6xO6P/jgAzly5IgsXrw4xnMWi8XmsarGmPa8F80zYMAAefDggfF3+fLlVy8cAAAAAIA4vBahu3v37vLjjz/Kzz//LFmyZDGme3p6iojEaLG+efOm0frt6ekpoaGhcu/evTjneZ6jo6O4uLjY/AEAAAAAkNiSNHSrqnzwwQeyYsUK2bp1q2TLls3m+WzZsomnp6ds2rTJmBYaGirbt2+XsmXLiohI8eLFxd7e3maea9euydGjR415AAAAAABICimT8sPff/99WbRokfzvf/8TZ2dno0Xb1dVVUqVKJRaLRXr27CmjR4+WXLlySa5cuWT06NGSOnVqadmypTFvUFCQ9O7dWzJkyCDp06eXPn36SMGCBaVq1apJ+fUAAAAAAP9xSRq6Z86cKSIilSpVspk+Z84cadeunYiI9O3bV54+fSrdunWTe/fuSalSpWTjxo3i7OxszD9p0iRJmTKlNG3aVJ4+fSoBAQEyd+5csbOz+7e+CgAAAAAAMbxW9+lOKtynO3ni/pIAACC+OI6yxXEU8M8ly/t0AwAAAADwJiF0AwAAAABgEkI3AAAAAAAmIXQDAAAAAGASQjcAAAAAACYhdAMAAAAAYBJCNwAAAAAAJiF0AwAAAABgEkI3AAAAAAAmIXQDAAAAAGASQjcAAAAAACYhdAMAAAAAYBJCNwAAAAAAJiF0AwAAAABgEkI3AAAAAAAmIXQDAAAAAGCSlEldAADgxRadeZDUJbxWWuZyTeoSAAAA4o2WbgAAAAAATELoBgAAAADAJIRuAAAAAABMwjXdAID/HK6T/xvXyAMAYC5augEAAAAAMAmhGwAAAAAAkxC6AQAAAAAwCaEbAAAAAACTELoBAAAAADAJoRsAAAAAAJNwyzAAAAAAeA1wS8u/vUm3tKSlGwAAAAAAk9DSDQAA/hFaZmy9Sa0zwIuw7tti3UdcaOkGAAAAAMAkhG4AAAAAAExC6AYAAAAAwCSEbgAAAAAATELoBgAAAADAJIxejv80Rt20lRijbrJMbTGSKQAAwH8bLd0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYJElD944dO6Ru3bri5eUlFotFVq1aZfN8u3btxGKx2PyVLl3aZp6QkBDp3r27ZMyYUdKkSSP16tWTK1eu/IvfAgAAAACA2CVp6H78+LEULlxYpk+fHuc8NWvWlGvXrhl/a9eutXm+Z8+esnLlSlmyZIns3LlTHj16JHXq1JGIiAizywcAAAAA4IVSJuWHBwYGSmBg4AvncXR0FE9Pz1ife/DggcyePVu+++47qVq1qoiILFiwQLy9vWXz5s1So0aNRK8ZAAAAAID4eu2v6d62bZu4u7tL7ty5pVOnTnLz5k3jud9//13CwsKkevXqxjQvLy/x8/OTXbt2JUW5AAAAAAAYEtzS/fTpU1FVSZ06tYiIXLx4UVauXCn58+e3Cb+JITAwUN555x3x8fGRCxcuyJAhQ6RKlSry+++/i6Ojo1y/fl0cHBwkXbp0Nq/z8PCQ69evx/m+ISEhEhISYjwODg5O1LoBAAAAABB5hdBdv359adSokXTp0kXu378vpUqVEnt7e7l9+7ZMnDhRunbtmmjFNWvWzPi3n5+flChRQnx8fGTNmjXSqFGjOF+nqmKxWOJ8fsyYMTJixIhEqxMAAAAAgNgkuHv5gQMHpEKFCiIisnz5cvHw8JCLFy/K/PnzZerUqYleYHSZMmUSHx8fOXPmjIiIeHp6SmhoqNy7d89mvps3b4qHh0ec7zNgwAB58OCB8Xf58mVT6wYAAAAA/DclOHQ/efJEnJ2dRURk48aN0qhRI0mRIoWULl1aLl68mOgFRnfnzh25fPmyZMqUSUREihcvLvb29rJp0yZjnmvXrsnRo0elbNmycb6Po6OjuLi42PwBAAAAAJDYEhy6c+bMKatWrZLLly/Lhg0bjOu4b968meDw+ujRIzl06JAcOnRIREQuXLgghw4dkkuXLsmjR4+kT58+snv3bvnzzz9l27ZtUrduXcmYMaM0bNhQRERcXV0lKChIevfuLVu2bJGDBw9Kq1atpGDBgsZo5gAAAAAAJJUEX9M9dOhQadmypfTq1UsCAgKkTJkyIhLV6l20aNEEvdf+/fulcuXKxuOPPvpIRETatm0rM2fOlD/++EPmz58v9+/fl0yZMknlypVl6dKlRku7iMikSZMkZcqU0rRpU3n69KkEBATI3Llzxc7OLqFfDQAA4LWw6MyDpC7htdIyl2tSlwAAryzBobtJkyZSvnx5uXbtmhQuXNiYHhAQYLRAx1elSpVEVeN8fsOGDS99DycnJ5k2bZpMmzYtQZ8NAAAAAIDZEhy6N23aJOXLlxdPT0+b6W+//XaiFQUAAAAAwJsgwaG7cePGEhISIsWLFxd/f3+pVKmSlCtXTtKmTWtGfQAAAAAAJFsJHkjt3r17sm3bNqlXr54cPHhQ3nnnHUmfPr2ULl1a+vfvb0aNAAAAAAAkSwkO3XZ2dlKmTBnp37+/rF+/Xnbt2iUtW7aU33//XcaPH29GjQAAAAAAJEsJ7l5+4sQJ2b59u2zbtk22b98uERERUr58eZkwYYL4+/ubUSMAAAAAAMlSgkN3gQIFxM3NTXr27ClDhgyRAgUKmFEXAAAAAADJXoK7l3/44YeSOXNmGT58uHTo0EH69esn69atk0ePHplRHwAAAAAAyVaCQ/fkyZPlwIEDcuPGDRk8eLBERETI0KFDJWPGjFK6dGkzagQAAAAAIFlKcOi2ioyMlPDwcAkNDZWQkBAJCwuTP//8MxFLAwAAAAAgeUtw6O7Ro4cULlxY3N3dpXPnzvLXX3/Je++9J4cPH5br16+bUSMAAAAAAMlSggdSu3r1qnTq1EkqVaokfn5+ZtQEAAAAAMAbIcGhe/ny5WbUAQAAAADAGyfBoVtE5Ny5czJ58mQ5ceKEWCwWyZcvn/To0UNy5MiR2PUBAAAAAJBsJfia7g0bNkj+/Pll7969UqhQIfHz85PffvtNChQoIJs2bTKjRgAAAAAAkqUEt3T3799fevXqJZ999lmM6f369ZNq1aolWnEAAAAAACRnCW7pPnHihAQFBcWY3qFDBzl+/HiiFAUAAAAAwJsgwaHbzc1NDh06FGP6oUOHxN3dPTFqAgAAAADgjZDg7uWdOnWS9957T86fPy9ly5YVi8UiO3fulLFjx0rv3r3NqBEAAAAAgGQpwaF7yJAh4uzsLBMmTJABAwaIiIiXl5cMHz5cPvzww0QvEAAAAACA5CrBodtisUivXr2kV69e8vDhQxERcXZ2FhGRq1evSubMmRO3QgAAAAAAkqkEX9MdnbOzszg7O8v169ele/fukjNnzsSqCwAAAACAZC/eofv+/fvy7rvvipubm3h5ecnUqVMlMjJShg4dKtmzZ5c9e/bIt99+a2atAAAAAAAkK/HuXj5w4EDZsWOHtG3bVtavXy+9evWS9evXy7Nnz2TdunXi7+9vZp0AAAAAACQ78Q7da9askTlz5kjVqlWlW7dukjNnTsmdO7dMnjzZxPIAAAAAAEi+4t29/K+//pL8+fOLiEj27NnFyclJOnbsaFphAAAAAAAkd/EO3ZGRkWJvb288trOzkzRp0phSFAAAAAAAb4J4dy9XVWnXrp04OjqKiMizZ8+kS5cuMYL3ihUrErdCAAAAAACSqXiH7rZt29o8btWqVaIXAwAAAADAmyTeoXvOnDlm1gEAAAAAwBsn3td0AwAAAACAhCF0AwAAAABgEkI3AAAAAAAmIXQDAAAAAGCSeIXuYsWKyb1790RE5JNPPpEnT56YWhQAAAAAAG+CeIXuEydOyOPHj0VEZMSIEfLo0SNTiwIAAAAA4E0Qr1uGFSlSRNq3by/ly5cXVZXPP/9c0qZNG+u8Q4cOTdQCAQAAAABIruIVuufOnSvDhg2Tn376SSwWi6xbt05Spoz5UovFQugGAAAAAOD/xSt058mTR5YsWSIiIilSpJAtW7aIu7u7qYUBAAAAAJDcxSt0RxcZGWlGHQAAAAAAvHESHLpFRM6dOyeTJ0+WEydOiMVikXz58kmPHj0kR44ciV0fAAAAAADJVoLv071hwwbJnz+/7N27VwoVKiR+fn7y22+/SYECBWTTpk1m1AgAAAAAQLKU4Jbu/v37S69eveSzzz6LMb1fv35SrVq1RCsOAAAAAIDkLMEt3SdOnJCgoKAY0zt06CDHjx9PlKIAAAAAAHgTJDh0u7m5yaFDh2JMP3ToECOaAwAAAAAQTYK7l3fq1Enee+89OX/+vJQtW1YsFovs3LlTxo4dK7179zajRgAAAAAAkqUEh+4hQ4aIs7OzTJgwQQYMGCAiIl5eXjJ8+HD58MMPE71AAAAAAACSqwSHbovFIr169ZJevXrJw4cPRUTE2dk50QsDAAAAACC5e6X7dFsRtgEAAAAAiFuCB1IDAAAAAADxQ+gGAAAAAMAkhG4AAAAAAEySoNAdFhYmlStXltOnT5tVDwAAAAAAb4wEhW57e3s5evSoWCwWs+oBAAAAAOCNkeDu5W3atJHZs2ebUQsAAAAAAG+UBN8yLDQ0VGbNmiWbNm2SEiVKSJo0aWyenzhxYqIVBwAAAABAcpbg0H306FEpVqyYiEiMa7vpdg4AAAAAwN8SHLp//vlnM+oAAAAAAOCN88q3DDt79qxs2LBBnj59KiIiqppoRQEAAAAA8CZIcOi+c+eOBAQESO7cuaVWrVpy7do1ERHp2LGj9O7dO9ELBAAAAAAguUpw6O7Vq5fY29vLpUuXJHXq1Mb0Zs2ayfr16xO1OAAAAAAAkrMEX9O9ceNG2bBhg2TJksVmeq5cueTixYuJVhgAAAAAAMldglu6Hz9+bNPCbXX79m1xdHRMlKIAAAAAAHgTJDh0V6xYUebPn288tlgsEhkZKePHj5fKlSsnanEAAAAAACRnCe5ePn78eKlUqZLs379fQkNDpW/fvnLs2DG5e/eu/Prrr2bUCAAAAABAspTglu78+fPLkSNH5O2335Zq1arJ48ePpVGjRnLw4EHJkSOHGTUCAAAAAJAsJbilW0TE09NTRowYkdi1AAAAAADwRnml0H3v3j2ZPXu2nDhxQiwWi+TLl0/at28v6dOnT+z6AAAAAABIthLcvXz79u2SLVs2mTp1qty7d0/u3r0rU6dOlWzZssn27dvNqBEAAAAAgGQpwS3d77//vjRt2lRmzpwpdnZ2IiISEREh3bp1k/fff1+OHj2a6EUCAAAAAJAcJbil+9y5c9K7d28jcIuI2NnZyUcffSTnzp1L1OIAAAAAAEjOEhy6ixUrJidOnIgx/cSJE1KkSJHEqAkAAAAAgDdCvLqXHzlyxPj3hx9+KD169JCzZ89K6dKlRURkz549MmPGDPnss8/MqRIAAAAAgGQoXqG7SJEiYrFYRFWNaX379o0xX8uWLaVZs2aJVx0AAAAAAMlYvEL3hQsXzK4DAAAAAIA3TrxCt4+Pj9l1AAAAAADwxknwLcNERK5evSq//vqr3Lx5UyIjI22e+/DDDxOlMAAAAAAAkrsEh+45c+ZIly5dxMHBQTJkyCAWi8V4zmKxELoBAAAAAPh/CQ7dQ4cOlaFDh8qAAQMkRYoE33EMAAAAAID/jASn5idPnkjz5s0J3AAAAAAAvESCk3NQUJB8//33ZtQCAAAAAMAbJcHdy8eMGSN16tSR9evXS8GCBcXe3t7m+YkTJyZacQAAAAAAJGcJDt2jR4+WDRs2SJ48eUREYgykBgAAAAAAoiQ4dE+cOFG+/fZbadeunQnlAAAAAADw5kjwNd2Ojo5Srlw5M2oBAAAAAOCNkuDQ3aNHD5k2bVqifPiOHTukbt264uXlJRaLRVatWmXzvKrK8OHDxcvLS1KlSiWVKlWSY8eO2cwTEhIi3bt3l4wZM0qaNGmkXr16cuXKlUSpDwAAAACAfyLBoXvv3r0yb948yZ49u9StW1caNWpk85cQjx8/lsKFC8v06dNjfX7cuHEyceJEmT59uuzbt088PT2lWrVq8vDhQ2Oenj17ysqVK2XJkiWyc+dOefTokdSpU0ciIiIS+tUAAAAAAEhUCb6m+6233kpwuI5LYGCgBAYGxvqcqsrkyZNl0KBBxufNmzdPPDw8ZNGiRdK5c2d58OCBzJ49W7777jupWrWqiIgsWLBAvL29ZfPmzVKjRo1EqRMAAAAAgFeR4NA9Z84cM+qI4cKFC3L9+nWpXr26Mc3R0VH8/f1l165d0rlzZ/n9998lLCzMZh4vLy/x8/OTXbt2EboBAAAAAEkqwaH733L9+nUREfHw8LCZ7uHhIRcvXjTmcXBwkHTp0sWYx/r62ISEhEhISIjxODg4OLHKBgAAAADAkODQnS1bthfej/v8+fP/qKDnPf9ZqvrS+4G/bJ4xY8bIiBEjEqU+AAAAAADikuDQ3bNnT5vHYWFhcvDgQVm/fr18/PHHiVWXeHp6ikhUa3amTJmM6Tdv3jRavz09PSU0NFTu3btn09p98+ZNKVu2bJzvPWDAAPnoo4+Mx8HBweLt7Z1otQMAAAAAIPIKobtHjx6xTp8xY4bs37//HxdklS1bNvH09JRNmzZJ0aJFRUQkNDRUtm/fLmPHjhURkeLFi4u9vb1s2rRJmjZtKiIi165dk6NHj8q4cePifG9HR0dxdHRMtFoBAAAAAIhNgm8ZFpfAwED54YcfEvSaR48eyaFDh+TQoUMiEjV42qFDh+TSpUtisVikZ8+eMnr0aFm5cqUcPXpU2rVrJ6lTp5aWLVuKiIirq6sEBQVJ7969ZcuWLXLw4EFp1aqVFCxY0BjNHAAAAACApJJoA6ktX75c0qdPn6DX7N+/XypXrmw8tnb5btu2rcydO1f69u0rT58+lW7dusm9e/ekVKlSsnHjRnF2djZeM2nSJEmZMqU0bdpUnj59KgEBATJ37lyxs7NLnC8GAAAAAMArSnDoLlq0qM0gZaoq169fl1u3bskXX3yRoPeqVKmSqGqcz1ssFhk+fLgMHz48znmcnJxk2rRpMm3atAR9NgAAAAAAZktw6G7QoIHN4xQpUoibm5tUqlRJ8ubNm1h1AQAAAACQ7CU4dA8bNsyMOgAAAAAAeOMk2kBqAAAAAADAVrxbulOkSGFzLXdsLBaLhIeH/+OiAAAAAAB4E8Q7dK9cuTLO53bt2iXTpk174aBoAAAAAAD818Q7dNevXz/GtJMnT8qAAQNk9erV8u6778rIkSMTtTgAAAAAAJKzV7qm+6+//pJOnTpJoUKFJDw8XA4dOiTz5s2TrFmzJnZ9AAAAAAAkWwkK3Q8ePJB+/fpJzpw55dixY7JlyxZZvXq1+Pn5mVUfAAAAAADJVry7l48bN07Gjh0rnp6esnjx4li7mwMAAAAAgL/FO3T3799fUqVKJTlz5pR58+bJvHnzYp1vxYoViVYcAAAAAADJWbxDd5s2bV56yzAAAAAAAPC3eIfuuXPnmlgGAAAAAABvnlcavRwAAAAAALwcoRsAAAAAAJMQugEAAAAAMAmhGwAAAAAAkxC6AQAAAAAwCaEbAAAAAACTELoBAAAAADAJoRsAAAAAAJMQugEAAAAAMAmhGwAAAAAAkxC6AQAAAAAwCaEbAAAAAACTELoBAAAAADAJoRsAAAAAAJMQugEAAAAAMAmhGwAAAAAAkxC6AQAAAAAwCaEbAAAAAACTELoBAAAAADAJoRsAAAAAAJMQugEAAAAAMAmhGwAAAAAAkxC6AQAAAAAwCaEbAAAAAACTELoBAAAAADAJoRsAAAAAAJMQugEAAAAAMAmhGwAAAAAAkxC6AQAAAAAwCaEbAAAAAACTELoBAAAAADAJoRsAAAAAAJMQugEAAAAAMAmhGwAAAAAAkxC6AQAAAAAwCaEbAAAAAACTELoBAAAAADAJoRsAAAAAAJMQugEAAAAAMAmhGwAAAAAAkxC6AQAAAAAwCaEbAAAAAACTELoBAAAAADAJoRsAAAAAAJMQugEAAAAAMAmhGwAAAAAAkxC6AQAAAAAwCaEbAAAAAACTELoBAAAAADAJoRsAAAAAAJMQugEAAAAAMAmhGwAAAAAAkxC6AQAAAAAwCaEbAAAAAACTELoBAAAAADAJoRsAAAAAAJMQugEAAAAAMAmhGwAAAAAAkxC6AQAAAAAwCaEbAAAAAACTELoBAAAAADAJoRsAAAAAAJMQugEAAAAAMAmhGwAAAAAAkxC6AQAAAAAwCaEbAAAAAACTELoBAAAAADAJoRsAAAAAAJMQugEAAAAAMAmhGwAAAAAAkxC6AQAAAAAwCaEbAAAAAACTvNahe/jw4WKxWGz+PD09jedVVYYPHy5eXl6SKlUqqVSpkhw7diwJKwYAAAAA4G+vdegWESlQoIBcu3bN+Pvjjz+M58aNGycTJ06U6dOny759+8TT01OqVasmDx8+TMKKAQAAAACI8tqH7pQpU4qnp6fx5+bmJiJRrdyTJ0+WQYMGSaNGjcTPz0/mzZsnT548kUWLFiVx1QAAAAAAJIPQfebMGfHy8pJs2bJJ8+bN5fz58yIicuHCBbl+/bpUr17dmNfR0VH8/f1l165dL3zPkJAQCQ4OtvkDAAAAACCxvdahu1SpUjJ//nzZsGGDfPPNN3L9+nUpW7as3LlzR65fvy4iIh4eHjav8fDwMJ6Ly5gxY8TV1dX48/b2Nu07AAAAAAD+u17r0B0YGCiNGzeWggULStWqVWXNmjUiIjJv3jxjHovFYvMaVY0x7XkDBgyQBw8eGH+XL19O/OIBAAAAAP95r3Xofl6aNGmkYMGCcubMGWMU8+dbtW/evBmj9ft5jo6O4uLiYvMHAAAAAEBiS1ahOyQkRE6cOCGZMmWSbNmyiaenp2zatMl4PjQ0VLZv3y5ly5ZNwioBAAAAAIiSMqkLeJE+ffpI3bp1JWvWrHLz5k359NNPJTg4WNq2bSsWi0V69uwpo0ePlly5ckmuXLlk9OjRkjp1amnZsmVSlw4AAAAAwOsduq9cuSItWrSQ27dvi5ubm5QuXVr27NkjPj4+IiLSt29fefr0qXTr1k3u3bsnpUqVko0bN4qzs3MSVw4AAAAAwGseupcsWfLC5y0WiwwfPlyGDx/+7xQEAAAAAEACJKtrugEAAAAASE4I3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJiE0A0AAAAAgEkI3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANAAAAAIBJCN0AAAAAAJjkjQndX3zxhWTLlk2cnJykePHi8ssvvyR1SQAAAACA/7g3InQvXbpUevbsKYMGDZKDBw9KhQoVJDAwUC5dupTUpQEAAAAA/sPeiNA9ceJECQoKko4dO0q+fPlk8uTJ4u3tLTNnzkzq0gAAAAAA/2Epk7qAfyo0NFR+//136d+/v8306tWry65du2J9TUhIiISEhBiPHzx4ICIiwcHB5hWaCJ48er3r+7cFB1v+8XuwTG2xTBMfyzTxsUwTF8sz8bFMEx/LNPGxTBMfyzRxJcbyNJs1P6rqC+dL9qH79u3bEhERIR4eHjbTPTw85Pr167G+ZsyYMTJixIgY0729vU2pEebolNQFvIFYpomPZZr4WKaJi+WZ+FimiY9lmvhYpomPZZq4ktPyfPjwobi6usb5fLIP3VYWi+2ZEFWNMc1qwIAB8tFHHxmPIyMj5e7du5IhQ4Y4X4MowcHB4u3tLZcvXxYXF5ekLueNwDJNfCzTxMcyTXws08TF8kx8LNPExzJNfCzTxMcyjT9VlYcPH4qXl9cL50v2oTtjxoxiZ2cXo1X75s2bMVq/rRwdHcXR0dFm2ltvvWVWiW8kFxcXVsJExjJNfCzTxMcyTXws08TF8kx8LNPExzJNfCzTxMcyjZ8XtXBbJfuB1BwcHKR48eKyadMmm+mbNm2SsmXLJlFVAAAAAAC8AS3dIiIfffSRtG7dWkqUKCFlypSRr7/+Wi5duiRdunRJ6tIAAAAAAP9hb0Tobtasmdy5c0c++eQTuXbtmvj5+cnatWvFx8cnqUt74zg6OsqwYcNidM/Hq2OZJj6WaeJjmSY+lmniYnkmPpZp4mOZJj6WaeJjmSY+i75sfHMAAAAAAPBKkv013QAAAAAAvK4I3QAAAAAAmITQDQAAAACASQjdAAAAAACYhNANIFlh7EcAAID4W7JkiWzevDmpy/hPeyNuGQbgzTd27FgpWLCg1KpVS1RVLBZLUpf0RmBZJq4zZ86Ij4+PODg4JHUpAADI+fPnZdq0aeLk5CQODg5SsWLFpC7pP4mW7v+4yMjIpC7hjRRbayzL+tU9e/ZMDh8+LHXr1pUtW7aIxWKhxfsfatKkicyePZvAnYhWrVolefLkkbVr10pYWFhSlwPgXxR9n8T+6Z9jGSae7Nmzy+DBgyV16tQyatQo2b59e1KX9J9ES/d/mKpKihRR510WLVokly9flkyZMkmzZs3E0dExiatLvqwth7t27ZITJ06IqkrHjh2NZY2Ec3JykhkzZshbb70ltWrVkp9++kmqVatGK+0rCgkJEQ8PD+ncubOkTp1aWrRokdQlvREaNGggjRo1kk6dOsns2bMlMDBQ7O3tk7qsZC2udZx1H68L62/x6dOn4ujoKHZ2dvw2/6HIyEjjmCkkJERUVZycnJK4quTJ+vsMDAyUFClSyJQpU2T06NEiIuLv75/E1f23kAL+o6IfsAwaNEg6duwo69atk3bt2knbtm3l2LFjSVxh8mWxWGTFihVSrVo1mTJlivTr109KlCghN2/eTOrSkrV06dLJqFGjpH379lKnTh3ZtGkTLd6v4MGDB+Lo6Chjx46V/v37S6tWrWTRokVJXVayFx4eLiIiy5cvl4CAAGnXrp2sW7eOFu9/wLqf2rt3r8yfP1/Gjx8vZ86ckcePH4vFYqH30CuIa5mxHX011t/ounXr5J133pFKlSpJlSpV5MCBAxIaGprU5SVb1sA9evRoadSokVSuXFl++umnJK4qebJYLMb+qUaNGtK9e3dJmTIlLd5JgND9HxQ9cJ85c0b2798vO3bskG3btsmhQ4dk+/btMmTIEDl69GgSV5q8WA9aQkJCZOXKlTJz5kzZuXOnbNu2TUREqlSpIlevXk3CCpMv67JNly6dfPrpp9K2bVuC9yto0KCB9O3bV0RE0qZNK/3795e+fftK69atCd7/UMqUKY0DmyVLlki1atUI3v+QxWKR5cuXS9WqVWXWrFkyduxYqVOnjowcOVJu374tKVKkYN1PgOith/PmzZOhQ4dK165d5fz587TMviKLxSKrV6+WJk2aSMmSJWXYsGGiqlKrVi05c+ZMUpeX7EQ/KTRu3DiZMmWKFCxYULJkySINGjSQSZMmybNnz5KwwuTFun2Mvn4HBgYSvJOK4j9j8+bNGhoaajwePXq0Vq1aVRs2bKgPHz40ph88eFA9PT21UaNG+scffyRFqcnGwYMHbR5v27ZNS5YsqQ0aNNDjx48b0y9evKglSpTQ/Pnz69WrV//lKpOvyMhIVVV9+vSpBgcHG9OfPHmiQUFB6uDgoBs3brSZF3E7f/68hoSEqGrUMlVVffTokfbv319TpEihCxcuTMry3jiNGzfWdOnS6f/+9z+bbS/i5/jx45olSxadPXu2Pnv2TFVVhwwZohUrVtRBgwbp48ePk7jC5Klfv37q5eWljRs31oCAAPXw8NAVK1bokydPkrq0ZOfx48davXp1/fTTT1VV9dq1a5ojRw7t3LmzzXzsnxLm7NmzOmTIEN28ebMxbdKkSWqxWPTzzz839l+Im/U3t3HjRm3durW+88472r17d+NYavPmzRoYGKjVqlXT7du3J2Wp/xmE7v+IPn366DvvvGOz4V+zZo1aLBb18PAwAqL1+UOHDmmWLFnU399fz507lyQ1v+5WrVql6dOn1/v37xvTfvvtN82dO7c6OTnpqVOnVFU1IiJCVaOCd5kyZTRTpkz6119/JUnNyYn1t/jTTz9pYGCg5s+fX5s2barLli3T8PBwDQ0NNYL3pk2bbF6DmKy/Q1XVGTNmaLFixfTWrVuqSvD+J6y/uYMHD+rixYv1hx9+0P379xvPN27cWN966y2C9yvYunWrZs2aVc+ePWtMCwsL0wEDBmjevHnZjr6Cr776SrNkyaIHDhxQ1agTxRaLRTNmzKiLFi0ieCdQcHCw5s+fX0+dOqW3b99WLy8vfe+994znFyxYwHofD9H3Txs2bFCLxaJubm66YcMGm/kmTZqkdnZ2OnHiRH6r8bBq1Sp1dHTUjh07atu2bTVHjhyaM2dO3bdvn6qqrl27VuvVq6dvv/227ty5M4mrffMRuv8jIiIijBauo0eP6qNHj1RVdceOHZoyZUpt166dcQBjPYjct2+f1qtXz2ZjCFvWVuvoy27v3r2aK1cuLV++vIaFhRnTVVUvXLigVapUsTmIRNzWrFmjDg4O2qdPH508ebJWrFhRS5UqpaNGjdKIiAh9/Pixdu3aVS0Wi/78889JXe5rK/o6vG/fPj1+/Lh6eXlpzZo1YwRvOzs7Xbx4cVKVmiwtX75c33rrLX377bc1Xbp0WrBgQR08eLDxfOPGjdXNzU2XLVvGAXg8WLeXW7Zs0SxZsujRo0dVVY19WGRkpKZNm1a/+eabJKsxuYi+7j979kzHjBmjs2bNUlXVlStXqouLi3733Xfarl07dXNz06VLl9KDIIEqV66sH330kfr6+mqXLl2M3+mdO3e0WrVqOn/+/CSuMPmwLrvBgwerxWLRqVOnxphnypQparFY2E+9QGRkpN6+fVuLFy+uo0aNMqY/ffpUK1WqpLly5TJOWqxatUqbNm2qFy9eTKpy/zMI3W+4GTNm6G+//WY8Xrx4sXp7e+vChQuNHevGjRvVzs5Og4KCYgRvK4J33E6cOKF2dnY2O9a9e/eqr6+v+vv7a3h4uKr+vUytQRxxi4yM1IcPH2rNmjVtwsujR4+0d+/e+vbbb+uPP/6oqqo3b97UXr162XTnx9+ir8sDBw7UkiVL6rVr1/TEiROaJUsWrVatmt6+fVtVo5bvwIED1WKxGN328WJ//PGHZsyYUb/44gt99uyZnjp1Sj/99FP18fHRYcOGGfPVrFlTfX19bS7lQZSIiIhYe6k8ffpUfX19tW7dujbT7969q8WLFze2AXi5kydPqmrUSbcrV67omTNnNH/+/Dp58mRVVd2zZ49aLBbW/Rew/kafPXtmXO4QERGhn3zyiaZPn179/f1t5h84cKDmz59f//zzz3+71GTpm2++0aJFixqPP/74Y3VwcNClS5fGmHfp0qUcS8Ui+nY0JCREs2fPrv/73/9UVY0Tvo8fP1ZfX1/t37+/Ma+1IQ7mInS/wbZt26be3t4aFBRkXJsdHh6uNWrU0GLFiumiRYtsgre9vb2+9957evny5aQsO1nq1q2bpkmTRpcsWWJMswbvgIAAdg6vqFy5cjpgwABVVePkxZMnT7RUqVLarl07Yz5OCr3cwYMHtVq1ajZdyKzXzEYP3sHBwTpz5kx+s/G0YsUKzZ8/v81lJtevX9dhw4Zp8eLF9cSJE8b0K1euJEWJr60bN26o6t/r9s6dO/Wzzz7TL7/80ui5sn//fnV3d9fatWvr7t279ciRIzp48GD18PDQCxcuJFHlycvChQs1d+7cNtPWr1+vxYsX1zNnzqhq1LIfNGiQjhkzhnU/FtYws3r1am3YsKGWL19e582bp2FhYXrnzh1t2rSpFi1aVDt06KATJ07UNm3aqKura4xxXxC3devWaYkSJWwuz+ndu3ecwVuVRozYLFy4UNu2bauqqnnz5tUPPvjAeC4sLEwjIyO1Xr162qVLlySq8L+L0P2Gmz9/vpYoUUI7dOigv//+u6pGHeDUrl1bCxcubBO8N23apBaLRT/77LOkLPm1Z935Pt8y06tXL3VwcLAJ3vv27VMXFxetXbv2v1pjchcREaFPnjzRmjVraqNGjVQ1anlbD86HDBmiFSpUMLqi4cWmT5+u9evX15o1axotrdYTFcePH1dvb2+tUaOGEYKsOKB5uc2bN6unp6fNgaKq6uHDhzVVqlS0GsZh4cKF6u/vb1xb/MMPP6iDg4OWKFFCCxQooClTpjS6RR44cEDz5Mmj3t7e6uPjo7ly5TL2Z3i5GzduaLp06XTixInGtHnz5mmaNGl0586deu7cOa1Tp47N4F+s+1Gi7+e3bdumadOm1U6dOmmLFi3Uzs5Oe/XqpY8ePdLbt2/ruHHjtFy5clquXDlt3bq1cVkEYoqtZ8vt27c1X7582qNHD5vpffr00dSpU+vcuXP/peqSr/Pnz2vevHmNdX3KlClaqFAhnTJlis18DRs21A8//FAjIyMZC+dfROh+Q0XfYc6ZM0eLFSsWZ/BevHixEbz37t3LzvYFrBunX375RceNG6dff/21TQtXbMH7999/N1oTEDvrcr1x44bNSOW7du1Se3t7HTRokM387777rrZo0cII4Xix2bNnq4uLi2bMmFH37t1rTLcG7xMnTmjKlCljHOzAlvV3evjwYaOV9fTp05o3b17t27evXr9+3Zj37t27WrRoUV2/fn1SlPramz9/vvr7+2uDBg1027Zt2rZtW/3qq69UNeqSkS+//FLt7e2Nk8DPnj3Tffv26f79+/XatWtJWfpr7fleP6GhoRoeHq79+vXThg0bGj1aVFUDAwPVzs5OfXx8tEiRIow38AJ//fWXTpgwweiOr6q6aNEidXFx0R49eujdu3eN6eHh4eyb4un5wdBWrFihPj4+xkBfVh07dozRfR+2Dh48qL1799YOHToY6/KlS5e0e/fuWqBAAQ0KCtJvv/1Wu3Tpos7OzlySlwQI3W+g2M5affvttzGCd0REhNatW1eLFi2qs2bNsrkFA8E7bmvXrlV7e3v19/dXi8WigYGBum3bNuP5Xr16aZo0aXTevHlJWGXys3LlSi1UqJAWLlxYW7VqpYcOHVLVqBaZlClTau3atbVz584aFBSkadOm5XZ2cYirq/3y5cvVw8NDg4KCjJH1Vf/eXvz5558cKL6AdTmtXLlSM2XKpGPGjDEOtL/99ltNmzat9u7dW3fs2KHXrl3Tfv36aaZMmbhc5wW+//57rVatmtavX19LlChhrPNWM2bMUCcnJ/3111+TqMLkI/rJX1WNcR3x1q1bNVWqVDGug1+9erVu2LDBWPfZ99uKiIjQ8+fPq8ViUXd39xgDey1cuFCdnZ21T58+3OklgT777DMNDAzUSZMmGdOuXLmixYsXNwZJjL5PokU2bsHBwdqiRQvNmDFjjJMTly9f1q+++koLFSqkxYoV0ypVqsTY1uLfQeh+g82ePVs/+ugj43FcwbtMmTLapk2bpCoz2fnggw90xowZqho1GnmhQoW0WrVqumXLFmOeTp06qbu7u829pRGTdSd6/PhxdXZ21vHjx+uAAQO0du3ami9fPuN6uL1792qzZs20Vq1a2qJFCwJ3HKIH7h07duiGDRv0999/N5bzvHnzNHPmzNq9e3c9ffq0MW/0gxmCt63oy2PNmjWaOnVq/eqrr2xatVWjDr4LFSqk6dKl03z58mnWrFmNrtOwFf13umjRIvX399eUKVPq1q1bbZ6/ePGi5siRg1GKX6JRo0Y2A3l+9913WqBAAR04cKBev37dCNLdunXT0qVLx9lTgHU/btYRszt16qT37t2zeW7x4sVqsVh00KBBnLR4gedPCP/666/avn17zZ8/vxYoUEAnTZqk9+/f1/Hjx2vmzJlteg9YEbzj9vvvv+u7776rLi4ucd7Z4fHjx9xqLQkRut9Qjx490u7du2vBggVtRtCNHrytB4SRkZEMRPUC1o38xYsX9erVqzpo0CCblpdz585p4cKFtWrVqsZBo6rGOChH7Pbt26czZ860+Z3u2rVLGzRooLlz5za6Q1t7YnAdd+yiH4z06tVLPT091dXVVfPly6dVqlQxltvcuXM1S5Ys2qNHD7qXvcCsWbNsRhoPCQnRJk2aaJ8+fVQ1qlvkuXPndOTIkbp06VJ9+PCh3r59W3/77TfdunUr95BOgJUrV2rRokW1bNmyNt1KQ0NDtUCBAjpz5swkrO71N2nSJJvt4qFDh3TKlCmaKVMmLVOmjHbu3Flv3ryp69at0woVKhg9swjZCTNp0iS1WCw6btw4ffDggc1z33//vTFCPGKKfoz5zTff6NKlS41xWu7evau9evXSqlWravr06bVr166aPn16nTNnTozXIop1f3/37l29d++eMZr+mTNntHnz5lq2bFn97rvvjPk5bno9ELrfELFtlP766y8dOHCgFi1aVIcMGWJMnzNnjpYsWVIbNmxo082UDVvcli1bplmzZlU3NzdNkSKFjh8/3ub58+fPa4kSJbRkyZK6ffv2JKry9de3b1+jl4Bq1ImJGjVqaOrUqbV79+428+7evVsbNmyo+fPn1z179hjTOdMdU/RlsnHjRvXz89Nff/1VT548qStWrNCCBQuqn5+f0QqzYMECtbOzs+nWh7/t27dPK1eurOfPnzemPXjwQEuVKqU9e/bUc+fOaffu3bVy5cqaKVMmzZs3r/br149rYl8i+jXxW7Zs0fnz5xv7ndWrV2ulSpW0ZMmSunbtWt2xY4cOHDhQnZ2d9ezZs0lZ9mvr+X32xIkTdeTIkUYgvH//vo4dO1bLly+vXl5eOmLECE2TJo3WqlUrKcpNFqy/0T/++EM3b96sP/30k03r9fjx49VisejYsWNjBG+8XN++fdXDw0O//vprvXnzps1zd+7c0fnz52tAQICmTZtWq1atmkRVvp6eH8R39erVWqZMGS1cuLDmypVL586dqyEhIXr8+HFt2bKllitXThcuXJiUJeM5hO43zPPdGa9du6b9+/fXokWL6vDhw43p06dP1/bt2xO0X8C6Ybtw4YIWLFhQP//8c12xYoWWK1dOy5QpYzNYmqrq2bNntUKFCnrx4sWkKPe19/DhQx0zZowePnzYZvrSpUvV399fvb29Y1yHuGfPHg0ICNASJUros2fPCNwvsWrVKm3Xrp1269bNmBYZGakHDhzQAgUKaIcOHYzpGzdupKUrDmFhYUbXxv379xsH1zNnzlQnJyd96623tHHjxkaX3u7du2v16tWTrN7kwLru/vDDD5olSxYtXbq0ZsmSRQsWLGjcR/aHH37QokWLqpOTk5YqVUq7dOnCLZdeIPr+OywsTIcMGaKenp46adIkowu5dZ6xY8dqixYt1GKxaKFChdiWxsK6TFasWKGenp5apEgRdXR01EaNGtmM2zJ+/Hh1cHDQ4cOHcwlZAkyZMkXd3d1trieOiIiIcY/oO3fu6NatW9XT05NLS/7f88to3bp1miZNGh0/fryeO3dOO3TooE5OTsatFg8fPqytW7fWAgUKxHm7Nfz7CN1vkNWrV2vevHn1iy++sJl+9epV7dSpk2bOnFnHjh1rTLfuYAjecTtw4IB2795dO3fubASU8+fPa61atbRKlSoxdghcz/Vi1mW4YcMG/fzzz43pP/74o/r7+2vFihVtWhdVo1odGYzq5e7fv68VKlTQ1KlTa7Vq1WI8P3ToUC1btqxNl2lVupg+L/ryuH79uhYtWlQDAgKMgaqs3cejz9u9e3dt0aKFzWCUiGnPnj2aIUMG49Y/f/75p1osFp02bZoxz+rVq7Vo0aLapk2bGNfO4m/RQ3O3bt20bt26qqrav39/9fHx0QkTJsRoSbx165b++uuvxn6KfX9Mmzdv1gwZMhjXxP76669qsVi0Vq1aunnzZmO+ESNGaLp06WxGg8eLvffee8Y4Q+fPn9clS5YYYwotW7bMZt6HDx9qzZo1dfTo0UlR6mulV69e2rRpU2NU/LCwMG3WrJn269dPVaN6tebKlcvmln+qUdd4d+rUybjTBpIeofsNcuzYMW3durWWL19ev/zyS5vn9u3bp+nTp1c3Nzeb5zjbHbcnT55o+/bt1c3NTcuXL2/z3JkzZzQwMFCrV69uc+9IlufLhYSE6PDhw9VisdjcfmXFihVatWpVrVChQozgjZhi+61dvHhRmzRpopkyZTJuv2S1YMECzZMnD2MNxMIaPp49e2b8+8iRI6oadQ18+fLltV69ejFGiD558qQOHDhQXVxcGNwvHubOnasNGjRQ1ajb1GXPnl07duxoPG+97vD777/XS5cuJUmNyUH0dX///v1avnx5m5bYvn37GsH71q1bsb4HJ4hjevz4sX700Uc6YMAAVY3qvZYjRw595513NEeOHFq6dGmb4H3nzp2kKjVZiYyM1LCwMG3QoIGWL19eJ06cqJUrV9ZatWrpu+++q3Xr1tVatWppcHCwzYmgqlWr6rvvvvufvpf0t99+q66ursZtZ63rbenSpXXbtm0aHBysXl5e+t577xmvWbBggTG/9VpvvB4I3cnU82eorY+PHz+u7du31zJlytiE6wMHDmjz5s111qxZnN1+iegb9zNnzmjnzp3Vzc0txvWvZ8+e1XLlymn9+vXpYpZAly9f1pEjR6qzs7NOmDDBmL5ixQqtWbOmFipUKEZXc/wt+jr8/HXEFy5c0Dp16mj58uV1woQJ+uTJE7148aJWqVJFa9So8Z89eHmRhw8f6tmzZ7VBgwZ67949Xbp0qVosFv3jjz80NDRU58+fr6VLl9Z69eoZ6/revXu1bt26mj9/frpAx9NHH32kjRs31rCwMPX29tb33nvP+C0vWrTIuCc34mfJkiVav359I5hE72nRt29f9fX11UmTJumNGzeSsMrkIzw8XLdu3aqnTp3S+/fva8mSJTUoKEhVo+4G4ejoqJUqVTJ6urAtjV1cx5hnz57VsmXLaoECBfSzzz4zBk388ssvtXLlyjYBcdeuXZonT57//K2tJk+erBUqVFBV1S1bthgn0xs3bqx169ZVHx8f7datm3HC8vHjx1q/fn2dOHHif/pkxeuK0J0MRV+JpkyZoh988IH27t3b2LFag/fbb7+t/fv314MHD2rNmjW1c+fOxmvpUhrT88vGuuM4e/asBgUFadmyZXX69Ok2rzl//jwtMi8QFhZmM8pm9JaBe/fu6bBhw2IE78WLF2uDBg0I3XGIfkAzZcoUbdWqlVapUkXnzJmjV69eVdWoEfXr1aunjo6OmjNnTm3YsKHWqlXLOCjnxNvfOnXqpG3bttVz586pvb29FilSRO3s7Gx6sISFhRnBu379+kYX/Z9//pn1Pw7W9f7s2bPGOBe//vqr5siRQ9OmTWuMO2Cdr3v37tqsWbMYlz8gdo8ePdJ27dpppkyZtFSpUsb06MGlf//+6ujoyHWxcbD+9n777TfdsWOHhoWFGS2JP/74o5YoUcLodbV27VqtUKGClitXjnFbXiD6vmXVqlX6+eef66xZs4yeQMHBwTZd8sPCwrRWrVrasmVLm2Pbe/fucbJIo27z6efnp61bt1aLxaI//fSTqkaNhZMjRw4tVKiQzfwDBw7UHDlycM/41xShOxn75JNPNGPGjFqvXj0tUKCAenp66rFjx1RV9dSpUzp06FD18PDQ7Nmza5kyZYwWMc58xWRdJlu2bNHu3btr8+bNdebMmUbXvFOnTmlQUJCWLl2a29fEw8KFC212vitXrtQCBQpo7ty5tVixYrp48WINDg7WR48eGcE7eldzDrxfrn///poxY0YdNWqUBgUFabFixTQoKMg4WfHnn39qgwYNtHDhwjYnNehu9relS5equ7u7cVu6OXPmqL29vebLl0+vXr1qs620Bu/y5ctr5cqV+Y2+QPQBqYoUKaIjR47Uu3fv6tWrVzUoKEizZcumX3/9tapGjTkycOBAzZgxI7ewe4G47lDSu3dvdXd316FDhxrTo98eaMaMGZxkj4X1N7p8+XLNkCGD9uvXz2bskG+//Vbz5MljHFMNHjxYhw8fzrgNLxB9e2m9xKF06dJarVo1zZcvn/7222/G8/fv39cFCxZo7dq11c/Pzzg+jYiI+M8fo65bt87mHuU1a9bUVKlSaaNGjYz994MHD3TgwIHq5+en/v7+2qtXL23SpImmS5cuxoDKeH0QupOR53e6PXv2NO4Xff78ea1du7ZmyJBBjx49qqpR3UyuXbumv//+u/FaruOK24oVKzRNmjTatWtXbd68uVaoUEEbN25sXAN76tQpfe+99zRv3rzGICuI6erVq5o2bVqtWLGiqkbdeiV16tQ6bNgwXbRokTZr1kxz586tn3zyiT58+FDv3r2rI0eOVIvFYnM7McRt4cKFmjNnTv39999VNWok8hQpUmj+/Pm1VatWRuvruXPntFatWlq5cuUYo+0jqutezpw5VTWqJSt37tw6c+ZM9fDw0CpVquiJEyds5g8NDdU5c+ZopUqVGNzvJdatW6dOTk46Y8YMoweGatQ9pDt27KgZMmRQHx8fLV68uGbLlo0DxReIvu8/deqUXrlyxWgFvHHjhn744Yf69ttv2ww69fzJNYJ3TL/88ou6uLjo3LlzY9z+6+TJk+rm5qaFCxfW0qVLq4uLy3++q3N8TZ06VbNkyWLc6nPq1KlqsVjUzc1Nd+7cqaqqV65c0XfeeUffeecd47j0v358GhERobt27dK0adPqtWvXNDw8XENCQjRDhgxauXJl9fPz01GjRhl3Jnjw4IGuXLlSmzVrpnXq1NGePXvG2Gfh9ULoTiai73R/++033bZtm1arVs24JkY16jrZOnXqqJubm3F2Nq73gK39+/drzpw5jTB9+fJlTZ8+vWbJkkWrV69uBO/jx49r9+7dGQ3yJXbv3q05cuTQatWq6Zo1a3Tw4ME2zw8ePFhz5cqlK1asUFXVS5cu6dixY/XkyZNJUW6ys2jRIh0yZIiqRnXhS58+vc6cOVPHjx+vLi4u2r59e+PexhcuXNAGDRpo0aJFY4wQ+1938OBB9fPz0/Lly6vFYrH5PXp4eGjlypX11KlTxvzbt29XVXpivEhkZKQ+fvxYmzRpYgxIZWUNfjdv3tQDBw7oxIkTdd26dXTRj6f+/furt7e3+vj4aPbs2Y178N68eVO7d++upUqV4rr4OMQ2gOSoUaO0bt26GhYWZhwfRT85cfToUe3Xr58OGDCAXhhxGDZsmM0gkrdv39a2bdvqnDlzVFX1p59+UmdnZx02bJjWqVNH3d3djePW27dvc8ljLKzd7637HmsvgD59+mj+/PltgjeSF0J3MtO3b19NmzatFihQQFOkSBHj/ntXrlzR+vXrq8ViIRi+RPSN/Jo1a7Rly5aqGhVScuTIoUFBQTpr1iz18PDQhg0b6l9//aWqMQeuQuz27Nmj2bJlU4vFou+++66q2i7zBg0aaNmyZY3H7HRjd+nSJePAxHo7wNDQUL1x44beunVL3377bR03bpyqRoXB7Nmzq7e3tw4bNsxYpufOndPmzZtznXwsPvzwQ7VYLFqiRAmb6ZcvX1ZPT08NCAjQtWvX6pAhQ9TOzs6m1Raxi4iI0KJFixonhp7HCPrxE72b7Y8//qhubm76v//9T1euXKkff/yxWiwW4zagf/31l/bo0UOzZ89u3D8eUSZPnqyFCxe26XYfGRmpTZo00YCAAGPa8z0K8GK3b99Wi8WiVatWtTlhvm/fPj179qwePXpUs2XLZoyF880336jFYlGLxWL00lKlQcgq+gmIy5cvq8Vi0b59+9pc2/7xxx8bwdt6S0Dr6/7r3fKTA0L3ay76SrRt2zYtXLiwbt68WX/++Wdt2rSppk+fXnfs2GHzmosXL+rHH39MiHmOdVneuXPH6Ma0fft249qZkydPamRkpNavX1/btGljvK5o0aKaOnVqrV+/voaHh7Nhe4Hnd567d+/WYsWKaf78+Y1B1Ky/y+nTp2vx4sX18ePH/3qdycW2bdvUz89PN23apD169FCLxWK0YKuqHj58WL29vY3LTE6ePKnNmzfXOXPmxGi5+a933XteeHi43rt3T6tXr65dunTRQoUKaePGjW3muXLliubLl0+LFCmiWbNmtTlQROwiIiL0wYMHWrZsWf3ggw9U1faE2vnz53Xo0KF65cqVpCox2Vm0aJF+/PHHxsk1K2u33U2bNqlq1O910qRJ7Pufc//+fSNEP3r0yJj+9ddfq6+vr9GDRTXqOOHWrVv6/vvvG92jEZN1/xL95OTzvQHmzJmjVatWNZb5jz/+qO+++65OnDiR32g8TJs2Te3t7XXYsGE2t/77+OOPtVChQjpo0KA4bwmI1xOhO5mYMmWK9u/fX/v162dMCw0N1aZNm2qGDBliBG8rDrT/dvDgQT179qzWqlVL58+fr0uWLFGLxaIbNmww5rl+/boWKFBAV65cqapRI2i2bNlSp0+fzkFiPG3YsEG//vprY6e6Z88e9fX1VX9/f71165YxPSgoSMuUKUPofoGQkBANCAhQLy8vdXFxMUKfdRkeOXJEixYtqn379tVff/1Va9eurU2aNDFODNGC8HLWrnzz5s3TAgUKaJMmTWyef/DggR45coTW2TjEdRJy7ty5arFYbEaBV43qIl22bFkOFuPpxIkTWqpUKXVyctIRI0aoatS+37puN27cWBs2bMg13PGwe/duzZ49uzHujfUe582bN9eff/5ZVdUY3NPb25vegi9hPb68dOmSuru7a0BAgM01xVOnTtU0adLoyZMn9enTp1q/fn3t3bt3jNfj7+3o88tk5syZarFYdPjw4UbLtqpqt27dtHTp0jYjweP1R+hOJho2bKgWi0Vr1qxpE1JCQ0O1WbNm6u7ubpztRkwffPCBVq5cWc+cOaONGjXSvHnzqoODg3777beq+vcByp07d7RUqVLavn17PXPmjA4cOFCLFy/OAXcCDBo0SC0Wi86ePds4MLQG71y5cmn9+vW1R48eDEzzEtad77hx49TJyUnz58+v69ati3FwPXDgQC1QoIB6eXlpuXLluEvBC1iXyaVLl3T//v167do14/rshw8f6vz582MN3oiddXnu2LFDR40apT169NAtW7YYLVuDBw9Wi8WiHTp00Pfff1/btWunLi4u3Nf8BWJbb5cuXapvv/22+vj4GLersu6zunbtqnXr1v1Xa0yu7t27p4ULF9Z8+fIZ4fDHH3/UGjVqaJYsWbREiRJavnx5zZAhAwP7vUBs3ZkvXryobm5uNsH7zJkzWqNGDU2VKpXmy5dP8+fPb+zX2D/9zbosNm/erJ07d9aPPvpIt23bZqzjX3zxhRG8o5+s5JZqyQ+h+zUU18aoa9eu6uDgoEuWLLE58A4LC9OqVatqYGDgv1VisvLrr7+qp6enbt26VVVVN23apOnSpdNs2bLp/PnzjQ1bZGSkhoeH66RJk9TPz089PDzU29ubLqUvENeZ6uHDh6udnZ1+/fXXNsG7TJkyarFY9JdffuFep3F4fv3ft2+fHjlyRKtXr67FixfXH374Ica4AteuXdP9+/dzl4IXiH4bqzx58miWLFnUz89P+/TpY/wWrcG7cOHCWr169aQs97VnXZ4//PCDOjs7a4sWLbRUqVJarlw57devnxG8ly1bpg0bNtQqVapou3btjFZGxPR8z5To+/nVq1dr6dKltUyZMsbI+aGhoVqhQgVt3br1v1pncnb//n0tU6aMZs+e3QiHx44d0xUrVuj777+v06ZN0zNnziRxla+v6L/Rv/76S+/cuWMM6vXnn3+qu7u7Vq5cWU+fPq2qqqdPn9Z58+bpl19+aeyX6IUR06ZNm9TOzk5btGihWbJk0bJly+rYsWONZfbFF1+ovb29fvzxx7RuJ2OE7tdM9A3atWvX9PLlyzYj5bZo0UJdXFx0+fLlNjvk8PBwupLGYd26dZohQwa9d++eLlmyRIsWLapr167Vd999V8uWLatffvmlzU4gPDxcT506pT///DNdyuMwdOhQm4Pn2HYC1oGnonc1/+WXX7Rw4cKMVhyH6OvwsWPH9NSpU8YANY8ePdJq1app8eLFddWqVUboiX5/XlUOaKyiL0vrgcv69evV1dVVJ02apI8fP9YhQ4aou7u7vvvuu3ru3DlVjQre33zzjU24Qex2796tWbNm1VmzZqlq1EF3mjRpNFeuXNq9e3fjNkzWAB59ICvYiv57nTx5sjZu3FgrVaqkw4YNM7avP/74oxYtWlRdXV21XLly2rp1ay1QoAC9W2JhXRYHDhzQxYsX62+//WZsGx88eKBlypTRHDlycIulBIj++xo5cqRWqFBB8+bNq/7+/rpq1SpVtb3zQ2wnL9g/xXT58mXt06ePMVDqgwcPtHPnzlqmTBkdNWqUsf+aNGmSvvXWW1yak4wRul8j0TdoQ4YM0VKlSqmzs7PWqVPH5v6bLVq0UFdXV12xYoU+ffrU5j0I3rGrUqWK+vr6Gt2eVaOCYvPmzbVs2bI2LbJLliwxBldDTJ9++qk6OjoaofvUqVPq6Oioq1evjjFv//791dHRUefPn28ccD//m0VMQ4YM0cKFC2uuXLk0S5YsOmrUKFVVffLkidHiPWDAAA0MDFRXV1cOZOLw559/GtvVa9euae3atfXTTz9V1ajbLPn4+Gj58uW1UKFC2rJlS6PF+9GjRzHu2/tfN3r0aP36669tps2fP187deqkqlEDpOXIkUPbtWun/fr1Uzc3N+3Tp4/NciQUvlz//v01Y8aM2rNnT+3Zs6c6OztrYGCgcVumH3/8UStWrKg5c+Y0go4qvVti87///c+4NMdisejHH39sDKhmDd758uWzueUVXm7IkCGaIUMG/fHHH/XXX3/VgIAAtbe3N+6OcfnyZc2UKZMWKlSI6+Jf4sCBA1q9enUtVKiQbt682Zh+9+5d7dKli5YuXVo/++wz48TavXv3kqhSJAZC92vok08+0fTp0+uyZct0/vz52r17d/X19bUZgKJ169ZqsVh027ZtSVjp688apL/++mu1WCyaOXNmvX//vvH87du3tUWLFlq+fHn9+OOPdcCAAWqxWOheFocHDx5oqVKljNvU7Nu3T69cuaJt2rTR9OnT67p161T174Prv/76SzNkyKAWi0XnzZuXZHW/7qK3/I8aNUozZMig27Zt01u3bmnHjh3VYrEY178/ffpU27dvr7Vr19Z69eoZO2NOuNl69uyZli5dWn19fY3f49KlS/WPP/7QW7duaf78+bVz586qqtqrVy9Nmzat1q5d22jxxt9CQkK0V69earFYbG5H9eDBAz1+/LiGhIRotWrVtH379sb8vr6+6unpqb179yZsx9PBgwfVx8dHt2zZYkw7deqU5siRQ+vXr29MW7ZsmVavXl2rVKlijDfC+v+3iIgIffr0qTZo0EC//vprffr0qS5cuFAzZcqkXbt2NUbZfvDggebLl0+LFy9OL4x4unnzpvr7++v69etVNeqyh7feestopbWeVL9w4YLWqVOH3+VLXL58WQMDAzV16tQ6fPhwm+fu37+vH3zwgebNm1cnTJigqqznyR2h+zVz+/Zt9ff3Nwb4Uo3ayE2dOlVz5sypCxYsMKZ/8sknnN1+icjISH3y5ImOGDFCp06dquXKldM8efLYXE98584d/eCDD7RSpUpapEgRBvl5gZCQEG3VqpU2aNBAP/vsM82QIYNxW5UOHTqos7OzEbxVo1oX33//fR0yZEiM24kgypIlS7R8+fL6+PFjDQkJ0QYNGujixYtVVXXlypWaLl06nTlzpqpGtXSrRnXRCw4OjnPEU0St+7/88ov6+flp0aJFbYLf9OnTtUaNGka33VmzZqmfn582a9aMS0qieb6L/qhRozRFihTG/sm6TE+fPq158+Y1br106dIlrV+/vg4ZMoRLSV7g+QPow4cPq5eXl7GttJ5Q++OPP4zxXKx++OEHrVq1qhYrVox7x/8/6+/x7t27+vTpU+3bt6/NLRaXLl2qmTNn1q5duxrdyoODg2mNfYHnT5idPHlS06dPr5cvX9a1a9dq2rRpjf3T06dP9fPPP4/RaEFPrBe7evWqNmrUSEuVKhXjbg93797V3r178xt9QxC6XzMPHjxQb29vozup1c2bN7VKlSrav3//GK/hgDumuFpWrly5oiVLltS8efPaHAw+e/ZMHzx4QNedeNixY4cWKFBAU6RIYXM9cWRkpHbo0EHTpEmjc+fO1X379unw4cO1bNmyMUbcxt9GjBihzZs3V9Wo0Ujd3Nx0586dunXrVpsDmpCQEB0yZIju27fP5vW0IkaJrQUgIiJCd+/erXny5NFixYoZy2rQoEHq5+dnXBv38ccf66hRo7isJBrr8rx48aJ+8803OnXqVF2xYoXOmDHDJnirRt3WKl++fDpmzBi9deuWDhs2TKtVq8byjKeOHTvq5MmT9erVq5oqVSqjN0FERISGhYVpSEiIFi5cWKdNm2bzukWLFmndunWNbr2IOhlRtGhRzZw5s3p6ehotslbLli1TX19fbdWqldHVHLGLPjr2N998o0+fPtUHDx5onTp1tFevXuri4qJfffWVMc/Jkye1fv36xm1Y2TfZsi6Pw4cP67Jly/THH380TlBcvnxZ69evrxUrVowRvFmObw5CdxKK7SDx0aNH2rx5c23dunWMFpcOHTpoo0aNWAFfwrp8Nm3apD169NBq1arpV199ZVy3deXKFS1VqpTmzZuXgZJewW+//aYWi0Xz5MmjrVu3jjG6e+/evTVt2rTq6+urmTJl4tYrL/Hee+9p06ZNjccdO3bUhg0bapo0aYwBqlSjzobXrFmTbvqxsG5Lr127prt377Z5LjQ0VH/77TfNlSuXFi5cWCMjI3Xt2rVatGhRrVGjhjZt2lRTp05tDFiHv5fn4cOH1dfXVwsXLqwuLi7q6uqqY8eO1WnTptlcMvL48WPt0qWL5syZU729vdXDw4O7PrxA9Ja/3bt3a+bMmY0eQv369dOsWbPajJHx9OlT9fPzM7YH0Y8dgoOD/6WqX38nTpxQd3d3HTZsmA4ZMkR9fHy0fv36MbYJCxYs0AIFChijbiOmzZs3q5eXlx47dkx79OihqVOnNlpbu3btqhaLRd9//31j/uDgYK1Vq5ZWq1aNLtDRWI9Hrcvk+++/Vzc3N82bN69my5ZN06RJo0uXLlXVv3sIValSRb/88sskqxnmIXQnkegbpT///FOvXLlirJw//vijuri46KBBg/T8+fOqGhXGrdcd4+VWrlypzs7O2qVLFx0yZIhmzpxZAwMDjZ3G5cuXtVy5curu7k530gS6c+eO7tixQ1esWKHlypXT5s2bxwjWv/32m3G9N2KKPtr7u+++q61atTIeT58+XZ2dnbVhw4ZGz4s7d+5orVq1tGLFinTVi8OlS5eM8QMqVaqkAwYM0C1bthihZO/evVqkSBEtWbKkqqp+++232rx5c23YsCEDKUUTPXCnTp1a+/Xrp3fv3tXdu3drmzZt1MPDQ7dv365DhgxRi8Wic+bMUdWog+7Nmzfr8uXL6QoZT3PnztXOnTvr4MGDjWnHjx/XTp06abp06XTAgAE6fvx4rVatmhYsWNBm3efku63Dhw/r4MGDdcCAAca0H3/8UUuVKqUtWrQwLoOy4mRF3KzbgDJlyqibm5s6OzvH2Mc3aNBAvb29tXnz5vr+++9rhQoVtGDBgowx8v+s3z96L7+DBw9qunTp9JtvvtF79+7p2bNn9eOPP1Z7e3tdvny5qkbtxypXrqy1a9e2GX8IbwZCdxIbOHCg+vj4aNasWTVfvnz6v//9T1WjrvN0d3fX8uXLa/Xq1bVcuXJaoEABupI/5/kDj4iICL106ZIWLlzY6JYbGRmpzs7O2q9fP5t5L168qFWrVrW55gsxWZfx1atXjZNAVvPnz9fy5ctr8+bNuRY+nnbs2KGVKlUyRipt06aN9u3b12ae/v37a7Zs2bR48eJavXp1LVmypBYpUsQ4oCF4x/Tnn39qkSJFNE+ePFqiRAlt27atOjk5aZEiRbRVq1a6dOlSXbZsmebIkUNr165tvI5LH2K6dOmSZsyYUd955x2b6daTmXv37tXQ0FAjeD/fHRKx27p1qw4dOlR79+6tU6dO1Y4dOxonh6O7cOGCTpkyRfPly6eVK1fW5s2bs+6/wO3bt7VOnTqaPn16bdu2rc1zq1at0pIlS2qrVq30l19+MaZz0iJ2GzZs0FGjRunVq1d15MiRarFYNGvWrHrw4MEYx59jx47VNm3aaNOmTXXYsGHG8//141Rr4D59+rQGBgYaYwitWrVKS5QoEeOET69evTR9+vTGycq//vqLXphvKEL3vyz62b9ly5ZphgwZdMmSJfrTTz9pq1atNEOGDDpjxgxVjTo4nzhxogYFBenIkSPZoD3Huixv3ryp+/btM7ozXrlyRYsWLaqPHz/W06dPa+bMmY3b2qhGtcJaN3ocwMTP8uXLtUCBApoxY0Zt1aqVza1qrMG7VatWMa43RkwnT57USpUqaWBgoNF6GP2WgFYbN27UBQsW6Icffqjz589n/Y+HM2fOaMOGDbV+/fq6Z88evXjxoi5evFjLlSunb7/9tqZKlUr9/PzUYrFogwYNVJWD79hcuHBBS5YsqfXq1bMJKr/++qu6urrq3r17VTWqB9awYcPUYrHYDPKFmL755ht1d3fXihUrapYsWTRdunTavHlzDQoKUhcXl1jvRPLkyROb3yfrftzWr1+v1atX18yZM9vcekk1qsU7V65c2rFjR25Z+QLffvutMdDc8ePH9ciRI3rq1CktW7as5siRQ3fu3Knh4eExWrGjP/6vH1NF7yn01ltvqcVi0cOHD6tqVGNaypQpjTsOWJfV4cOH1dvb2xiIEm8uQncSWbRokU6dOtW4zYJVnz59bA5qnvdf36BZWTdsx44d03LlymnNmjW1UaNGGhYWpgcPHlQPDw/dtm2b5siRQzt27GizIWzevDnXG8ZD9GXs7e2tEydO1FmzZmmlSpW0SpUqNtcWL1iwQP38/DQoKIiWw3g4c+aM1qxZUxs0aKCenp6aN29e9ff314oVK6q/v79WqVJFK1SooGXKlNFPPvnEeB3r/8udPHlSa9SoodWqVbPZjt67d0/nz5+vgwYN0mLFijHWwEucPn1aa9asqdWrV9fjx49rcHCwuru7a58+fWzme/jwoY4aNYq7E7zAN998ow4ODvr9999rWFiYHj58WFu2bKk5c+bUuXPnav369bVw4cK6c+dOVY06ERQREWETuDk59Le4lsXmzZs1MDBQq1evbnPbNVXVtWvXxuiphb/9X3t3HhXVef4B/HtBFIQJCJFFZEABlQZxX9gUDdupNBgw2oaIaNMEFcWtWfDYNopiIsaUQ6PVKLbRGBtjIFhMUCQqmOhRQRFZRg9oXAJqUmslrPP8/siPCRMxbowj8fs5x3My79x732fuIXPnue/zvnfbtm3SvXt32b59e7tlzQEBAeLq6qo3P37p0qW83rfR+pupqKhILCwsZObMmeLj4yOffPKJiPxQXTlq1ChJSEjQJd4iP4xse3p6Sm5urjHCpoeISbcRaDQaUavVoiiKbpXytndfg4KCJCoqSkQ4L6Y9rRfcU6dOiY2NjSQlJcm5c+f0ztXzzz8viqLoLVAlIvL666/LiBEj5NKlSw815s6g9fy1/Vs8deqUvPHGG3qr5peVlUl0dLQEBQXpJd4ffvgh53Leg/LycgkPDxcbGxvx9vaWlStXyuzZs+Xll1+WhQsXyh//+EdJTEzk6NZ9qKyslLCwMAkLC2t3BJHn9O60lkeOHTtWevToIfPmzdO9x/nFdyc/P18URZE33nhDRH48V5s2bRJHR0e5ePGiHDp0SCZNmiSDBw+WwsJCY4b7yGs9f4WFhbJixQpZunSp7Nq1S/d+Tk6OTJgwQYKDgyU/P99IUXYuNTU1MmbMGElPT9drv3HjhhQUFOgWmfz1r38tarVaVq9eLaGhoeLm5sYbwf+v9fdTcXGxWFhYyOLFi0VExNnZWe+pAykpKeLv7y/x8fFSXV0tly9flqSkJFGr1VwD5zHApNsI6uvrJTMzUwYPHixDhgzRtbfO2YqPj79lLh3pu3btmgQEBMicOXP02lu/+Pbt2ychISHSr18/2bNnj+zYsUPmz58vKpVKiouLjRFyp3DhwgV57rnndOV5fn5+olKpdI+0alVaWipRUVESHBys98gQujcajUYiIiIkNDT0ZxfzYpJ471pHasPCwpjIPIDKykoZP368uLq66pU/MtG+O5WVlRIYGCiRkZF65y8tLU0cHR11K2gfOHBAJk+eLL169ZKTJ08aK9xHWuvf3McffyzW1tby7LPPiq+vr/j6+uotRpeTkyORkZEyYsQIOXDggLHC7TRqamrEy8tLNyIrIvLuu+/KpEmTRFEU6dmzp0RGRoqIyNSpU2XcuHESHh7ORdN+4tixY6JSqSQpKUnX5uvrq7vh1mrlypXi5+cniqKIj4+PODs7s/ryMcGk28Bu92VUV1cn2dnZ4urqKoGBgVJfXy/19fWi1WrF19dX4uLiHnKknUtpaam4u7vLF198cdtzXFBQIDExMaJSqeSpp56S4OBg3dwaat/Zs2fF19dXJkyYIBUVFVJeXi6BgYHSr18/ycnJ0dv29OnTEhwcLL/5zW+4yuYDqKiokLCwMAkPD9ebPyvCxOZBVVZWSkREhIwePfqWxwbR3WudDhEWFqYrgaa717ZUv7KyUvLy8sTc3Fw++ugjve327t0rixcv5ujhzygsLBQXFxfdzd6ioiKxtraWXr16SWJiom67zMxMmTJlim4RK7q9mpoacXZ2lhdffFHy8vIkOjpavL29JT4+XnJzc+Wjjz4SFxcX3YhtbW2t7trEG8I/uHbtmtjZ2cmCBQv02idOnCgxMTEiItLQ0KBrv379uhw4cEDy8/O5aNpjRBERARmEVquFiYkJAODDDz9ERUUFTExMMHHiRAwcOBD19fXIy8vD7NmzAQB9+/aFi4sLDh8+jJKSEpiZmUFEoCiKMT/GI+mDDz7AtGnT0NjYCEVR9M51S0sLTE1NUVdXh3PnzqF3795QFAUiApVKZeTIH30ajQYJCQkQEfz1r3+FmZkZ4uLiYGtri4SEBISGhuq2raiogKWlJXr37m3EiDs/jUaD+fPno6amBhs3boSPj4+xQ/rFKC8vx5IlS7B69Wqo1Wpjh9NpaTQaLFiwAFevXsWaNWswevRoY4fUqWg0GiQmJqKmpgYlJSXIyMhATEwMWlpaoCiK7vrVqvU69rhqe01v65133sGJEyeQkZGB6upqPP300/Dz84OLiws2bNiA+Ph4LFu2DABw8+ZNWFpaPuzQO6W8vDxER0fDzs4OKpUKb7/9Nnx8fPDkk0/iu+++w/jx4xEREaE7twD4+7SNxsZGnDhxAiNGjADw4/+/M2bMQE1NDf79738D+PHvevXq1QgMDMTIkSONGTY9bMbM+H/J2o5QvfLKK6JWqyUkJESeeeYZsba21pWZ1dfXS3Z2towcOVKcnJz0Sp95B/H2CgsLxdzcXPdsw/akpaVJSEgIVyu9D5WVlRIaGiqhoaFSUVEhZWVlEhAQIBEREbJnzx5jh/eLdPr0aVmwYAFL9Qyg7QgD3b+ysjKZNGkSRw/vU2upvre3t95zo1nRoq/1O7CqqkrWrFkjycnJuidmtLS0yOHDh6WhoUGCgoJ0VYHnz58XJycn6datmyxcuFBEeF7vVW1tbbuLzX377bcSGBjIqWT3oLVaZdWqVTJmzBgR+fHv8U9/+pMoisJpJI8hJt0G9u6770rv3r11q+hu2bJFFEWRbt266cp16+rqJCsrS371q19JSEiIbl+WmN3ehQsXxN7eXp555hmprq7Wtbe9yC5cuFBee+01XnjvU3uJd1BQkAQGBsq+ffuMHd4vGhNvelTxBsaDaS3VDw8PZ6l+O9o+acTFxUUCAgKkb9++0r17d1m7dq1uu9LSUvH29tbNha2urpZnn31WUlNT9X4T0IOpra2VCRMmyKhRo/ib9D5kZGSIg4ODfPvttyLyQ8Jtbm4uR48eNXJkZAy31u7QAzlx4gSysrJQUFAAADh79iyWLVuGESNGYNeuXZg5cyZSU1MxefJkTJo0CV988QUsLCwQGhqKt956C5cuXdKVmzzOpWV34uzsjLVr1+Lzzz/HkiVLcPr0aQCAoiioq6tDUlISduzYgenTp7P86T55enoiPT0dADBnzhyYmpoiPT0dlpaW8PDwMHJ0v2ztlVUSPQq6du1q7BA6NQ8PD6SlpcHU1BTz5s3DyZMnjR3SI6O19PbkyZPw9fVFTEwM8vLysHPnTvTp0wd/+9vfUFtbCwDo0qULrl27hry8PDQ1NWHDhg2oq6tDXFwcXF1djfxJOr+rV69i5cqVmD59Ompra3Hw4EGYmpqipaXF2KF1Ko6OjrqpjcnJyXjrrbdQUFCAYcOGGTs0MgLO6e5AW7duRWpqKtRqNZ566imsWLECxcXFeOKJJ9Dc3IyIiAjMnTsXCQkJyMzMRFRUFACgoKAAfn5+aGpqQnZ2NlauXIkdO3Zw/uEdaLVabNiwAQkJCXB3d4efnx/Mzc1x8eJFfPXVV/jss88wZMgQY4fZ6Wk0GsybNw9Xr17F1q1b4erqCjMzM2OHRUTUaZWVleG9997DqlWreJOtja+//hpDhw7FuHHj8K9//UvX/vTTT6OiogJHjx6FnZ0dzMzMMH/+fGRlZUGr1eJ///sf9uzZw2t+BykuLsaSJUvg7u6O1NRUdOnSBc3NzejSpYuxQ+tUzp8/j9DQUAwYMAC7d+/GoUOHmHA/xph0d5B//vOfiI+Px6ZNmxAeHg4bGxu99zMzM5Gamors7Gz06NED+/fvx7Zt2+Dj44OXXnpJ90XW1NSExsZGLv5xD44cOYJVq1bh7NmzsLS0hL+/P37/+9/D09PT2KH9YpSXl2Px4sVYs2YNbwYREXWg2y0a9jiqrq7G5MmT4eTkhFdeeQX+/v5ISUnB4sWL4ePjAwcHB7S0tCA8PByenp5QFAUNDQ0YPnw4+vTpY+zwf1H+85//wNraGoqiPPYL+92vr7/+WjdQceTIEQwaNMjYIZERMenuAKWlpZgyZQoSExPxhz/8QdcubVZ23LJlC2JjY1FSUgJHR0dMnz4djo6OWL9+PQDwDuID4o8Ww2tsbGRpKRERGZRGo8HcuXPRtWtX2NvbIysrC+vWrUNAQAAqKipQVlaG1NRU1NfXw8PDA3l5eZxGZkDCVcrvW0tLC1JSUjBp0iQMGDDA2OGQkTHp7gC5ubmIj4/H7t270a9fv1u+nEQEN2/eRFxcHHbu3Al3d3eYm5vj+PHjfCxYB2l7Dnk+iYiIOq/KykokJCSgoKAAS5cuxaJFi/Tev3HjBk6dOgV7e3u4u7sbKUqiO2OVALVi0t0BUlJS8Pbbb+PKlSsA2k/6ysrKcObMGahUKly5cgVRUVEwNTXlCDcRERHRT5w9exazZs2CqakpkpKSEBAQAICVgUTUObEetwN4eHjg5s2byM3NBYB2R7rff/99ZGdnIygoCM8995xuFUheOIiIiIj0ubu7Iz09HSKC5ORkFBYWAgB/NxFRp8SkuwMMGzYMXbt2xfr163H+/Hlde2sRwY0bN1BZWQlvb2+9/VhuQkRERNQ+T09PpKWlwczMDIsWLcJXX31l7JCIiO4Lk+4O0LdvX6xbtw67du1CUlISiouLAfww4n3p0iX89re/xTfffINZs2YZN1AiIiKiTsTT0xOrVq1C79690atXL2OHQ0R0Xzinu4O0tLQgIyMDs2bNgoODA7y9vaHVanH9+nVotVoUFhbCzMyMCyoQERER3SM+QYOIOjMm3R2suLgYmzZtQmVlJXr37o0hQ4YgPj6ei6YRERERERE9hph0PyQc4SYiIiIiInr8MOk2AD4nmoiIiIiIiAAupGYQTLiJiIiIiIgIYNJNREREREREZDBMuomIiIiIiIgMhEk3ERERERERkYEw6SYiIiIiIiIyECbdRERERERERAbCpJuIiIiIiIjIQJh0ExERERERERkIk24iIiIyqKCgIMybN8/YYRARERkFk24iIiIDiouLg6IoUBQFZmZmcHBwQEhICDZt2gStVmu0uKqrq3VxKYoCa2trjB49GtnZ2R3e186dO7Fs2bIOPy4REVFnwKSbiIjIwMLDw3H58mVUV1dj9+7dGDduHBITExEREYHm5ubb7tfU1GTw2Pbu3YvLly/j8OHDGDlyJKKjo3Hq1KkO7cPW1hYqlapDj0lERNRZMOkmIiIysG7dusHR0RHOzs4YOnQokpKSkJWVhd27d2Pz5s267RRFwbp16xAZGQlLS0skJydj8+bNsLGx0TteZmYmFEXRa0tOToa9vT1UKhVefPFFvPbaaxg8ePAdY7Ozs4OjoyMGDBiA5cuXo6mpCfn5+br3L168iClTpqBHjx6ws7NDZGQkqqurde83Nzdj7ty5sLGxgZ2dHV599VVMmzYNEydO1G3z0/JyNzc3JCcnIzY2FlZWVnB1dUVWVhauXLmCyMhIWFlZYeDAgTh69KherIcOHcKYMWNgYWEBFxcXzJ07Fzdv3tQ77ooVKzBjxgyoVCqo1WqsX7/+jueAiIjIkJh0ExERGcH48eMxaNAg7Ny5U6/9z3/+MyIjI1FSUoIZM2bc1bG2bt2K5cuX480338SxY8egVquxdu3ae4qnqakJGzZsAACYmZkBAOrq6jBu3DhYWVnhwIEDKCgogJWVFcLDw9HY2AgAePPNN7F161ZkZGSgsLAQ//3vf5GZmXnH/tasWQN/f38UFRVhwoQJmDp1KmJjY/HCCy/g+PHj8PDwQGxsLEQEAFBSUoKwsDBERUXh5MmT2L59OwoKCpCQkKB33NWrV2P48OEoKirCrFmzMHPmTJSXl9/TuSAiIupQQkRERAYzbdo0iYyMbPe9KVOmiJeXl+41AJk3b57eNhkZGWJtba3X9sknn0jbS/ioUaNk9uzZetv4+/vLoEGDbhtXVVWVABALCwuxtLQUExMTASBubm5y7do1ERHZuHGj9O/fX7RarW6/hoYGsbCwkM8//1xERBwcHGTVqlW695ubm0WtVut95rFjx0piYqLutaurq7zwwgu615cvXxYAsmTJEl3bl19+KQDk8uXLIiIydepUeemll/Q+w8GDB8XExES+//77do+r1WrF3t5e1q5de9vzQEREZGgc6SYiIjISEbmlTHz48OH3fJyKigqMHDlSr+2nr29n+/btKCoqwqeffgoPDw+89957sLW1BQAcO3YMZ86cgUqlgpWVFaysrGBra4v6+nqcPXsW169fR01NjV5fpqamGDZs2B379fHx0f23g4MDAGDgwIG3tNXW1upi2bx5sy4OKysrhIWFQavVoqqqqt3jKooCR0dH3TGIiIiMoYuxAyAiInpclZWVoU+fPnptlpaWeq9NTEx0Jdat2ltg7afJ+0/3uR0XFxd4enrC09MTVlZWiI6OxunTp2Fvbw+tVothw4Zh69att+zXs2fPB+q7tYS97f7ttbWu8K7VavHyyy9j7ty5txxLrVa3e9zW4xhzlXgiIiKOdBMRERnBvn37UFJSgujo6J/drmfPnrhx44begmHFxcV62/Tv3x9HjhzRa/vpImR3Y+zYsfD29sby5csBAEOHDoVGo4G9vT08PDz0/llbW8Pa2hoODg56fbe0tKCoqOie+76ToUOHorS09JY4PDw80LVr1w7vj4iIqKMw6SYiIjKwhoYGfPPNN7h48SKOHz+OFStWIDIyEhEREYiNjf3ZfUeNGoXu3bsjKSkJZ86cwQcffKC34jkAzJkzBxs3bsQ//vEPaDQaJCcn4+TJk7eMQN+NhQsX4u9//zsuXryImJgYPPnkk4iMjMTBgwdRVVWF/fv3IzExERcuXND1nZKSgqysLFRUVCAxMRHffffdffX9c1599VV8+eWXmD17NoqLi6HRaPDpp59izpw5HdoPERFRR2PSTUREZGCfffYZnJyc4ObmhvDwcOTn5yMtLQ1ZWVkwNTX92X1tbW2xZcsW5OTkYODAgdi2bRv+8pe/6G0TExOD119/HYsWLcLQoUNRVVWFuLg4mJub33OsERERcHNzw/Lly9G9e3ccOHAAarUaUVFR8PLywowZM/D999/jiSeeAPBDMvy73/0OsbGx8PX11c21vp++f46Pjw/2798PjUaDwMBADBkyBEuWLIGTk1OH9kNERNTRFLnbSV9ERETUaYSEhMDR0RHvv//+Q+1Xq9XCy8sLkydPxrJlyx5q30RERI8iLqRGRETUydXV1WHdunUICwuDqakptm3bhr1792LPnj0G7/vcuXPIzc3F2LFj0dDQgPT0dFRVVeH55583eN9ERESdAZNuIiKiTk5RFOTk5CA5ORkNDQ3o378/Pv74YwQHBxu8bxMTE2zevBmLFi2CiMDb2xt79+6Fl5eXwfsmIiLqDFheTkRERERERGQgXEiNiIiIiIiIyECYdBMREREREREZCJNuIiIiIiIiIgNh0k1ERERERERkIEy6iYiIiIiIiAyESTcRERERERGRgTDpJiIiIiIiIjIQJt1EREREREREBsKkm4iIiIiIiMhA/g+5j5n6UiobUwAAAABJRU5ErkJggg==",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Generate a bar plot showing the total number of rows (Mouse ID/Timepoints) for each drug regimen using pyplot.\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "# Group the data by 'Drug Regimen' and count the number of rows in each group\n",
    "rows_per_regimen = cleaned_data.groupby('Drug Regimen').size()\n",
    "\n",
    "# Get the drug regimens and corresponding row counts\n",
    "drug_regimens = rows_per_regimen.index\n",
    "row_counts = rows_per_regimen.values\n",
    "\n",
    "# Create a bar plot\n",
    "plt.figure(figsize=(10, 6))\n",
    "plt.bar(drug_regimens, row_counts, color='skyblue', alpha=0.75)\n",
    "\n",
    "# Add labels and title\n",
    "plt.title('Total Number of Rows (Mouse ID/Timepoints) for Each Drug Regimen')\n",
    "plt.xlabel('Drug Regimen')\n",
    "plt.ylabel('Number of Rows')\n",
    "plt.xticks(rotation=45, ha='right')  # Rotate x-axis labels for better readability\n",
    "plt.tight_layout()\n",
    "\n",
    "# Show the plot\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 800x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Generate a pie plot showing the distribution of female versus male mice using Pandas\n",
    "# Count the number of mice for each gender\n",
    "gender_distribution = cleaned_data['Sex'].value_counts()\n",
    "\n",
    "# Create a pie plot\n",
    "gender_distribution.plot(kind='pie', figsize=(8, 8), autopct='%1.1f%%', colors=['skyblue', 'lightcoral'], startangle=140)\n",
    "\n",
    "# Add title\n",
    "plt.title('Distribution of Female vs Male Mice')\n",
    "\n",
    "# Equal aspect ratio ensures that pie is drawn as a circle\n",
    "plt.axis('equal')\n",
    "\n",
    "# Show the plot\n",
    "plt.show()\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 800x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Generate a pie plot showing the distribution of female versus male mice using pyplot\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "# Count the number of mice for each gender\n",
    "gender_distribution = cleaned_data['Sex'].value_counts()\n",
    "\n",
    "# Create a pie plot\n",
    "plt.figure(figsize=(8, 8))\n",
    "plt.pie(gender_distribution, labels=gender_distribution.index, autopct='%1.1f%%', colors=['skyblue', 'lightcoral'], startangle=140)\n",
    "\n",
    "# Add title\n",
    "plt.title('Distribution of Female vs Male Mice')\n",
    "\n",
    "# Equal aspect ratio ensures that pie is drawn as a circle\n",
    "plt.axis('equal')\n",
    "\n",
    "# Show the plot\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Quartiles, Outliers and Boxplots"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "    Mouse ID  Timepoint Drug Regimen     Sex  Age_months  Weight (g)  \\\n",
      "0       a203         45    Infubinol  Female          20          23   \n",
      "1       a251         45    Infubinol  Female          21          25   \n",
      "3       a275         45     Ceftamin  Female          20          28   \n",
      "6       a411         45     Ramicane    Male           3          22   \n",
      "7       a444         45     Ramicane  Female          10          25   \n",
      "..       ...        ...          ...     ...         ...         ...   \n",
      "238     y769         45     Ceftamin  Female           6          27   \n",
      "239     y793         45    Capomulin    Male          17          17   \n",
      "240     y865         45     Ceftamin    Male          23          26   \n",
      "244     z578         45     Ramicane    Male          11          16   \n",
      "245     z581         45    Infubinol  Female          24          25   \n",
      "\n",
      "     Tumor Volume (mm3)  Metastatic Sites  \n",
      "0             67.973419                 2  \n",
      "1             65.525743                 1  \n",
      "3             62.999356                 3  \n",
      "6             38.407618                 1  \n",
      "7             43.047543                 0  \n",
      "..                  ...               ...  \n",
      "238           68.594745                 4  \n",
      "239           31.896238                 2  \n",
      "240           64.729837                 3  \n",
      "244           30.638696                 0  \n",
      "245           62.754451                 3  \n",
      "\n",
      "[100 rows x 8 columns]\n"
     ]
    }
   ],
   "source": [
    "# Calculate the final tumor volume of each mouse across four of the treatment regimens:  \n",
    "# Capomulin, Ramicane, Infubinol, and Ceftamin\n",
    "\n",
    "# Step 1: Get the last (greatest) timepoint for each mouse\n",
    "last_timepoints = cleaned_data.groupby('Mouse ID')['Timepoint'].max()\n",
    "\n",
    "# Step 2: Merge this information with the original DataFrame to get the tumor volume at the last timepoint\n",
    "final_tumor_volume = pd.merge(last_timepoints, cleaned_data, on=['Mouse ID', 'Timepoint'])\n",
    "\n",
    "# Filter the DataFrame to include only the specified treatment regimens: Capomulin, Ramicane, Infubinol, and Ceftamin\n",
    "specified_regimens = ['Capomulin', 'Ramicane', 'Infubinol', 'Ceftamin']\n",
    "final_tumor_volume_specified_regimens = final_tumor_volume[final_tumor_volume['Drug Regimen'].isin(specified_regimens)]\n",
    "\n",
    "# Display the DataFrame with the final tumor volume for each mouse across the specified treatment regimens\n",
    "print(final_tumor_volume_specified_regimens)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "----------------------------------------\n",
      "Capomulin IQR data:\n",
      "Lower Quartile (Q1): 32.37735684\n",
      "Upper Quartile (Q3): 40.1592203\n",
      "Interquartile Range (IQR): 7.781863460000004\n",
      "Lower Bound: 20.70456164999999\n",
      "Upper Bound: 51.83201549\n",
      "No potential outliers for Capomulin.\n",
      "----------------------------------------\n",
      "----------------------------------------\n",
      "Ramicane IQR data:\n",
      "Lower Quartile (Q1): 31.56046955\n",
      "Upper Quartile (Q3): 40.65900627\n",
      "Interquartile Range (IQR): 9.098536719999998\n",
      "Lower Bound: 17.912664470000003\n",
      "Upper Bound: 54.30681135\n",
      "No potential outliers for Ramicane.\n",
      "----------------------------------------\n",
      "----------------------------------------\n",
      "Infubinol IQR data:\n",
      "Lower Quartile (Q1): 54.04860769\n",
      "Upper Quartile (Q3): 65.52574285\n",
      "Interquartile Range (IQR): 11.477135160000003\n",
      "Lower Bound: 36.83290494999999\n",
      "Upper Bound: 82.74144559000001\n",
      "Potential outliers for Infubinol: [36.3213458]\n",
      "----------------------------------------\n",
      "----------------------------------------\n",
      "Ceftamin IQR data:\n",
      "Lower Quartile (Q1): 48.72207785\n",
      "Upper Quartile (Q3): 64.29983003\n",
      "Interquartile Range (IQR): 15.577752179999997\n",
      "Lower Bound: 25.355449580000002\n",
      "Upper Bound: 87.66645829999999\n",
      "No potential outliers for Ceftamin.\n",
      "----------------------------------------\n"
     ]
    }
   ],
   "source": [
    "# Put treatments into a list for for loop (and later for plot labels)\n",
    "treatments = ['Capomulin', 'Ramicane', 'Infubinol', 'Ceftamin']\n",
    "\n",
    "# Create empty list to fill with tumor vol data (for plotting)\n",
    "tumor_vol_data = []\n",
    "\n",
    "# Loop through each treatment regimen\n",
    "for treatment in treatments:\n",
    "    # Locate the rows which contain mice on each drug and get the tumor volumes\n",
    "    tumor_vol = final_tumor_volume_specified_regimens.loc[final_tumor_volume_specified_regimens['Drug Regimen'] == treatment, 'Tumor Volume (mm3)']\n",
    "    \n",
    "    # Add subset\n",
    "    tumor_vol_data.append(tumor_vol)\n",
    "    \n",
    "    # Calculate the quartiles and IQR\n",
    "    quartiles = tumor_vol.quantile([0.25, 0.5, 0.75])\n",
    "    lowerq = quartiles[0.25]\n",
    "    upperq = quartiles[0.75]\n",
    "    iqr = upperq - lowerq\n",
    "    \n",
    "    # Determine outliers using upper and lower bounds\n",
    "    lower_bound = lowerq - (1.5 * iqr)\n",
    "    upper_bound = upperq + (1.5 * iqr)\n",
    "    \n",
    "    # Print results\n",
    "    print(f\"----------------------------------------\")\n",
    "    print(f\"{treatment} IQR data:\")\n",
    "    print(f\"Lower Quartile (Q1): {lowerq}\")\n",
    "    print(f\"Upper Quartile (Q3): {upperq}\")\n",
    "    print(f\"Interquartile Range (IQR): {iqr}\")\n",
    "    print(f\"Lower Bound: {lower_bound}\")\n",
    "    print(f\"Upper Bound: {upper_bound}\")\n",
    "    \n",
    "    # Check for potential outliers\n",
    "    potential_outliers = tumor_vol.loc[(tumor_vol < lower_bound) | (tumor_vol > upper_bound)]\n",
    "    if not potential_outliers.empty:\n",
    "        print(f\"Potential outliers for {treatment}: {potential_outliers.values}\")\n",
    "    else:\n",
    "        print(f\"No potential outliers for {treatment}.\")\n",
    "    print(f\"----------------------------------------\")\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Generate a box plot that shows the distrubution of the tumor volume for each treatment group.\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "# Create boxplot\n",
    "plt.figure(figsize=(10,6))\n",
    "plt.boxplot(tumor_vol_data, labels=treatments, flierprops=dict(marker='o', markerfacecolor='r', markersize=8, linestyle='none'))\n",
    "\n",
    "# Add labels and title\n",
    "plt.title('Distribution of Tumor Volume for Each Treatment Group')\n",
    "plt.xlabel('Treatment Group')\n",
    "plt.ylabel('Tumor Volume (mm3)')\n",
    "\n",
    "# Show plot\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Line and Scatter Plots"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Generate a line plot of tumor volume vs. time point for a single mouse treated with Capomulin\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "# Select a single mouse treated with Capomulin\n",
    "mouse_id_capomulin = 's185'\n",
    "mouse_data_capomulin = cleaned_data[(cleaned_data['Drug Regimen'] == 'Capomulin') & (cleaned_data['Mouse ID'] == mouse_id_capomulin)]\n",
    "\n",
    "# Plot tumor volume vs. time point\n",
    "plt.figure(figsize=(10, 6))\n",
    "plt.plot(mouse_data_capomulin['Timepoint'], mouse_data_capomulin['Tumor Volume (mm3)'], marker='o', color='blue', linestyle='-')\n",
    "\n",
    "# Add labels and title\n",
    "plt.title(f'Tumor Volume vs. Time Point for Mouse {mouse_id_capomulin} (Capomulin)')\n",
    "plt.xlabel('Timepoint')\n",
    "plt.ylabel('Tumor Volume (mm3)')\n",
    "\n",
    "# Show plot\n",
    "plt.grid(True)\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Generate a scatter plot of mouse weight vs. the average observed tumor volume for the entire Capomulin regimen\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "# Filter data for Capomulin regimen\n",
    "capomulin_data = cleaned_data[cleaned_data['Drug Regimen'] == 'Capomulin']\n",
    "\n",
    "# Calculate the average tumor volume for each mouse\n",
    "average_tumor_volume = capomulin_data.groupby('Mouse ID')['Tumor Volume (mm3)'].mean()\n",
    "\n",
    "# Get corresponding mouse weights\n",
    "mouse_weights = capomulin_data.groupby('Mouse ID')['Weight (g)'].mean()\n",
    "\n",
    "# Create scatter plot\n",
    "plt.figure(figsize=(10, 6))\n",
    "plt.scatter(mouse_weights, average_tumor_volume, marker='o', color='blue')\n",
    "\n",
    "# Add labels and title\n",
    "plt.title('Mouse Weight vs. Average Tumor Volume (Capomulin Regimen)')\n",
    "plt.xlabel('Weight (g)')\n",
    "plt.ylabel('Average Tumor Volume (mm3)')\n",
    "\n",
    "# Show plot\n",
    "plt.grid(True)\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Correlation and Regression"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Correlation coefficient: 0.841936342469472\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Calculate the correlation coefficient and a linear regression model \n",
    "# for mouse weight and average observed tumor volume for the entire Capomulin regimen\n",
    "from scipy.stats import pearsonr, linregress\n",
    "\n",
    "# Calculate correlation coefficient\n",
    "correlation_coefficient, _ = pearsonr(mouse_weights, average_tumor_volume)\n",
    "print(\"Correlation coefficient:\", correlation_coefficient)\n",
    "\n",
    "# Perform linear regression\n",
    "slope, intercept, rvalue, pvalue, stderr = linregress(mouse_weights, average_tumor_volume)\n",
    "\n",
    "# Create linear regression line\n",
    "regress_values = mouse_weights * slope + intercept\n",
    "\n",
    "# Plot scatter plot and linear regression line\n",
    "plt.figure(figsize=(10, 6))\n",
    "plt.scatter(mouse_weights, average_tumor_volume, marker='o', color='blue', label='Data')\n",
    "plt.plot(mouse_weights, regress_values, color='red', linestyle='-', label='Linear Regression')\n",
    "\n",
    "# Add labels and title\n",
    "plt.title('Mouse Weight vs. Average Tumor Volume (Capomulin Regimen)')\n",
    "plt.xlabel('Weight (g)')\n",
    "plt.ylabel('Average Tumor Volume (mm3)')\n",
    "plt.legend()\n",
    "\n",
    "# Show plot\n",
    "plt.grid(True)\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "anaconda-cloud": {},
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.13"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
